US20060106456A9 - Devices, systems, and methods for reshaping a heart valve annulus - Google Patents
Devices, systems, and methods for reshaping a heart valve annulus Download PDFInfo
- Publication number
- US20060106456A9 US20060106456A9 US10/677,104 US67710403A US2006106456A9 US 20060106456 A9 US20060106456 A9 US 20060106456A9 US 67710403 A US67710403 A US 67710403A US 2006106456 A9 US2006106456 A9 US 2006106456A9
- Authority
- US
- United States
- Prior art keywords
- implant
- annulus
- heart valve
- valve annulus
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2418—Scaffolds therefor, e.g. support stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/50—Supports for surgical instruments, e.g. articulated arms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2445—Annuloplasty rings in direct contact with the valve annulus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2454—Means for preventing inversion of the valve leaflets, e.g. chordae tendineae prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2466—Delivery devices therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22004—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
- A61B17/22012—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
- A61B2017/00247—Making holes in the wall of the heart, e.g. laser Myocardial revascularization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22097—Valve removal in veins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B2017/320052—Guides for cutting instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
- A61B2018/00392—Transmyocardial revascularisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0008—Fixation appliances for connecting prostheses to the body
- A61F2220/0016—Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
- Y10S623/902—Method of implanting
- Y10S623/904—Heart
Definitions
- the invention is directed to devices, systems, and methods for improving the function of a heart valve, e.g., in the treatment of mitral valve regurgitation.
- the heart (see FIG. 1 ) is slightly larger than a clenched fist. It is a double (left and right side), self-adjusting muscular pump, the parts of which work in unison to propel blood to all parts of the body.
- the right side of the heart receives poorly oxygenated (“venous”) blood from the body from the superior vena cava and inferior vena cava and pumps it through the pulmonary artery to the lungs for oxygenation.
- the left side receives well-oxygenation (“arterial”) blood from the lungs through the pulmonary veins and pumps it into the aorta for distribution to the body.
- the heart has four chambers, two on each side —the right and left atria, and the right and left ventricles.
- the atria are the blood-receiving chambers, which pump blood into the ventricles.
- the ventricles are the blood-discharging chambers.
- the synchronous pumping actions of the left and right sides of the heart constitute the cardiac cycle.
- the cycle begins with a period of ventricular relaxation, called ventricular diastole.
- the cycle ends with a period of ventricular contraction, called ventricular systole.
- the heart has four valves (see FIGS. 2 and 3 ) that ensure that blood does not flow in the wrong direction during the cardiac cycle; that is, to ensure that the blood does not back flow from the ventricles into the corresponding atria, or back flow from the arteries into the corresponding ventricles.
- the valve between the left atrium and the left ventricle is the mitral valve.
- the valve between the right atrium and the right ventricle is the tricuspid valve.
- the pulmonary valve is at the opening of the pulmonary artery.
- the aortic valve is at the opening of the aorta.
- ventricular diastole i.e., ventricular filling
- the aortic and pulmonary valves are closed to prevent back flow from the arteries into the ventricles.
- the tricuspid and mitral valves open (as FIG. 2 shows), to allow flow from the atria into the corresponding ventricles.
- the tricuspid and mitral valves close (see FIG. 3 )—to prevent back flow from the ventricles into the corresponding atria—and the aortic and pulmonary valves open—to permit discharge of blood into the arteries from the corresponding ventricles.
- the opening and closing of heart valves occur primarily as a result of pressure differences.
- the opening and closing of the mitral valve occurs as a result of the pressure differences between the left atrium and the left ventricle.
- the mitral valve opens, allowing blood to enter the ventricle.
- the ventricle contracts during ventricular systole, the intraventricular pressure rises above the pressure in the atrium and pushes the mitral valve shut.
- the mitral and tricuspid valves are defined by fibrous rings of collagen, each called an annulus, which forms a part of the fibrous skeleton of the heart.
- the annulus provides attachments for the two cusps or leaflets of the mitral valve (called the anterior and posterior cusps) and the three cusps or leaflets of the tricuspid valve.
- the leaflets receive chordae tendineae from more than one papillary muscle. In a healthy heart, these muscles and their tendinous cords support the mitral and tricuspid valves, allowing the leaflets to resist the high pressure developed during contractions (pumping) of the left and right ventricles.
- chordae tendineae become taut, preventing the leaflets from being forced into the left or right atria and everted. Prolapse is a term used to describe this condition. This is normally prevented by contraction of the papillary muscles within the ventricle, which are connected to the mitral valve leaflets by the chordae tendineae. Contraction of the papillary muscles is simultaneous with the contraction of the ventricle and serves to keep healthy valve leaflets tightly shut at peak contraction pressures exerted by the ventricle.
- the leaflets coapt at the opposing medial and lateral sides of the annulus are called the leaflet commissures, and are designated in FIG. 4 and in other Figures as CP(denoting the posterior commissure) and CA (denoting the anterior commissure).
- Valve malfunction can result from the chordae tendineae (the chords) becoming stretched, and in some cases tearing. When a chord tears, the result is a leaflet that flails. Also, a normally structured valve may not function properly because of an enlargement of or shape change in the valve annulus. This condition is referred to as a dilation of the annulus and generally results from heart muscle failure. In addition, the valve may be defective at birth or because of an acquired disease.
- mitral valve dysfunction can occur when the leaflets do not coapt at peak contraction pressures.
- FIG. 5 shows, the coaptation line of the two leaflets is not tight at ventricular systole. As a result, an undesired back flow of blood from the left ventricle into the left atrium can occur. This condition is called regurgitation.
- the leaflets do not form a tight coaptation junction because the dimensions of the mitral valve annulus, measured from commissure to commissure—CP to CA—and/or septal to lateral—S to L—change. The changed dimensions no longer create the anatomic shape and tension in which the leaflets coapt at peak contraction pressures.
- the unhealthy annulus is dilated and, in particular, the septal-to-lateral distance is increased.
- the shape and tension defined by the annulus becomes less oval (see FIG. 4 ) and more round (see FIG. 6 ). This condition is called dilation.
- the shape and tension conducive for coaptation at peak contraction pressures progressively deteriorate. Instead, at peak contraction pressures, the leaflets do not coapt completely, and a gap forms between the leaflets. During ventricular systole, regurgitation can occur through this gap.
- the ratio between the commissure distance and septal-to-lateral distance bears a relationship to the effectiveness of leaflet coaptation. If the septal-to-lateral distance increases, the ratio changes, and when the ratio reaches a certain value, regurgitation or the likelihood of regurgitation is indicated.
- Mitral valve regurgitation can be an acute or chronic condition. It is sometimes called mitral insufficiency.
- diuretics and/or vasodilators can be used to help reduce the amount of blood flowing back into the left atrium.
- An intra-aortic balloon counterpulsation device is used if the condition is not stabilized with medications.
- surgery to repair or replace the mitral valve is often necessary.
- annulus can be reshaped with annular or peri-annular rings or similar ring-like devices.
- the repair devices are typically secured to the annulus and surrounding tissue with suture-based fixation.
- the repair devices extend over the top and over much or all of the circumference of the annulus and leaflet surfaces.
- a physician may decide to replace an unhealthy mitral valve rather than repair it.
- Invasive, open heart surgical approaches are used to replace the natural valve with either a mechanical valve or biological tissue (bioprosthetic) taken from pigs, cows, or horses.
- the invention provides devices, systems and methods that reshape a valve annulus.
- the devices, systems, and methods include an implant that is sized and configured to rest near or within the leaflet commissures of a heart valve annulus. In use, the implant contacts and outwardly displaces tissue to reshape the heart valve annulus.
- the implant in use, may restore to the heart valve annulus and leaflets a more effective anatomic shape and tension. The more normal anatomic shape and tension are conducive to coaptation of the leaflets, which, in turn, reduces retrograde flow or regurgitation.
- the implant restores function to the valve, without surgically cinching, resecting, and/or fixing in position large portions of a dilated annulus, or without the surgical fixation of ring-like structures.
- FIG. 1 is a perspective, anterior anatomic view of the interior of a healthy heart.
- FIG. 2 is a superior anatomic view of the interior of a healthy heart, with the atria removed, showing the condition of the heart valves during ventricular diastole.
- FIG. 3 is a superior anatomic view of the interior of a healthy heart, with the atria removed, showing the condition of the heart valves during ventricular systole.
- FIG. 4 is a superior anatomic view of a healthy mitral valve during ventricular systole, showing the leaflets properly coapting.
- FIG. 5 is a superior anatomic view of the interior of a heart, with the atria removed, showing the condition of the heart valves during ventricular systole, and further showing a dysfunctional mitral valve in which the leaflets are not properly coapting, causing regurgitation.
- FIG. 6 is a superior anatomic view of a disfunctional mitral valve during ventricular systole, showing that the leaflets are not properly coapting, causing regurgitation.
- FIG. 7A is a side perspective view of an elastic implant sized and configured to rest within or near the leaflet commissures of a dysfunctional heart valve annulus to reshape the annulus and improve leaflet coaptation.
- FIGS. 7B to 7 E are side perspective views of illustrative alternative configurations of the elastic implant shown in FIG. 7A .
- FIG. 8 is a side anterior anatomic view of a mitral valve annulus in which the elastic implant shown in FIG. 7A has been implanted.
- FIG. 9 is a superior anatomic view of a mitral valve in which the elastic implant shown in FIG. 7A has been implanted, showing the implant stretching the commissures to restore leaflet coaptation.
- FIG. 10 is a side perspective view of another embodiment of an elastic implant sized and configured to rest within or near the leaflet commissures of a dysfunctional heart valve annulus to reshape the annulus and restore leaflet coaptation, the implant defining a closed annular structure.
- FIG. 11 is a perspective anatomic view, taken from an anterior and slightly superior viewpoint, of a mitral valve in which the elastic implant of the type shown in FIG. 10 has been implanted, showing the implant stretching the commissures to restore leaflet coaptation, and also showing the implant as hugging the annulus.
- FIG. 12 is a perspective anatomic view, taken from an anterior and slightly superior viewpoint, of a mitral valve in which the elastic implant of the type shown in FIG. 10 has been implanted, showing the implant stretching the commissures to restore leaflet coaptation, and also showing the implant as rising above the annulus.
- FIGS. 13A to 13 C are side perspective views of illustrative embodiments of an elastic implant sized and configured to rest within or near the leaflet commissures of a dysfunctional heart valve annulus to reshape the annulus and restore leaflet coaptation, the implant defining an open annular structure.
- FIGS. 13D and 13E are side perspective views of illustrative embodiments of an elastic implant sized and configured to rest within or near the leaflet commissures of a dysfunctional heart valve annulus to reshape the annulus and restore leaflet coaptation, the implant defining an open annular structure that can be optionally closed.
- FIG. 14 is a side perspective view of an elastic implant of the open annular type shown in FIGS. 13D and 13E , showing how the mechanical characteristics of the implant can be varied along its structure, surface area, and interface with the tissue.
- FIG. 15A is a side perspective view of another embodiment of an elastic implant sized and configured to rest within or near the leaflet commissures of a dysfunctional heart valve annulus to reshape the annulus and restore leaflet coaptation, the implant defining a closed annular structure that can be symmetrically folded upon itself.
- FIG. 15B is a side view of the implant shown in FIG. 15A when folded upon itself.
- FIG. 15C is a perspective anatomic view, taken from an anterior and slightly superior viewpoint, of a mitral valve in which the elastic implant of the type shown in FIG. 15A has been implanted, showing the implant stretching the commissures to restore leaflet coaptation, and also showing the implant as hugging the annulus.
- FIG. 15D is a side perspective view of another embodiment of an elastic implant sized and configured to rest within or near the leaflet commissures of a dysfunctional heart valve annulus to reshape the annulus and restore leaflet coaptation, the implant defining a closed annular structure that can be asymmetrically folded upon itself.
- FIG. 15E is a perspective anatomic view, taken from an anterior and slightly superior viewpoint, of a mitral valve in which the elastic implant of the type shown in FIG. 15D has been implanted, showing the implant stretching the commissures to restore leaflet coaptation, and also showing the implant as hugging the annulus.
- FIG. 16A is a side perspective view of an elastic implant of the type shown in FIG. 10 , showing an illustrative embodiment of tab structures that serve to anchor and stabilize the implant in an annulus.
- FIG. 16B is a side anterior anatomic view of a mitral valve annulus in which the elastic implant shown in FIG. 16A has been implanted.
- FIG. 17A is a side perspective view of an elastic implant of the type shown in FIG. 10 , showing an illustrative embodiment of multiple contact structures that serve to anchor and stabilize the implant in an annulus.
- FIG. 17B is a side anterior anatomic view of a mitral valve annulus in which the elastic implant shown in FIG. 17A has been implanted.
- FIGS. 18A and 18B are side perspective views of an elastic implant of the type shown in FIG. 10 , showing illustrative embodiments of frictional struts that serve to anchor and stabilize the implant in an annulus.
- FIG. 19 is a side perspective view of an elastic implant of the type shown in FIG. 10 , showing an illustrative embodiment of tissue in-growth surfaces that serve to anchor and stabilize the implant in an annulus.
- FIGS. 20A and 20B are, respectively, a side perspective view and an anatomic view (when implanted) of an elastic implant sized and configured to rest within or near the leaflet commissures of a dysfunctional heart valve annulus to reshape the annulus and restore leaflet coaptation and also showing the implant as rising significantly above the annulus.
- FIGS. 20B and 20C are, respectively, a side perspective view and an anatomic view (when implanted) of an elastic implant sized and configured to rest within or near the leaflet commissures of a dysfunctional heart valve annulus to reshape the annulus and restore leaflet coaptation, and showing the presence of one rail that hugs the annulus and another rail that rises above the implant to serve as a mechanism that anchors and stabilizes the implant in the annulus.
- FIG. 21 is a side elevation view of a tool for implanting an elastic implant in a valve annulus in a open heart surgical procedure to reshape the annulus and restore leaflet coaptation.
- FIGS. 22A to 22 F diagrammatically show a method of using the tool shown in FIG. 21 to install an elastic implant in a valve annulus to reshape the annulus and restore leaflet coaptation.
- FIGS. 23A to 23 C diagrammatically show a method of gaining intravascular access to the left atrium for the purpose of deploying a delivery catheter to place an implant in a valve annulus to reshape the annulus and restore leaflet coaptation.
- FIG. 24 is a side elevation view of the distal end of the implant delivery catheter shown in FIG. 23C , showing an elastic implant of the type shown in FIG. 10 collapsed in a sleeve for deployment into the left atrium in the manner shown in FIGS. 23A to 23 C.
- FIGS. 25A to 25 E are diagrammatic perspective views of a method for manipulating the distal end of the implant delivery catheter shown in FIG. 24 to deploy an elastic implant of the type shown in FIG. 10 into a valve annulus to reshape the annulus and restore leaflet coaptation.
- FIG. 26 is a side view of the distal end of the implant delivery catheter of the type shown in FIG. 23C , showing an elastic implant of the type shown in FIG. 10 collapsed in a sleeve for deployment into the left atrium in the manner shown in FIGS. 23A to 23 C, also and showing the presence of a guide wire loop to aid in the deployment.
- FIGS. 27A to 27 I are diagrammatic views of a method for deploying an elastic implant of the type shown in FIG. 10 into a valve annulus with the aid of a guide wire loop to reshape the annulus and restore leaflet coaptation.
- FIGS. 28A and 28B are perspective view of elastic implants of the type shown in FIGS. 13B to 13 E, showing the tethering of such implants to one or more wire loops to aid in their deployment into a valve annulus to reshape the annulus and restore leaflet coaptation.
- FIG. 29 is a side view of the distal end of the implant delivery catheter of the type shown in FIG. 23C , showing a symmetrical foldable elastic implant of the type shown in FIG. 15A folded and collapsed in a sleeve for deployment into the left atrium in the manner shown in FIGS. 23A to 23 C.
- FIGS. 30A to 30 D are diagrammatic views of a method for manipulating the distal end of the implant delivery catheter shown in FIG. 29 to deploy a symmetrically folded and collapsed elastic implant of the type shown in FIG. 15A into a valve annulus to reshape the annulus and restore leaflet coaptation.
- FIGS. 31A to 31 E are diagrammatic views of a method for manipulating the distal end of the implant delivery catheter shown in FIG. 29 to deploy an asymmetrically folded and collapsed elastic implant of the type shown in FIG. 15D into a valve annulus to reshape the annulus and restore leaflet coaptation.
- FIG. 32 is a side view of the distal end of the implant delivery catheter of the type shown in FIG. 23C , showing a symmetrical foldable elastic implant of the type shown in FIG. 15A tethered to a guide wire loop to aid in its implantation into a valve annulus to reshape the annulus and restore leaflet coaptation.
- FIGS. 33A to 33 D are diagrammatic views of a method for manipulating the distal end of the implant delivery catheter shown in FIG. 32 to deploy a symmetrically folded and collapsed elastic implant of the type shown in FIG. 15A into a valve annulus with the aid of a guide wire loop to reshape the annulus and restore leaflet coaptation.
- FIG. 34 is a side elevation view of the distal end of the implant delivery catheter of the type shown in FIG. 23C , showing a symmetrical foldable elastic implant of the type shown in FIG. 15A tethered to two guide wire loops to aid in its implantation into a valve annulus to reshape the annulus and restore leaflet coaptation.
- FIGS. 35 and 36 A to 36 D are diagrammatic views of a method for manipulating the distal end of the implant delivery catheter to deploy a symmetrically folded and collapsed elastic implant of the type shown in FIG. 15A into a valve annulus with the aid of a separate guide wires to reshape the annulus and restore leaflet coaptation.
- FIGS. 37A to 37 C are diagrammatic views of the deployment a symmetrically folded and collapsed elastic implant of the type shown in FIG. 15A into a valve annulus with the aid of a wrapper or bag to reshape the annulus and restore leaflet coaptation.
- FIG. 38 is a side perspective view of a plastically deformable implant sized and configured to be expanded in situ to rest within or near the leaflet commissures of a dysfunctional heart valve annulus to reshape the annulus and restore leaflet coaptation.
- FIGS. 39A to 39 C are diagrammatic views of the deployment of a plastically deformable implant of the type shown in FIG. 38 into a valve annulus with the aid of a mechanical expansion device.
- FIGS. 40A to 40 C are diagrammatic anatomic views of the deployment of a plastically deformable implant of the type shown in FIG. 38 into a valve annulus with the aid of a balloon expansion device.
- FIG. 41 is a diagrammatic view of a non-compliant balloon deployed into a valve annulus for the purpose of assessing the size and mechanical properties of an implant for the annulus.
- FIG. 42 is a side perspective view of a multi-functional elastic implant sized and configured to rest within or near the leaflet commissures of a dysfunctional heart valve annulus to reshape the annulus and restore leaflet coaptation as well serve as a neo-leaflet to either replace or supplement a damaged heart valve leaflet.
- FIGS. 43 and 44 are side perspective views of a multi-functional elastic implants sized and configured to rest within or near the leaflet commissures of a dysfunctional heart valve annulus to reshape the annulus and restore leaflet coaptation as well serve as a leaflet retainer to prevent a native valve leaflet from being pushed into the atrium upon ventricular contraction.
- FIGS. 45 to 47 are side perspective views of a multi-functional elastic implants sized and configured to rest within or near the leaflet commissures of a dysfunctional heart valve annulus to reshape the annulus and restore leaflet coaptation as well serve as a leaflet retainer to prevent a native valve leaflet from being pushed into the atrium upon ventricular contraction, the implants also including a framework that serves to help position and secure the implant in situ.
- FIGS. 7A and 8 show an implant 10 sized and configured to rest within or near a heart valve annulus.
- the implant is shown in a mitral valve, and, in this arrangement, extends along the major (i.e., longest) axis above and/or along the valve annulus.
- the implant 10 is sized and shaped so that, in use, it applies a mechanical force along the major axis.
- the mechanical force serves to outwardly displace tissue (i.e., to displace tissue away from the center of the annulus) to reshape the annulus.
- the mechanical-force serves to lengthen the long axis of the annulus and, in doing so, can reactively shorten in the minor (i.e.
- the implant may only need to reshape the annulus during a portion of the heart cycle, such as during ventricular systolic contraction.
- the implant may be sized to produce small or negligible outward displacement of tissue during ventricular diastole when the tissue is relaxed, but restrict the inward movement of tissue during ventricular systolic contraction.
- the mechanical force applied by the implant 10 restores to the heart valve annulus and leaflets a more normal anatomic shape and tension (see FIG. 9 ).
- the more normal anatomic shape and tension are conducive to coaptation of the leaflets during ventricular systole, which, in turn, reduces regurgitation.
- the implant 10 restores normal function to the valve, without surgically cinching, resecting, and/or fixing in position large portions of a dilated annulus or leaflets, or without the surgical fixation of ring-like structures.
- the implant 10 lends itself to delivery to a targeted heart valve site by catheter-based, intravascular techniques, under image guidance.
- Image guidance includes but is not limited to fluoroscopy, ultrasound, magnetic resonance, computed tomography, or combinations thereof.
- the implant 10 can be delivered using conventional open heart surgical techniques or by thoracoscopic surgery techniques.
- the implant 10 is made—e.g., by bending, shaping, joining, machining, molding, or extrusion—from a biocompatible metallic or polymer material, or a metallic or polymer material that is suitably coated, impregnated, or otherwise treated with a material to impart biocompatibility, or a combination of such materials.
- the material is also desirably radio-opaque to facilitate fluoroscopic visualization.
- the rail 14 spans the struts 12 .
- the rail 14 (like the struts 12 ) can take various shapes and have various cross-sectional geometries.
- the rail 14 (and/or the struts 12 ) can have, e.g., a generally curvilinear (i.e., round or oval) cross-section, or a generally rectilinear cross section (i.e., square or rectangular), or combinations thereof.
- the implant is “elastic.”
- the rail 14 is sized and configured to possess a normal, unloaded, shape or condition (shown in FIG. 7A ), in which the rail 14 is not in compression and the struts 12 are spaced apart farther than the anterior commissure to posterior commissure dimension of the targeted heart valve annulus.
- the material of the implant is selected to possess a desired spring constant.
- the spring constant imparts to the rail 14 the ability to be elastically compressed out of its normal, unloaded condition, in response to external compression forces applied at the struts.
- the rail 14 is sized and configured to assume an elastically loaded, in compression condition, during which the struts 12 are spaced apart a sufficiently shorter distance to rest in engagement with tissue at or near the leaflet commissures (see FIG. 8 ).
- the rail 14 When in its elastically loaded, compressed condition (see FIG. 9 ), the rail 14 exerts opposing forces to the tissues at or near the commissures through the struts 12 , tending to outwardly displace tissue and stretch the annulus along its major axis, which also typically stretches the leaflet commissures, shortens the minor axis, and/or reshapes surrounding anatomic structures.
- the implant thereby reshapes the valve annulus toward a shape more conducive to leaflet coaptation.
- An elastic implant can be made, e.g., from superelastic alloy, such that the implant can be elastically straightened and/or folded to fit within a catheter or sheath during deployment, and will regain its shape upon deployment (this characteristic will be described in greater detail later).
- the elasticity of the implant 10 itself, along with the elasticity of the valve tissue, ensure that the implant 10 can be positioned in the valve under a state of net compression and thus remain anchored without the use of sutures, adhesives, or other fixation materials, i.e. which is called compressive anchoring.
- the implant 10 may itself deform elastically, although not necessarily so, but the characteristic of the implant 10 being elastically deformable may help to maintain compressive anchoring. If the implant 10 does not deform elastically or does so only slightly, the implant 10 relies on tissue elasticity to keep the implant anchored.
- the struts 12 may carry other structures or mechanisms 16 to further enhance the anchorage and stabilization of the implant in the heart valve annulus.
- the mechanisms 16 may be located below the plane of the annulus, to engage infra-annular heart tissue adjoining the annulus in the ventricle, and/or be located at or above the plane of the annulus, to engage tissue on the annulus or in the atrium.
- the spring constant of the implant may be selected to be greater than the spring constant of adjoining tissue.
- the spring constant of the implant may be selected to approximate the spring constant of adjoining tissue, thereby providing compliance to allow the implant 10 to adapt to tissue morphology during use.
- the spring constant of the implant 10 may vary along the length of the rail 14 , so that some portions of the rail 14 are stiffer or more compliant than other portions of the rail 14 .
- the implant 10 may be formed from a plastically deformable material.
- the implant 10 is manufactured in a normally collapsed condition.
- the implant 10 is expanded in situ into an in use condition within the annulus, e.g., by an inflatable body (e.g., balloon) or by a suitable mechanical device (e.g., a scissorjack).
- an inflatable body e.g., balloon
- a suitable mechanical device e.g., a scissorjack
- An elastic implant 10 having the characteristic just described can take various forms and configurations. The following describes various illustrative arrangements.
- the implants 10 in FIGS. 7A to 7 C comprise a single rail 14 spanning the distance between the struts 12 .
- an implant 10 can include more than a single rail 14 , imparting a normally closed, annular shape to the implant.
- an implant 10 of this type can be conveyed to an implantation site, e.g., within a catheter or sheath, in a collapsed, straightened condition (with the rails 14 collapsed side-by-side) When deployed from the catheter or sheath, the implant 10 springs open to assume the normally closed, annular shape shown in FIGS. 7D and 10 .
- the implant 10 includes two rails 14 spanning the struts 12 .
- the shape and configuration of the rails 14 can be varied, depending upon the desired orientation of the rails 14 with respect to the annulus itself.
- the two rails 14 are shaped and configured so that, when implanted, the rails 14 follow the circumferential path of the annulus and rest in generally the same plane as the annulus.
- This implant can be characterized as “hugging” the annulus.
- the two rails 14 are shaped and configured so that, when implanted, the rails 14 follow the circumferential path of the annulus, and also rise above the plane of the annulus.
- This implant 10 can be characterized as “riding above” the annulus.
- An implant 10 that “rides above” the annulus can extend close to the annulus (as FIG. 12 shows) or rise significantly above the annulus toward the dome of the atrium as FIGS. 20A and 20B show.
- an implant 10 can include a rail 14 A that hugs the annulus and a rail 14 B that rides above the annulus and contacts a heart wall, serving as a mechanism 16 that orients and stabilizes the implant.
- FIGS. 13A to 13 E show, the rails 14 of a given annular implant 10 can be interrupted to impart a normally open annular (“hemi”) shape to the implant 10 .
- an implant 10 of this type also can be conveyed to an implantation site, e.g., within a catheter or sheath, in a collapsed, straightened condition, and then deployed to assume the open, annular shape shown in FIGS. 13A to 13 E.
- the open annular shape is configured so that, when implanted, the implant 10 hugs the annulus.
- the open annular shape is configured so that, when implanted, the implant rides above the annulus.
- FIGS. 13C and 13D show another style of open annular implant, one that hugs the annulus ( FIG. 13C ) and the other that rides above the annulus ( FIG. 13D ).
- the interrupted rail 14 includes interlocking hooks 18 that can be coupled, if desired, to close the annulus of the implant 10 (see FIG. 13E ).
- the interlocked implant 10 is configured to ride above the annulus.
- the struts 12 need not be placed at diametrically opposite sides of the rail or rails 14 .
- the commissures of a given valve annulus may not be at geometrically opposite sides of the annulus. Accordingly, the position of the struts 12 may be selected to conform to an asymmetric morphology of the annulus.
- the struts 12 may be used to simply locate the implant 10 in the valve, imparting little or no force on their own. In this arrangement, the annulus reshaping forces emanate from the rail or rails 14 above the commissures.
- the implant possesses a spring constant that approximates the spring constant of tissue, making the implant more accommodating to the movement of the tissue.
- a given rail or rails 14 can include undulations or the like to impart regions having different spring constants and/or mechanical properties along the length of the rail 14 .
- the cross-sectional width and/or thickness and/or geometry of a given rail 14 need not be uniform, but can vary along the length of the rail 14 to impart regions of different spring constants and/or mechanical properties.
- the region of the continuous rail 14 between the asymmetrically placed struts 12 may be thickened or thinned to impart different mechanical properties to achieve the desired shape changing objectives.
- the implants 10 shown in FIGS. 15A to 15 E comprise more than a single rail 14 , imparting a normally closed, annular shape to the implant.
- the rails 14 of the implants 10 shown in FIGS. 15A to 15 E include cusps 20 .
- the cusps 20 permit the implants to be resiliently folded along their minor (transverse axis) axis—with the cusps 20 occupying the fold—without permanently deforming the implant (see FIG. 15B ).
- an implant 10 of this type can be conveyed to an implantation site, e.g., within a catheter or sheath, in a folded as well as collapsed condition, and then deployed to assume the normally closed, annular shape shown in FIG. 15A , as FIG. 15C shows.
- the shape and configuration of the rails 14 can be varied so that, when deployed, the implant hugs the annulus or rides above the annulus.
- FIG. 15A the cusps 20 are symmetric, being formed on each rail 14 equidistant to the struts 12 .
- the struts 12 are also shown symmetric as to height above the rail 14 .
- FIG. 15D shows that the cusps 20 need not be symmetric in either respect. As will be described in greater detail later, this asymmetry permits a stepwise, staggered deployment of the implant, in which the parts of the implant are deployed one at a time in succession—e.g., one strut, then one cusp, then another strut, and then the other cusp—until the implant assumes the closed, annular shape shown in FIG. 15D , as FIG. 15E shows.
- the struts 12 can include other structures or mechanisms 16 to further enhance the anchorage and stabilization of the implant in the heart valve annulus.
- These structures or other mechanisms 16 can comprise, e.g., loops, pads, barbs, vertical legs, or circumferential legs, or other anchoring structures below, at, and/or above the valve plane.
- the structures and mechanisms 16 desirably increase the surface area of contact between the struts 12 and tissue adjoining the annulus.
- the structures and mechanism 16 desirably rely solely or partly on the valve and neighboring anatomic structures to anchor and fix the position of the implant in the annulus and resist its migration out of the annulus. Implant fixation can also assist in the achieving the desired coaptation of the leaflets and to resist upward movement or eversion of the leaflets during the cardiac cycle.
- the rails 14 carry four struts 12 , two supra-annular (contacting tissue on the atrial side of the valve) and two infra-annular (contacting tissue on the ventricular size of the valve).
- the struts 12 are separated by a thin spine that curves away from the struts 12 to avoid contact with the commissures themselves, so as not to interfere with the opening and closing of the valve.
- the struts 12 may be cushioned to increase traction, decrease erosion, and improve their interaction with the valve annulus.
- the struts 12 may be coated, covered, or impregnated with a tissue growth promoting material.
- the rails 14 spanning the struts 12 functions to exert compressive forces on the annulus.
- the struts 12 are secured by the compression forces created by the rail's interaction with the valve annulus. The struts 12 assure that the implant is positioned correctly in situ, because they will only seat when positioned at or near the commissures of the valve.
- the struts 12 may be sized and shaped in various ways.
- FIGS. 7B, 7C , and 7 D show various embodiments with alternative designs for the struts 12 .
- the supra-annular struts 12 are somewhat larger than the infra-annular struts 12 to improve the anatomical fit of the device in situ.
- the struts 12 can carry flat infra-annular tissue contacting pads 26 , located below the plane of the valve annulus.
- the pads 26 rest on outwardly bowed extensions below the commissures, applying holding forces upon the heart walls.
- the pads 26 can take the form of flat surfaces, as FIGS. 16A and 16B show.
- Tissue penetrating barbs 28 may enhance the effect of the compression forces to fix the location of the implant.
- the struts 12 can extend in an undulating fashion below the plane of the valve annulus, to create a series of infra-annular contact surfaces 30 between the implant and the heart walls below and adjoining the annulus.
- the series of contact surfaces 30 increase the points of contact between the implant and tissue below the annulus. These multiple points of contact 30 are additive to the contact between the implant and tissue at or near the commissures themselves.
- additional struts and/or barbs or similar anchoring surfaces are not shown associated with the contact surfaces, but they could be included, if desired.
- the implant can include infra-annular frictional struts 32 located below the level of the annulus.
- the infra-annular frictional struts 32 engage tissue of the heart walls below and adjoining the annulus.
- the struts 32 resist migration of the implant out of the annulus.
- the frictional struts 32 can be placed in a single level immediately below the commissures, or (as FIG. 18B shows) the struts 32 can be arranged in multiple levels below the commissures.
- the struts 12 and/or the rails 14 can include tissue in-growth surfaces 34 .
- the surfaces 14 provide an environment that encourages the in-growth of neighboring tissue on the implant. Once in-growth occurs, the implant 10 becomes resistant to migration or dislodgment from the annulus. Conventional in-growth materials such as polyester fabric can be used.
- fixation mechanism or structure may, if desired, be combined with an adhesive or like material to further secure the implant.
- the various implants as just described lend themselves to implantation in a heart valve annulus in various ways. They can be implanted, e.g., in an open heart surgical procedure. Alternatively, they can be implanted using catheter-based technology via a peripheral venous access site, such as in the femoral or jugular vein or femoral artery, or alternatively by thoracoscopically through the chest or by means of other surgical access through the right atrium.
- FIG. 21 shows a tool 40 for deploying an elastic implant 10 of the type generally described in an annulus of a heart valve in an open surgical procedure.
- FIGS. 22A to 22 F diagrammatically show the steps of an open surgical procedure for deploying the implant 10 in a mitral valve annulus using the tool 40 shown in FIG. 21 .
- the tool 40 includes a scissors-action mechanism 42 comprising an operating end 46 and a handle end 48 .
- the operating end 46 includes prongs 44 that can be moved apart and together by manipulation of the handle end 48 (see FIGS. 22A and 22B ).
- the prongs 44 are sized and configured to mate with deployment apertures 50 formed on the struts 12 of the implant 10 (shown in FIG. 21 ).
- the deployment apertures 50 are also shown in the implants in preceding FIGS. 10 to 19 , which can be likewise be deployed using the tool 40 .
- the scissors-action mechanism 42 is manipulated to spread the prongs 44 apart (see FIGS. 22A and 22B ), so that they can be mated in the apertures 50 of the implant 10 .
- the scissors-action mechanism 44 is manipulated to bring the prongs 44 together, thereby applying force to the struts 12 to place the implant 10 in a compressed condition (see FIG. 22C ).
- the tool 40 and implant 10 are introduced through an open surgical approach into the left atrium.
- the tool 40 places the implant 10 within the mitral valve annulus (see FIG. 22D ).
- the annulus is shown to have a dimension of D 1 .
- This dimension D 1 is not conducive to leaflet coaptation, and regurgitation is occurring. It is the purpose of the surgical procedure to repair this dysfunction by reshaping the annulus with the implant 10 .
- the scissors-action mechanism 42 is manipulated to spread the prongs 44 apart until the struts 12 of the implant 10 rest within or near the commissures of the mitral valve (see FIG. 22E ). At this point in the procedure, the dimension D 1 of the annulus remains unchanged.
- the tool 40 is withdrawn, freeing the prongs 12 from the apertures 50 (see FIG. 22F ).
- the elastic unloading of the implant 10 displaces and spreads the valve tissue apart, achieving a new dimension D 2 for the annulus, which is larger than D 1 .
- the new dimension D 2 is conducive to leaflet coaptation.
- the implant 10 has reshaped the annulus to restore valve function.
- FIGS. 23 to 25 show a representative embodiment of a percutaneous catheter-based linear deployment of an unfolded elastic implant 10 of the type shown in FIGS. 7 to 14 .
- Percutaneous vascular access is achieved by conventional methods into the femoral or jugular vein.
- a catheter 52 is steered through the vasculature into the right atrium.
- a needle cannula 54 carried on the distal end of the catheter is deployed to pierce the septum between the right and left atrium.
- a guide wire 56 is advanced trans-septally through the needle catheter 52 into the left atrium.
- the first catheter 52 is withdrawn, and (as FIG. 23C shows) under image guidance, an implant delivery catheter 58 is advanced over the guide wire 56 into the left atrium into proximity with the mitral valve.
- the implant delivery catheter 58 can be deployed trans-septally by means of surgical access through the right atrium.
- the implant delivery catheter 58 carries a sheath 60 at its distal end (see FIG. 24 ).
- the sheath 60 encloses an elastic implant 10 of a type shown in FIGS. 7 to 14 .
- the implant 10 is constrained in a collapsed, straightened condition within the sheath, as FIG. 24 shows.
- the sheath 60 can be sized and configured to be withdrawn (e.g., by sliding it proximally), to free the implant 10 . Free of the sheath 60 , the elastic implant 10 will expand.
- a flexible push rod 62 in the catheter 58 can be used to expel the implant 10 from the sheath 60 , with the same result.
- the strut 12 on the trailing end of the implant 10 is folded within the sheath 60 to reduce the collapsed profile and facilitate the expansion of the implant 10 once free from the sheath 60 .
- FIG. 25A shows, under image guidance, the strut 12 on the leading end of the implant 10 is freed from the sheath 60 and seated retrograde in the posterior commissure of the valve annulus. Anchoring structures or mechanisms associated with the strut are also placed into desired contact with adjoining tissue below and/or above the plane of the annulus.
- FIG. 25B shows, the delivery catheter 58 maintains force on the leading strut 12 within the posterior commissure, as the sheath 60 is withdrawn in line with the coaptation line in a posterior-to-anterior direction along the coaptation line. As shown in FIG.
- the delivery catheter 58 may need to dip down retrograde below the plane of the leaflets to maintain sufficient force on the leading end of the implant while the trailing end is freed from the sheath 60 .
- the delivery catheter 58 may be sized and configured to have the column strength sufficient to maintain force on the leading strut without passage below the leaflet plane.
- the elastic implant 10 shapes and seats (as FIGS. 25 B/C and 25 D shows), until the trailing strut 12 unfolds and seats within the anterior commissure (see FIG. 25E ).
- the implant can also be positioned or repositioned under image guidance within the left atrium using a catheter-deployed grasping instrument.
- FIGS. 26 and 27 A to 27 I show another embodiment of an implant delivery catheter 58 that can be used to deploy a folded elastic implant 10 of the type shown in FIGS. 7 to 14 within the left atrium.
- the implant delivery catheter 58 includes a sheath 60 that constrains the implant 10 in a collapsed, straightened condition for passage into the left atrium (see FIG. 26 ).
- the sheath 60 is sized and configured to be withdrawn (e.g., by sliding it proximally), to free the implant for expansion within the left atrium, or a push rod 62 can be used to eject the implant from the sheath 60 .
- a push rod 62 can be used to eject the implant from the sheath 60 .
- one or both struts can be folded against the body of the implant within the sheath 60 .
- a metallic, fiber, or polymer guide wire 64 is looped through the deployment apertures 50 on the struts 12 of the implant 10 prior to the insertion of the implant 12 into the sheath 60 .
- the legs of the resulting guide wire loop 66 are passed out the proximal end of the sheath 60 for manipulation, as will now be described.
- the implant delivery catheter 58 is introduced trans-septally into the left atrium in the manner previously described. With the distal end of the catheter 58 positioned above the valve annulus (see FIG. 27A ), and prior to withdrawal of the sheath 60 , both legs of the guide wire loop 66 are advanced distally in tandem through the sheath 60 to advance the loop 60 beyond the deployment apertures 50 and out the distal end of the sheath 60 .
- the guide wire loop 66 desirably carries radio-opaque markers 68 to aid in fluoroscopic visualization.
- the markers 68 identify a desired distance between them and the distal end of the sheath 60 , marking a space in which the implant 10 can freely expand without contacting tissue or anatomic structures within the atrium. Guided by the markers 68 , the loop 66 can be dropped into the annulus a desired distance beyond the distal end of the sheath 60 , as FIG. 27A shows.
- the sheath 60 can be withdrawn to free the implant 10 for expansion (see FIG. 27B ). While tethered to the guide wire loop 66 , the implant 10 opens within the left atrium—first one strut, then the other—as the sheath 60 is withdrawn, as FIGS. 27C and 27D show.
- both legs of the guide wire loop 66 can be advanced proximally in tandem through the sheath 60 (see FIG. 27E ).
- the wire loop 66 applies force to the struts 12 and brings them together (see FIG. 27F ). This places the implant 10 in a compressed, elastically loaded condition. Proximal advancement of the legs of the wire loop 66 also draws the implant 10 in this condition snuggly against the distal end of the catheter 58 for greater control, as FIG. 27F shows.
- the catheter 58 can be advanced under image guidance to place the implant 10 within the annulus. Manipulation of the catheter 58 will bring the struts of the implant into desired alignment. Subsequent distal advancement of the legs of the wire loop 66 (see FIG. 27H ) allows the struts of the implant 10 to be elastically unloaded and brought into contact with the surrounding tissue. Anchoring structures or mechanisms associated with the struts 12 can also be placed into desired contact with adjoining tissue below and/or above the plane of the annulus. The legs of the wire loop 66 can be manipulated to pull the struts 12 together and/or allow them to separate, until the desired orientation and tissue contact in and about the annulus are achieved.
- one leg of the wire loop 66 can be pulled to release the implant from the guide wire 64 (see FIG. 27I ).
- the implant 10 is allowed to fully unfold and seat within the annulus.
- a guide loop 66 can be used to deploy open annular implants as well as closed annular implants. As shown in FIG. 28A , a single guide loop 66 can be threaded through an open annular implant 10 of the type shown in FIG. 13B . Or, as shown in FIG. 28B , two guide wire loops 66 A and 66 B can be threaded through an inter-locking implant of the type shown in FIGS. 13D and 13E . In this arrangement, the first guide wire loop 66 A can be manipulated to position the struts 12 of the implant within the annulus, as just described. The second guide wire loop 66 B can be separately manipulated to pull the rails 14 together for interlocking, once the struts rest in a desired manner in the commissures.
- FIGS. 15A to 15 E show elastic implants 10 that can be folded about cusps 20 .
- the folding allows the implant 10 to be conveyed into the left atrium within a sheath 60 of an implant delivery catheter 58 with a delivery profile that not only constitutes a side-to-side collapsed condition—which minimizes the delivery profile diameter—but also constitutes a lengthwise folded condition—which minimizes the delivery profile length.
- FIGS. 30A to 30 D illustrate the deployment of a symmetrically folded elastic implant 10 of the type shown in FIGS. 15A and 15B .
- the implant 10 is constrained in a symmetrically folded and collapsed condition within the sheath 60 , as FIG. 30A shows.
- the struts 12 form the leading end of the implant.
- a push rod 62 in the catheter 58 includes a gripping mechanism 70 that holds the folded implant 10 by the cusps 20 .
- the push rod 62 is advanced to expel the implant 12 from the sheath 60 , both struts 12 first.
- the folded implant 10 is aligned with coaptation line generally equidistant from the commissures, with the struts 12 oriented to face the commissures (the delivery catheter 58 has been previously introduced trans-septally into the left atrium, as already described).
- Manipulating the push rod 62 advances the implant 10 , both struts first, from the sheath 60 .
- Connecting the push rod 62 to the implant 10 allows the implant 10 to be translated and rotated and retracted during deployment. Freed from the sheath 60 (see FIG. 30B ), the implant 10 begins to unfold along the cusps 20 , and the struts 12 draw apart toward the commissures.
- the implant 10 Prior to release of the cusps 20 from the gripping mechanism 70 , the implant 10 can be manipulated to assure that anchoring structures or mechanisms associated with the strut are placed into desired contact with adjoining tissue below and/or above the plane of the annulus. The gripping mechanism 70 can then be activated (see FIG. 30D ), releasing the implant 10 .
- FIGS. 31A to 31 E illustrate the deployment of an asymmetrically folded elastic implant 10 of the type shown in FIGS. 15D and 15E .
- the implant 10 is constrained in an asymmetrically folded and collapsed condition within the sheath 60 , as FIG. 31A shows.
- the gripping mechanism 70 holds one, but not both of the cusps 20 . This is because the height of the cusps 20 above the rails 14 is also asymmetric.
- the gripping mechanism 70 will couple to the taller cusp 20 .
- the push rod 62 can be advanced to expel the implant 10 from the sheath 60 . Due to the asymmetry of the cusps 20 , one of the struts 12 is positioned for deployment before the other strut 12 . Also due to the asymmetry of the cusps 20 , the shorter cusp 20 is positioned for advancement out of the sheath 60 before the taller cusp 20 is released by the gripping mechanism 70 .
- FIG. 31B shows, under image guidance, the folded and collapsed implant 10 is aligned with coaptation line near one of the commissures (the delivery catheter 58 has been previously introduced trans-septally into the left atrium, as already described).
- Manipulating the push rod 62 advances the implant 10 from the sheath 60 .
- the leading strut 12 is freed first (see FIG. 31B ) and placed against the adjacent commissure.
- the implant 10 can be manipulated to assure that anchoring structures or mechanisms associated with the leading strut are placed into desired contact with adjoining tissue below and/or above the plane of the annulus. Further advancement of push rod 62 causes the implant 10 to unfold toward the opposite commissure.
- FIG. 31C shows.
- the implant 10 can be manipulated to assure that anchoring structures or mechanisms associated with the trailing strut 12 are placed into desired contact with adjoining tissue below and/or above the plane of the annulus. Further advancement of the push rod 62 frees the shorter cusp 12 from the sheath 60 , and the implant 10 springs open along this side (see FIG. 31D ). The gripping mechanism 70 can then be activated (see FIG. 31 ), releasing the taller cusp 12 . The implant 10 springs open in this direction. It can be seen that the. asymmetry of the implant 10 make possible a step-wise deployment of the implant 10 , one component at a time, in the annulus.
- One or more guide loops 66 or tethers can likewise be employed to assist in the deployment of folded elastic implants of either symmetric or asymmetric types.
- a metallic, fiber, or polymer guide wire 64 can be looped through the deployment apertures on the struts of a folded symmetric or asymmetric implant 10 prior to the folding and insertion of the implant 10 into the sheath 60 .
- the legs of the resulting guide wire loop 66 are passed out the proximal end of the sheath 60 for manipulation.
- both legs of the guide wire loop 66 are advanced distally in tandem through the sheath 60 to advance the loop 66 beyond the deployment apertures and out the distal end of the sheath 60 .
- the loop 66 is placed within the annulus.
- the push rod 62 is manipulated to free the folded implant 10 for expansion (see FIG. 33B ).
- the implant 10 opens while tethered to the guide wire loop 66 .
- the loop 66 increases in diameter as the struts 12 expand apart.
- the perimeter of the loop 66 will orient itself along the greatest dimension of the annulus—which is the distance between the commissures.
- the loop 66 thereby orients the implant 10 with the coaptation line during implant 10 expansion.
- the legs of the loop 66 guide the struts 12 to the commissures (as FIG. 33C shows).
- the implant 10 is deployed in the annulus.
- the guide wire loop 66 maintains control of the strut spacing within the commissures during implant expansion.
- the gripping mechanism 70 can release the implant 10 .
- One leg of the wire loop 66 can be pulled to release the implant 10 from the guide wire (see FIG. 33D ).
- the implant 10 is allowed to fully unfold and seat within the annulus.
- a second guide wire loop 72 can also be passed through apertures on the cusps 20 .
- This guide wire loop 72 can be manipulated independently of the first guide wire loop 66 , to control deployment of the expanding implant 10 in the septal-to-lateral dimension. Simultaneous, although independent, control of the expanding implant 10 can be achieved by manipulation of the first guide wire 66 .
- separate metallic, fiber, or polymer guide wires 92 can be individually threaded (without looping) through small holes on the struts of a folded symmetric or asymmetric implant 10 prior to the folding and insertion of the implant 10 into the sheath 60 (see FIG. 35 ).
- the separate guide wires 92 are passed out the proximal end of the sheath 60 for manipulation.
- the implant delivery catheter 58 is introduced trans-septally into the left atrium in the manner previously described, and prior to activation of the push rod 62 —the separate guide wires 92 are advanced distally in tandem through the sheath 60 and out the distal end of the sheath 60 . The ends of the wires 92 are placed within the annulus.
- the push rod 62 is manipulated to free the folded implant 10 for expansion (see FIG. 36B ).
- the implant 10 opens while tethered to the separate guide wires 92 .
- the guide wires 92 will orient themselves along the major axis of the annulus—which is the distance between the commissures, to orient the implant 10 with the coaptation line during implant 10 expansion.
- the guide wires 92 separately guide the respective struts 12 to the commissures (as FIG. 36C shows).
- the implant 10 is deployed in the annulus.
- the guide wires 92 maintain control of the strut spacing within the commissures during implant expansion.
- the gripping mechanism 70 can release the implant 10 .
- the guide wires 92 can be pulled to release the implant 10 from the guide wires (see FIG. 36D ).
- the implant 10 is allowed to fully unfold and seat within the annulus.
- the foregoing embodiments demonstrate that the unfolding of an elastic implant 10 can be controlled during deployment in either the major axis dimension, or the minor axis (septal-to-lateral) dimension, or in both dimensions by means of guide wires.
- Other forms of restraining mechanisms can be used to control the unfolding of the implant 10 .
- the folded implant 10 can be restrained within a bag or wrapper 76 as the implant 10 is advanced from the delivery sheath 60 .
- the bag or wrapper 76 restricts expansion of the implant 10 beyond a selected point (e.g., 80% of full deployment), allowing the physician to attend to the important task of seating the struts in the commissures before the implant 10 fully opens across the annulus.
- a ripcord 78 coupled to the bag or wrapper 76 can be pulled, to release the bag or wrapper 76 from the implant 10 (see FIG. 37C ).
- the implant 10 Freed from the bag or wrapper 76 , the implant 10 completes its expansion, to achieve final shaping and seating within the annulus.
- One or more guide wires can be used in combination with the bag or wrapper 76 .
- the bag or wrapper 76 can alternatively be sized and configured to tear away as a result of the implant 10 expanding beyond a given point, without the use of a ripcord 78 or similar induced tearing mechanism.
- the implant 10 can be enclosed within a shrink-wrap structure having a score line.
- the structure is sized and configured to restrain expansion of the implant 10 until the implant 10 is advanced outside of the delivery sheath beyond a given point, at which time the score line parts or the material strength of the structure is exceeded, to open and fully release the implant 10 .
- the implant 10 may be formed from plastically deformable material (see FIG. 38 ).
- the implant 10 includes struts and one or more rails, as previously described.
- the implant 10 is deployed by an implant delivery catheter 58 into the left atrium in a normally collapsed condition.
- an implant delivery catheter 58 can carry a mechanical expansion device 80 , such as a scissorjack or the like (see FIGS. 39A to 39 C), to expand the plastically deformable material of the implant 10 in situ within the annulus.
- an implant delivery catheter 58 can carry an inflatable body 82 (e.g., balloon) (see FIGS. 40A to 40 C), to expand the implant 10 within the annulus.
- the plastically deformable implant 10 stretches the annulus to achieve a desired major axis size. Once expanded, the plastically deformable implant 10 maintains the desired distance, thereby resisting contraction of the annulus.
- the plastically deformable implant 10 may include other structures or mechanisms to further anchor and stabilize the implant 10 in the heart valve annulus.
- a heart valve such as a mitral valve and the neighboring anatomic structures are generally understood by medical professionals using textbooks of human anatomy along with their knowledge of the site and its disease or injury. Ranges of shapes and dimensions for a given implant are defined by the site to be treated. Precise dimensions for a given patient can be determined by X-ray, MRI, or CT scanning of the site to be treated prior to implantation of an implant.
- a physician may also ascertain the size and resistance for a given implant by the deployment of a non-compliant balloon gauge 84 in the targeted annulus, as shown in FIG. 41 .
- the balloon gauge 84 can carry radio-opaque markers 86 so that dimensions of the annulus can be determined using imaging means and/or other forms of in situ visualization.
- the compliance and tension forces of the annulus can also be physically measured, by sensing and quantifying the resistance the balloon gauge 84 encounters during expansion in the annulus. Based upon this data, and taking into account the physician's knowledge of the site and its disease or injury, a physician can select a desired size and mechanical properties for the implant.
- implants 10 have described the context of reshaping a heart valve annulus.
- a given implant 10 having technical features suited for this function can also incorporate other technical features well suited for other functions.
- FIG. 42 shows an annulus remodeling implant 10 in which the rails 14 are sized and configured to define a pseudo-annulus.
- a neoleaflet element 88 comprising a fabric-covered bridge structure is coupled to the rails.
- the neoleaflet element is sized and configured to occupy the space of at least a portion of a native heart valve leaflet to provide a one-way valve function.
- the one-way valve function assumes a valve opened condition within the pseudo-annulus.
- ventricular systolic pressure the one-way valve function assumes a valve closed condition within the pseudo-annulus.
- the neoleaflet element 88 serves to repair, replace, or supplement a damaged heart valve.
- FIGS. 43 and 44 show an annulus remodeling implant 10 in which the rails 14 are sized and configured serve as a pseudo-annulus.
- the implant 10 includes a retaining structure 90 near or within the pseudo-annulus that is sized and shaped to overlay at least a portion of one or more native valve leaflets.
- the retaining structure 90 retains a native valve leaflet, keeping the valve leaflet from a retrograde flow condition, e.g., by being pushed into the atrium, i.e., eversion and/or prolapse.
- FIGS. 45 to 47 shows an annulus remodeling implant 10 in which the rails further include a framework 38 (as previously described) to help position and secure the device in situ.
- the framework 38 also includes a leaflet retaining structure 90 , as just described.
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Surgery (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Prostheses (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Surgical Instruments (AREA)
- External Artificial Organs (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
- This application claims the benefit of co-pending U.S. patent application Ser. No. 09/666,617, filed Sep. 20, 2000 and entitled “Heart Valve Annulus Device and Methods of Using Same,” which is incorporated herein by reference. This application also claims the benefit of Patent Cooperation Treaty application Ser. No. PCT/US 02/31376, filed Oct. 1, 2002 and entitled “Systems and Devices for Heart Valve Treatments,” which claimed the benefit of U.S. Provisional Patent Application Serial No. 60/326,590, filed Oct. 1, 2001, which are incorporated herein by reference. This application also claims the benefit of U.S. Provisional Application Serial No. 60/429,444, filed Nov. 26, 2002, and entitled “Heart Valve Remodeling Devices;” U.S. Provisional Patent Application Serial No. 60/429,709, filed Nov. 26, 2002, and entitled “Neo-Leaflet Medical Devices;” and U.S. Provisional Patent Application Serial No. 60/429,462, filed Nov. 26, 2002, and entitled “Heart Valve Leaflet Retaining Devices,” which are each incorporated herein by reference.
- The invention is directed to devices, systems, and methods for improving the function of a heart valve, e.g., in the treatment of mitral valve regurgitation.
- I. The Anatomy of a Healthy Heart
- The heart (see
FIG. 1 ) is slightly larger than a clenched fist. It is a double (left and right side), self-adjusting muscular pump, the parts of which work in unison to propel blood to all parts of the body. The right side of the heart receives poorly oxygenated (“venous”) blood from the body from the superior vena cava and inferior vena cava and pumps it through the pulmonary artery to the lungs for oxygenation. The left side receives well-oxygenation (“arterial”) blood from the lungs through the pulmonary veins and pumps it into the aorta for distribution to the body. - The heart has four chambers, two on each side —the right and left atria, and the right and left ventricles. The atria are the blood-receiving chambers, which pump blood into the ventricles. A wall composed of membranous and muscular parts, called the interatrial septum, separates the right and left atria. The ventricles are the blood-discharging chambers. A wall composed of membranous and muscular parts, called the interventricular septum, separates the right and left ventricles.
- The synchronous pumping actions of the left and right sides of the heart constitute the cardiac cycle. The cycle begins with a period of ventricular relaxation, called ventricular diastole. The cycle ends with a period of ventricular contraction, called ventricular systole.
- The heart has four valves (see
FIGS. 2 and 3 ) that ensure that blood does not flow in the wrong direction during the cardiac cycle; that is, to ensure that the blood does not back flow from the ventricles into the corresponding atria, or back flow from the arteries into the corresponding ventricles. The valve between the left atrium and the left ventricle is the mitral valve. The valve between the right atrium and the right ventricle is the tricuspid valve. The pulmonary valve is at the opening of the pulmonary artery. The aortic valve is at the opening of the aorta. - At the beginning of ventricular diastole (i.e., ventricular filling)(see
FIG. 2 ), the aortic and pulmonary valves are closed to prevent back flow from the arteries into the ventricles. Shortly thereafter, the tricuspid and mitral valves open (asFIG. 2 shows), to allow flow from the atria into the corresponding ventricles. Shortly after ventricular systole (i.e., ventricular emptying) begins, the tricuspid and mitral valves close (seeFIG. 3 )—to prevent back flow from the ventricles into the corresponding atria—and the aortic and pulmonary valves open—to permit discharge of blood into the arteries from the corresponding ventricles. - The opening and closing of heart valves occur primarily as a result of pressure differences. For example, the opening and closing of the mitral valve occurs as a result of the pressure differences between the left atrium and the left ventricle. During ventricular diastole, when ventricles are relaxed, the venous return of blood from the pulmonary veins into the left atrium causes the pressure in the atrium to exceed that in the ventricle. As a result, the mitral valve opens, allowing blood to enter the ventricle. As the ventricle contracts during ventricular systole, the intraventricular pressure rises above the pressure in the atrium and pushes the mitral valve shut.
- The mitral and tricuspid valves are defined by fibrous rings of collagen, each called an annulus, which forms a part of the fibrous skeleton of the heart. The annulus provides attachments for the two cusps or leaflets of the mitral valve (called the anterior and posterior cusps) and the three cusps or leaflets of the tricuspid valve. The leaflets receive chordae tendineae from more than one papillary muscle. In a healthy heart, these muscles and their tendinous cords support the mitral and tricuspid valves, allowing the leaflets to resist the high pressure developed during contractions (pumping) of the left and right ventricles.
- In a healthy heart, the chordae tendineae become taut, preventing the leaflets from being forced into the left or right atria and everted. Prolapse is a term used to describe this condition. This is normally prevented by contraction of the papillary muscles within the ventricle, which are connected to the mitral valve leaflets by the chordae tendineae. Contraction of the papillary muscles is simultaneous with the contraction of the ventricle and serves to keep healthy valve leaflets tightly shut at peak contraction pressures exerted by the ventricle.
- II. Characteristics and Causes of Mitral Valve Dysfunction
- In a healthy heart (see
FIG. 4 ), the dimensions of the mitral valve annulus—when measured septal (S)- to -lateral (L), as well as from posterior commissure CP to anterior commissure CA—create an anatomic shape and tension such that the leaflets coapt, forming a tight junction, at peak contraction pressures. Where the leaflets coapt at the opposing medial and lateral sides of the annulus are called the leaflet commissures, and are designated inFIG. 4 and in other Figures as CP(denoting the posterior commissure) and CA (denoting the anterior commissure). - Valve malfunction can result from the chordae tendineae (the chords) becoming stretched, and in some cases tearing. When a chord tears, the result is a leaflet that flails. Also, a normally structured valve may not function properly because of an enlargement of or shape change in the valve annulus. This condition is referred to as a dilation of the annulus and generally results from heart muscle failure. In addition, the valve may be defective at birth or because of an acquired disease.
- Regardless of the cause (see
FIG. 5 ), mitral valve dysfunction can occur when the leaflets do not coapt at peak contraction pressures. AsFIG. 5 shows, the coaptation line of the two leaflets is not tight at ventricular systole. As a result, an undesired back flow of blood from the left ventricle into the left atrium can occur. This condition is called regurgitation. - In some cases (see
FIG. 6 ), the leaflets do not form a tight coaptation junction because the dimensions of the mitral valve annulus, measured from commissure to commissure—CP to CA—and/or septal to lateral—S to L—change. The changed dimensions no longer create the anatomic shape and tension in which the leaflets coapt at peak contraction pressures. - Comparing a healthy annulus in
FIG. 4 to an unhealthy annulus inFIG. 6 , the unhealthy annulus is dilated and, in particular, the septal-to-lateral distance is increased. As a result, the shape and tension defined by the annulus becomes less oval (seeFIG. 4 ) and more round (seeFIG. 6 ). This condition is called dilation. When the annulus is dilated, the shape and tension conducive for coaptation at peak contraction pressures progressively deteriorate. Instead, at peak contraction pressures, the leaflets do not coapt completely, and a gap forms between the leaflets. During ventricular systole, regurgitation can occur through this gap. It is believed that the ratio between the commissure distance and septal-to-lateral distance bears a relationship to the effectiveness of leaflet coaptation. If the septal-to-lateral distance increases, the ratio changes, and when the ratio reaches a certain value, regurgitation or the likelihood of regurgitation is indicated. - As a result of regurgitation, “extra” blood back flows into the left atrium. During subsequent ventricular diastole (when the heart relaxes), this “extra” blood returns to the left ventricle, creating a volume overload, i.e., too much blood in the left ventricle. During subsequent ventricular systole (when the heart contracts), there is more blood in the ventricle than expected. This means that: (1) the heart must pump harder to move the extra blood; (2) too little blood may move from the heart to the rest of the body; and (3) over time, the left ventricle may begin to stretch and enlarge to accommodate the larger volume of blood, and the left ventricle may become weaker.
- Although mild cases of mitral valve regurgitation result in few problems, more severe and chronic cases eventually weaken the heart and can result in heart failure. Mitral valve regurgitation can be an acute or chronic condition. It is sometimes called mitral insufficiency.
- III. Prior Treatment Modalities
- In the treatment of mitral valve regurgitation, diuretics and/or vasodilators can be used to help reduce the amount of blood flowing back into the left atrium. An intra-aortic balloon counterpulsation device is used if the condition is not stabilized with medications. For chronic or acute mitral valve regurgitation, surgery to repair or replace the mitral valve is often necessary.
- To date, invasive, open heart surgical approaches have been used to repair mitral valve dysfunction. During these surgical repair procedures, efforts are made to cinch or resect portions and/or fix in position large portions of the dilated annulus. During these surgical repair procedures, the annulus can be reshaped with annular or peri-annular rings or similar ring-like devices. The repair devices are typically secured to the annulus and surrounding tissue with suture-based fixation. The repair devices extend over the top and over much or all of the circumference of the annulus and leaflet surfaces.
- A physician may decide to replace an unhealthy mitral valve rather than repair it. Invasive, open heart surgical approaches are used to replace the natural valve with either a mechanical valve or biological tissue (bioprosthetic) taken from pigs, cows, or horses.
- The need remains for simple, cost-effective, and less invasive devices, systems, and methods for treating dysfunction of a heart valve, e.g., in the treatment of mitral valve regurgitation.
- The invention provides devices, systems and methods that reshape a valve annulus. The devices, systems, and methods include an implant that is sized and configured to rest near or within the leaflet commissures of a heart valve annulus. In use, the implant contacts and outwardly displaces tissue to reshape the heart valve annulus. The implant, in use, may restore to the heart valve annulus and leaflets a more effective anatomic shape and tension. The more normal anatomic shape and tension are conducive to coaptation of the leaflets, which, in turn, reduces retrograde flow or regurgitation. The implant restores function to the valve, without surgically cinching, resecting, and/or fixing in position large portions of a dilated annulus, or without the surgical fixation of ring-like structures.
- Other features and advantages of the invention shall be apparent based upon the accompanying description, drawings, and claims.
-
FIG. 1 is a perspective, anterior anatomic view of the interior of a healthy heart. -
FIG. 2 is a superior anatomic view of the interior of a healthy heart, with the atria removed, showing the condition of the heart valves during ventricular diastole. -
FIG. 3 is a superior anatomic view of the interior of a healthy heart, with the atria removed, showing the condition of the heart valves during ventricular systole. -
FIG. 4 is a superior anatomic view of a healthy mitral valve during ventricular systole, showing the leaflets properly coapting. -
FIG. 5 is a superior anatomic view of the interior of a heart, with the atria removed, showing the condition of the heart valves during ventricular systole, and further showing a dysfunctional mitral valve in which the leaflets are not properly coapting, causing regurgitation. -
FIG. 6 is a superior anatomic view of a disfunctional mitral valve during ventricular systole, showing that the leaflets are not properly coapting, causing regurgitation. -
FIG. 7A is a side perspective view of an elastic implant sized and configured to rest within or near the leaflet commissures of a dysfunctional heart valve annulus to reshape the annulus and improve leaflet coaptation. -
FIGS. 7B to 7E are side perspective views of illustrative alternative configurations of the elastic implant shown inFIG. 7A . -
FIG. 8 is a side anterior anatomic view of a mitral valve annulus in which the elastic implant shown inFIG. 7A has been implanted. -
FIG. 9 is a superior anatomic view of a mitral valve in which the elastic implant shown inFIG. 7A has been implanted, showing the implant stretching the commissures to restore leaflet coaptation. -
FIG. 10 is a side perspective view of another embodiment of an elastic implant sized and configured to rest within or near the leaflet commissures of a dysfunctional heart valve annulus to reshape the annulus and restore leaflet coaptation, the implant defining a closed annular structure. -
FIG. 11 is a perspective anatomic view, taken from an anterior and slightly superior viewpoint, of a mitral valve in which the elastic implant of the type shown inFIG. 10 has been implanted, showing the implant stretching the commissures to restore leaflet coaptation, and also showing the implant as hugging the annulus. -
FIG. 12 is a perspective anatomic view, taken from an anterior and slightly superior viewpoint, of a mitral valve in which the elastic implant of the type shown inFIG. 10 has been implanted, showing the implant stretching the commissures to restore leaflet coaptation, and also showing the implant as rising above the annulus. -
FIGS. 13A to 13C are side perspective views of illustrative embodiments of an elastic implant sized and configured to rest within or near the leaflet commissures of a dysfunctional heart valve annulus to reshape the annulus and restore leaflet coaptation, the implant defining an open annular structure. -
FIGS. 13D and 13E are side perspective views of illustrative embodiments of an elastic implant sized and configured to rest within or near the leaflet commissures of a dysfunctional heart valve annulus to reshape the annulus and restore leaflet coaptation, the implant defining an open annular structure that can be optionally closed. -
FIG. 14 is a side perspective view of an elastic implant of the open annular type shown inFIGS. 13D and 13E , showing how the mechanical characteristics of the implant can be varied along its structure, surface area, and interface with the tissue. -
FIG. 15A is a side perspective view of another embodiment of an elastic implant sized and configured to rest within or near the leaflet commissures of a dysfunctional heart valve annulus to reshape the annulus and restore leaflet coaptation, the implant defining a closed annular structure that can be symmetrically folded upon itself. -
FIG. 15B is a side view of the implant shown inFIG. 15A when folded upon itself. -
FIG. 15C is a perspective anatomic view, taken from an anterior and slightly superior viewpoint, of a mitral valve in which the elastic implant of the type shown inFIG. 15A has been implanted, showing the implant stretching the commissures to restore leaflet coaptation, and also showing the implant as hugging the annulus. -
FIG. 15D is a side perspective view of another embodiment of an elastic implant sized and configured to rest within or near the leaflet commissures of a dysfunctional heart valve annulus to reshape the annulus and restore leaflet coaptation, the implant defining a closed annular structure that can be asymmetrically folded upon itself. -
FIG. 15E is a perspective anatomic view, taken from an anterior and slightly superior viewpoint, of a mitral valve in which the elastic implant of the type shown inFIG. 15D has been implanted, showing the implant stretching the commissures to restore leaflet coaptation, and also showing the implant as hugging the annulus. -
FIG. 16A is a side perspective view of an elastic implant of the type shown inFIG. 10 , showing an illustrative embodiment of tab structures that serve to anchor and stabilize the implant in an annulus. -
FIG. 16B is a side anterior anatomic view of a mitral valve annulus in which the elastic implant shown inFIG. 16A has been implanted. -
FIG. 17A is a side perspective view of an elastic implant of the type shown inFIG. 10 , showing an illustrative embodiment of multiple contact structures that serve to anchor and stabilize the implant in an annulus. -
FIG. 17B is a side anterior anatomic view of a mitral valve annulus in which the elastic implant shown inFIG. 17A has been implanted. -
FIGS. 18A and 18B are side perspective views of an elastic implant of the type shown inFIG. 10 , showing illustrative embodiments of frictional struts that serve to anchor and stabilize the implant in an annulus. -
FIG. 19 is a side perspective view of an elastic implant of the type shown inFIG. 10 , showing an illustrative embodiment of tissue in-growth surfaces that serve to anchor and stabilize the implant in an annulus. -
FIGS. 20A and 20B are, respectively, a side perspective view and an anatomic view (when implanted) of an elastic implant sized and configured to rest within or near the leaflet commissures of a dysfunctional heart valve annulus to reshape the annulus and restore leaflet coaptation and also showing the implant as rising significantly above the annulus. -
FIGS. 20B and 20C are, respectively, a side perspective view and an anatomic view (when implanted) of an elastic implant sized and configured to rest within or near the leaflet commissures of a dysfunctional heart valve annulus to reshape the annulus and restore leaflet coaptation, and showing the presence of one rail that hugs the annulus and another rail that rises above the implant to serve as a mechanism that anchors and stabilizes the implant in the annulus. -
FIG. 21 is a side elevation view of a tool for implanting an elastic implant in a valve annulus in a open heart surgical procedure to reshape the annulus and restore leaflet coaptation. -
FIGS. 22A to 22F diagrammatically show a method of using the tool shown inFIG. 21 to install an elastic implant in a valve annulus to reshape the annulus and restore leaflet coaptation. -
FIGS. 23A to 23C diagrammatically show a method of gaining intravascular access to the left atrium for the purpose of deploying a delivery catheter to place an implant in a valve annulus to reshape the annulus and restore leaflet coaptation. -
FIG. 24 is a side elevation view of the distal end of the implant delivery catheter shown inFIG. 23C , showing an elastic implant of the type shown inFIG. 10 collapsed in a sleeve for deployment into the left atrium in the manner shown inFIGS. 23A to 23C. -
FIGS. 25A to 25E are diagrammatic perspective views of a method for manipulating the distal end of the implant delivery catheter shown inFIG. 24 to deploy an elastic implant of the type shown inFIG. 10 into a valve annulus to reshape the annulus and restore leaflet coaptation. -
FIG. 26 is a side view of the distal end of the implant delivery catheter of the type shown inFIG. 23C , showing an elastic implant of the type shown inFIG. 10 collapsed in a sleeve for deployment into the left atrium in the manner shown inFIGS. 23A to 23C, also and showing the presence of a guide wire loop to aid in the deployment. -
FIGS. 27A to 27I are diagrammatic views of a method for deploying an elastic implant of the type shown inFIG. 10 into a valve annulus with the aid of a guide wire loop to reshape the annulus and restore leaflet coaptation. -
FIGS. 28A and 28B are perspective view of elastic implants of the type shown inFIGS. 13B to 13E, showing the tethering of such implants to one or more wire loops to aid in their deployment into a valve annulus to reshape the annulus and restore leaflet coaptation. -
FIG. 29 is a side view of the distal end of the implant delivery catheter of the type shown inFIG. 23C , showing a symmetrical foldable elastic implant of the type shown inFIG. 15A folded and collapsed in a sleeve for deployment into the left atrium in the manner shown inFIGS. 23A to 23C. -
FIGS. 30A to 30D are diagrammatic views of a method for manipulating the distal end of the implant delivery catheter shown inFIG. 29 to deploy a symmetrically folded and collapsed elastic implant of the type shown inFIG. 15A into a valve annulus to reshape the annulus and restore leaflet coaptation. -
FIGS. 31A to 31E are diagrammatic views of a method for manipulating the distal end of the implant delivery catheter shown inFIG. 29 to deploy an asymmetrically folded and collapsed elastic implant of the type shown inFIG. 15D into a valve annulus to reshape the annulus and restore leaflet coaptation. -
FIG. 32 is a side view of the distal end of the implant delivery catheter of the type shown inFIG. 23C , showing a symmetrical foldable elastic implant of the type shown inFIG. 15A tethered to a guide wire loop to aid in its implantation into a valve annulus to reshape the annulus and restore leaflet coaptation. -
FIGS. 33A to 33D are diagrammatic views of a method for manipulating the distal end of the implant delivery catheter shown inFIG. 32 to deploy a symmetrically folded and collapsed elastic implant of the type shown inFIG. 15A into a valve annulus with the aid of a guide wire loop to reshape the annulus and restore leaflet coaptation. -
FIG. 34 is a side elevation view of the distal end of the implant delivery catheter of the type shown inFIG. 23C , showing a symmetrical foldable elastic implant of the type shown inFIG. 15A tethered to two guide wire loops to aid in its implantation into a valve annulus to reshape the annulus and restore leaflet coaptation. -
FIGS. 35 and 36 A to 36D are diagrammatic views of a method for manipulating the distal end of the implant delivery catheter to deploy a symmetrically folded and collapsed elastic implant of the type shown inFIG. 15A into a valve annulus with the aid of a separate guide wires to reshape the annulus and restore leaflet coaptation. -
FIGS. 37A to 37C are diagrammatic views of the deployment a symmetrically folded and collapsed elastic implant of the type shown inFIG. 15A into a valve annulus with the aid of a wrapper or bag to reshape the annulus and restore leaflet coaptation. -
FIG. 38 is a side perspective view of a plastically deformable implant sized and configured to be expanded in situ to rest within or near the leaflet commissures of a dysfunctional heart valve annulus to reshape the annulus and restore leaflet coaptation. -
FIGS. 39A to 39C are diagrammatic views of the deployment of a plastically deformable implant of the type shown inFIG. 38 into a valve annulus with the aid of a mechanical expansion device. -
FIGS. 40A to 40C are diagrammatic anatomic views of the deployment of a plastically deformable implant of the type shown inFIG. 38 into a valve annulus with the aid of a balloon expansion device. -
FIG. 41 is a diagrammatic view of a non-compliant balloon deployed into a valve annulus for the purpose of assessing the size and mechanical properties of an implant for the annulus. -
FIG. 42 is a side perspective view of a multi-functional elastic implant sized and configured to rest within or near the leaflet commissures of a dysfunctional heart valve annulus to reshape the annulus and restore leaflet coaptation as well serve as a neo-leaflet to either replace or supplement a damaged heart valve leaflet. -
FIGS. 43 and 44 are side perspective views of a multi-functional elastic implants sized and configured to rest within or near the leaflet commissures of a dysfunctional heart valve annulus to reshape the annulus and restore leaflet coaptation as well serve as a leaflet retainer to prevent a native valve leaflet from being pushed into the atrium upon ventricular contraction. - FIGS. 45 to 47 are side perspective views of a multi-functional elastic implants sized and configured to rest within or near the leaflet commissures of a dysfunctional heart valve annulus to reshape the annulus and restore leaflet coaptation as well serve as a leaflet retainer to prevent a native valve leaflet from being pushed into the atrium upon ventricular contraction, the implants also including a framework that serves to help position and secure the implant in situ.
- Although the disclosure hereof is detailed and exact to enable those skilled in the art to practice the invention, the physical embodiments herein disclosed merely exemplify the invention, which may be embodied in other specific structure. While the preferred embodiment has been described, the details may be changed without departing from the invention, which is defined by the claims.
- I. Implants for Reshaping a Heart Valve Annulus
- A. Overview
-
FIGS. 7A and 8 show animplant 10 sized and configured to rest within or near a heart valve annulus. The implant is shown in a mitral valve, and, in this arrangement, extends along the major (i.e., longest) axis above and/or along the valve annulus. Theimplant 10 is sized and shaped so that, in use, it applies a mechanical force along the major axis. The mechanical force serves to outwardly displace tissue (i.e., to displace tissue away from the center of the annulus) to reshape the annulus. In the illustrated embodiment (on the mitral valve), the mechanical-force serves to lengthen the long axis of the annulus and, in doing so, can reactively shorten in the minor (i.e. shortest) axis, as well as correspondingly reshape other surrounding anatomic structures. It should be appreciated that, when situated in other valve structures, the axes affected may not be the “major” and “minor” axes, due to the surrounding anatomy. It should also be appreciated that, in order to be therapeutic, the implant may only need to reshape the annulus during a portion of the heart cycle, such as during ventricular systolic contraction. For example, the implant may be sized to produce small or negligible outward displacement of tissue during ventricular diastole when the tissue is relaxed, but restrict the inward movement of tissue during ventricular systolic contraction. - The mechanical force applied by the
implant 10 restores to the heart valve annulus and leaflets a more normal anatomic shape and tension (seeFIG. 9 ). The more normal anatomic shape and tension are conducive to coaptation of the leaflets during ventricular systole, which, in turn, reduces regurgitation. Theimplant 10 restores normal function to the valve, without surgically cinching, resecting, and/or fixing in position large portions of a dilated annulus or leaflets, or without the surgical fixation of ring-like structures. - As will be described in greater detail later, the
implant 10 lends itself to delivery to a targeted heart valve site by catheter-based, intravascular techniques, under image guidance. Image guidance includes but is not limited to fluoroscopy, ultrasound, magnetic resonance, computed tomography, or combinations thereof. Alternatively, theimplant 10 can be delivered using conventional open heart surgical techniques or by thoracoscopic surgery techniques. - In its most basic form, the
implant 10 is made—e.g., by bending, shaping, joining, machining, molding, or extrusion—from a biocompatible metallic or polymer material, or a metallic or polymer material that is suitably coated, impregnated, or otherwise treated with a material to impart biocompatibility, or a combination of such materials. The material is also desirably radio-opaque to facilitate fluoroscopic visualization. - As
FIG. 7A shows, theimplant 10 includes a pair ofstruts 12 joined by anintermediate rail 14. AsFIG. 8 shows, thestruts 14 are sized and configured to rest at or near the leaflet commissures. It should be appreciated that the leaflet commissures may not, and typically are not, situated at geometrically opposite sides of the annulus (although for the purpose of illustration, they are shown that way in the Figures). The position of thestruts 12 can be selected to conform to an asymmetric morphology of the annulus, as is later described in connection withFIGS. 13A and 13B . - The
rail 14 spans thestruts 12. The rail 14 (like the struts 12) can take various shapes and have various cross-sectional geometries. The rail 14 (and/or the struts 12) can have, e.g., a generally curvilinear (i.e., round or oval) cross-section, or a generally rectilinear cross section (i.e., square or rectangular), or combinations thereof. - In
FIGS. 7A and 8 , the implant is “elastic.” Therail 14 is sized and configured to possess a normal, unloaded, shape or condition (shown inFIG. 7A ), in which therail 14 is not in compression and thestruts 12 are spaced apart farther than the anterior commissure to posterior commissure dimension of the targeted heart valve annulus. The material of the implant is selected to possess a desired spring constant. The spring constant imparts to therail 14 the ability to be elastically compressed out of its normal, unloaded condition, in response to external compression forces applied at the struts. Therail 14 is sized and configured to assume an elastically loaded, in compression condition, during which thestruts 12 are spaced apart a sufficiently shorter distance to rest in engagement with tissue at or near the leaflet commissures (seeFIG. 8 ). - When in its elastically loaded, compressed condition (see
FIG. 9 ), therail 14 exerts opposing forces to the tissues at or near the commissures through thestruts 12, tending to outwardly displace tissue and stretch the annulus along its major axis, which also typically stretches the leaflet commissures, shortens the minor axis, and/or reshapes surrounding anatomic structures. The implant thereby reshapes the valve annulus toward a shape more conducive to leaflet coaptation. - An elastic implant can be made, e.g., from superelastic alloy, such that the implant can be elastically straightened and/or folded to fit within a catheter or sheath during deployment, and will regain its shape upon deployment (this characteristic will be described in greater detail later).
- Desirably, the elasticity of the
implant 10 itself, along with the elasticity of the valve tissue, ensure that theimplant 10 can be positioned in the valve under a state of net compression and thus remain anchored without the use of sutures, adhesives, or other fixation materials, i.e. which is called compressive anchoring. Theimplant 10 may itself deform elastically, although not necessarily so, but the characteristic of theimplant 10 being elastically deformable may help to maintain compressive anchoring. If theimplant 10 does not deform elastically or does so only slightly, theimplant 10 relies on tissue elasticity to keep the implant anchored. - As
FIGS. 7A to 7E and 8 show, and as will be described in greater detail later, thestruts 12 may carry other structures ormechanisms 16 to further enhance the anchorage and stabilization of the implant in the heart valve annulus. Themechanisms 16 may be located below the plane of the annulus, to engage infra-annular heart tissue adjoining the annulus in the ventricle, and/or be located at or above the plane of the annulus, to engage tissue on the annulus or in the atrium. - The spring constant of the implant may be selected to be greater than the spring constant of adjoining tissue. Alternatively, the spring constant of the implant may be selected to approximate the spring constant of adjoining tissue, thereby providing compliance to allow the
implant 10 to adapt to tissue morphology during use. The spring constant of theimplant 10 may vary along the length of therail 14, so that some portions of therail 14 are stiffer or more compliant than other portions of therail 14. - In an alternative arrangement, the
implant 10 may be formed from a plastically deformable material. In this embodiment, theimplant 10 is manufactured in a normally collapsed condition. Theimplant 10 is expanded in situ into an in use condition within the annulus, e.g., by an inflatable body (e.g., balloon) or by a suitable mechanical device (e.g., a scissorjack). The use and deployment of a plastically deformable implant will be described in greater detail later, after the structure, deployment, and use of elastic implants are described. - B. Illustrative Elastic Implant Configurations
- An
elastic implant 10 having the characteristic just described can take various forms and configurations. The following describes various illustrative arrangements. - 1. Collapsible Annular Implants
- The
implants 10 inFIGS. 7A to 7C comprise asingle rail 14 spanning the distance between thestruts 12. As shown inFIGS. 7D and 10 , animplant 10 can include more than asingle rail 14, imparting a normally closed, annular shape to the implant. As will be described in greater detail later, animplant 10 of this type can be conveyed to an implantation site, e.g., within a catheter or sheath, in a collapsed, straightened condition (with therails 14 collapsed side-by-side) When deployed from the catheter or sheath, theimplant 10 springs open to assume the normally closed, annular shape shown inFIGS. 7D and 10 . - In the arrangement illustrated in
FIG. 10 , theimplant 10 includes tworails 14 spanning thestruts 12. The shape and configuration of therails 14 can be varied, depending upon the desired orientation of therails 14 with respect to the annulus itself. For example, inFIG. 11 , the tworails 14 are shaped and configured so that, when implanted, therails 14 follow the circumferential path of the annulus and rest in generally the same plane as the annulus. This implant can be characterized as “hugging” the annulus. In the example shown inFIG. 12 , the tworails 14 are shaped and configured so that, when implanted, therails 14 follow the circumferential path of the annulus, and also rise above the plane of the annulus. Thisimplant 10 can be characterized as “riding above” the annulus. Animplant 10 that “rides above” the annulus can extend close to the annulus (asFIG. 12 shows) or rise significantly above the annulus toward the dome of the atrium asFIGS. 20A and 20B show. AsFIGS. 20C and 20D show, animplant 10 can include arail 14A that hugs the annulus and arail 14B that rides above the annulus and contacts a heart wall, serving as amechanism 16 that orients and stabilizes the implant. - When the rail or rails 14 of a given implant follow the circumferential contour of the annulus, either at or above the plane of the annulus, the
rails 14 rest out of the way of blood flow though the valve and may reduce hemolysis or thrombosis. - As
FIGS. 13A to 13E show, therails 14 of a givenannular implant 10 can be interrupted to impart a normally open annular (“hemi”) shape to theimplant 10. As will be described in greater detail later, animplant 10 of this type also can be conveyed to an implantation site, e.g., within a catheter or sheath, in a collapsed, straightened condition, and then deployed to assume the open, annular shape shown inFIGS. 13A to 13E. - In
FIG. 13A , the open annular shape is configured so that, when implanted, theimplant 10 hugs the annulus. InFIG. 13B , the open annular shape is configured so that, when implanted, the implant rides above the annulus.FIGS. 13C and 13D show another style of open annular implant, one that hugs the annulus (FIG. 13C ) and the other that rides above the annulus (FIG. 13D ). In this arrangement, the interruptedrail 14 includes interlocking hooks 18 that can be coupled, if desired, to close the annulus of the implant 10 (seeFIG. 13E ). InFIG. 13E , the interlockedimplant 10 is configured to ride above the annulus. - As
FIGS. 13A and 13B show, thestruts 12 need not be placed at diametrically opposite sides of the rail or rails 14. The commissures of a given valve annulus may not be at geometrically opposite sides of the annulus. Accordingly, the position of thestruts 12 may be selected to conform to an asymmetric morphology of the annulus. Thestruts 12 may be used to simply locate theimplant 10 in the valve, imparting little or no force on their own. In this arrangement, the annulus reshaping forces emanate from the rail or rails 14 above the commissures. - The implant possesses a spring constant that approximates the spring constant of tissue, making the implant more accommodating to the movement of the tissue. As
FIG. 14 shows, a given rail or rails 14 can include undulations or the like to impart regions having different spring constants and/or mechanical properties along the length of therail 14. Alternatively, or in combination, the cross-sectional width and/or thickness and/or geometry of a givenrail 14 need not be uniform, but can vary along the length of therail 14 to impart regions of different spring constants and/or mechanical properties. For example, inFIG. 13A , the region of thecontinuous rail 14 between the asymmetrically placedstruts 12 may be thickened or thinned to impart different mechanical properties to achieve the desired shape changing objectives. - 2. Foldable Elastic Annular Implants
- The
implants 10 shown inFIGS. 15A to 15E comprise more than asingle rail 14, imparting a normally closed, annular shape to the implant. Unlike the normally closed,annular implant 10 shown inFIG. 10 , therails 14 of theimplants 10 shown inFIGS. 15A to 15E includecusps 20. Thecusps 20 permit the implants to be resiliently folded along their minor (transverse axis) axis—with thecusps 20 occupying the fold—without permanently deforming the implant (seeFIG. 15B ). As will be described in greater detail later, animplant 10 of this type can be conveyed to an implantation site, e.g., within a catheter or sheath, in a folded as well as collapsed condition, and then deployed to assume the normally closed, annular shape shown inFIG. 15A , asFIG. 15C shows. As before explained, the shape and configuration of therails 14 can be varied so that, when deployed, the implant hugs the annulus or rides above the annulus. - In
FIG. 15A , thecusps 20 are symmetric, being formed on eachrail 14 equidistant to thestruts 12. InFIG. 15A , thestruts 12 are also shown symmetric as to height above therail 14.FIG. 15D shows that thecusps 20 need not be symmetric in either respect. As will be described in greater detail later, this asymmetry permits a stepwise, staggered deployment of the implant, in which the parts of the implant are deployed one at a time in succession—e.g., one strut, then one cusp, then another strut, and then the other cusp—until the implant assumes the closed, annular shape shown inFIG. 15D , asFIG. 15E shows. - 3. Fixation of Implants
- As before stated, the
struts 12 can include other structures ormechanisms 16 to further enhance the anchorage and stabilization of the implant in the heart valve annulus. These structures orother mechanisms 16 can comprise, e.g., loops, pads, barbs, vertical legs, or circumferential legs, or other anchoring structures below, at, and/or above the valve plane. The structures andmechanisms 16 desirably increase the surface area of contact between thestruts 12 and tissue adjoining the annulus. The structures andmechanism 16 desirably rely solely or partly on the valve and neighboring anatomic structures to anchor and fix the position of the implant in the annulus and resist its migration out of the annulus. Implant fixation can also assist in the achieving the desired coaptation of the leaflets and to resist upward movement or eversion of the leaflets during the cardiac cycle. - For example, in the embodiment shown in
FIGS. 7A and 8 , therails 14 carry four struts12, two supra-annular (contacting tissue on the atrial side of the valve) and two infra-annular (contacting tissue on the ventricular size of the valve). Thestruts 12 are separated by a thin spine that curves away from thestruts 12 to avoid contact with the commissures themselves, so as not to interfere with the opening and closing of the valve. - As shown in
FIG. 7A , thestruts 12 may be cushioned to increase traction, decrease erosion, and improve their interaction with the valve annulus. In addition, thestruts 12 may be coated, covered, or impregnated with a tissue growth promoting material. Therails 14 spanning thestruts 12 functions to exert compressive forces on the annulus. Thestruts 12 are secured by the compression forces created by the rail's interaction with the valve annulus. Thestruts 12 assure that the implant is positioned correctly in situ, because they will only seat when positioned at or near the commissures of the valve. - The
struts 12 may be sized and shaped in various ways.FIGS. 7B, 7C , and 7D show various embodiments with alternative designs for thestruts 12. As another example, inFIG. 7E , the supra-annular struts 12 are somewhat larger than the infra-annular struts 12 to improve the anatomical fit of the device in situ. - In the embodiment shown in
FIGS. 16A and 16B , thestruts 12 can carry flat infra-annulartissue contacting pads 26, located below the plane of the valve annulus. Thepads 26 rest on outwardly bowed extensions below the commissures, applying holding forces upon the heart walls. Thepads 26 can take the form of flat surfaces, asFIGS. 16A and 16B show. Tissue penetrating barbs 28 (shown in phantom lines inFIG. 16B ) may enhance the effect of the compression forces to fix the location of the implant. - As
FIGS. 17A and 17B show, thestruts 12 can extend in an undulating fashion below the plane of the valve annulus, to create a series of infra-annular contact surfaces 30 between the implant and the heart walls below and adjoining the annulus. The series of contact surfaces 30 increase the points of contact between the implant and tissue below the annulus. These multiple points ofcontact 30 are additive to the contact between the implant and tissue at or near the commissures themselves. InFIGS. 17A and 17B , additional struts and/or barbs or similar anchoring surfaces (such as shown inFIGS. 16A and 16B ) are not shown associated with the contact surfaces, but they could be included, if desired. - As
FIGS. 18A and 18B show, the implant can include infra-annular frictional struts 32 located below the level of the annulus. The infra-annular frictional struts 32 engage tissue of the heart walls below and adjoining the annulus. Thestruts 32 resist migration of the implant out of the annulus. AsFIG. 18A shows, the frictional struts 32 can be placed in a single level immediately below the commissures, or (asFIG. 18B shows) thestruts 32 can be arranged in multiple levels below the commissures. - As
FIG. 19 shows, thestruts 12 and/or therails 14 can include tissue in-growth surfaces 34. Thesurfaces 14 provide an environment that encourages the in-growth of neighboring tissue on the implant. Once in-growth occurs, theimplant 10 becomes resistant to migration or dislodgment from the annulus. Conventional in-growth materials such as polyester fabric can be used. - Any fixation mechanism or structure may, if desired, be combined with an adhesive or like material to further secure the implant.
- II. Deployment of Elastic Implants for Reshaping a Heart Valve Annulus
- The various implants as just described lend themselves to implantation in a heart valve annulus in various ways. They can be implanted, e.g., in an open heart surgical procedure. Alternatively, they can be implanted using catheter-based technology via a peripheral venous access site, such as in the femoral or jugular vein or femoral artery, or alternatively by thoracoscopically through the chest or by means of other surgical access through the right atrium.
- A. Open Heart Surgical Procedures
-
FIG. 21 shows atool 40 for deploying anelastic implant 10 of the type generally described in an annulus of a heart valve in an open surgical procedure.FIGS. 22A to 22F diagrammatically show the steps of an open surgical procedure for deploying theimplant 10 in a mitral valve annulus using thetool 40 shown inFIG. 21 . - The
tool 40 includes a scissors-action mechanism 42 comprising an operatingend 46 and ahandle end 48. The operatingend 46 includesprongs 44 that can be moved apart and together by manipulation of the handle end 48 (seeFIGS. 22A and 22B ). Theprongs 44 are sized and configured to mate withdeployment apertures 50 formed on thestruts 12 of the implant 10 (shown inFIG. 21 ). The deployment apertures 50 are also shown in the implants in preceding FIGS. 10 to 19, which can be likewise be deployed using thetool 40. - In using the
tool 40, the scissors-action mechanism 42 is manipulated to spread theprongs 44 apart (seeFIGS. 22A and 22B ), so that they can be mated in theapertures 50 of theimplant 10. The scissors-action mechanism 44 is manipulated to bring theprongs 44 together, thereby applying force to thestruts 12 to place theimplant 10 in a compressed condition (seeFIG. 22C ). - With the
tool 40 holding theimplant 10 in this condition, thetool 40 andimplant 10 are introduced through an open surgical approach into the left atrium. Thetool 40 places theimplant 10 within the mitral valve annulus (seeFIG. 22D ). As shown inFIG. 22D , the annulus is shown to have a dimension of D1. This dimension D1 is not conducive to leaflet coaptation, and regurgitation is occurring. It is the purpose of the surgical procedure to repair this dysfunction by reshaping the annulus with theimplant 10. - The scissors-
action mechanism 42 is manipulated to spread theprongs 44 apart until thestruts 12 of theimplant 10 rest within or near the commissures of the mitral valve (seeFIG. 22E ). At this point in the procedure, the dimension D1 of the annulus remains unchanged. Thetool 40 is withdrawn, freeing theprongs 12 from the apertures 50 (seeFIG. 22F ). The elastic unloading of theimplant 10 displaces and spreads the valve tissue apart, achieving a new dimension D2 for the annulus, which is larger than D1. The new dimension D2 is conducive to leaflet coaptation. Theimplant 10 has reshaped the annulus to restore valve function. - B. Illustrative Catheter-Based Intra-Vascular Procedures
- 1. Linear Deployment of Elastic Implants
- FIGS. 23 to 25 show a representative embodiment of a percutaneous catheter-based linear deployment of an unfolded
elastic implant 10 of the type shown in FIGS. 7 to 14. - Percutaneous vascular access is achieved by conventional methods into the femoral or jugular vein. As
FIG. 23A shows, under image guidance, acatheter 52 is steered through the vasculature into the right atrium. Aneedle cannula 54 carried on the distal end of the catheter is deployed to pierce the septum between the right and left atrium. AsFIG. 23B shows, aguide wire 56 is advanced trans-septally through theneedle catheter 52 into the left atrium. Thefirst catheter 52 is withdrawn, and (asFIG. 23C shows) under image guidance, animplant delivery catheter 58 is advanced over theguide wire 56 into the left atrium into proximity with the mitral valve. Alternatively, theimplant delivery catheter 58 can be deployed trans-septally by means of surgical access through the right atrium. - The
implant delivery catheter 58 carries asheath 60 at its distal end (seeFIG. 24 ). Thesheath 60 encloses anelastic implant 10 of a type shown in FIGS. 7 to 14. Theimplant 10 is constrained in a collapsed, straightened condition within the sheath, asFIG. 24 shows. Thesheath 60 can be sized and configured to be withdrawn (e.g., by sliding it proximally), to free theimplant 10. Free of thesheath 60, theelastic implant 10 will expand. Alternatively, aflexible push rod 62 in thecatheter 58 can be used to expel theimplant 10 from thesheath 60, with the same result. Desirably, thestrut 12 on the trailing end of theimplant 10 is folded within thesheath 60 to reduce the collapsed profile and facilitate the expansion of theimplant 10 once free from thesheath 60. - As
FIG. 25A shows, under image guidance, thestrut 12 on the leading end of theimplant 10 is freed from thesheath 60 and seated retrograde in the posterior commissure of the valve annulus. Anchoring structures or mechanisms associated with the strut are also placed into desired contact with adjoining tissue below and/or above the plane of the annulus. AsFIG. 25B shows, thedelivery catheter 58 maintains force on the leadingstrut 12 within the posterior commissure, as thesheath 60 is withdrawn in line with the coaptation line in a posterior-to-anterior direction along the coaptation line. As shown inFIG. 25B , thedelivery catheter 58 may need to dip down retrograde below the plane of the leaflets to maintain sufficient force on the leading end of the implant while the trailing end is freed from thesheath 60. However, as shown inFIG. 25C , thedelivery catheter 58 may be sized and configured to have the column strength sufficient to maintain force on the leading strut without passage below the leaflet plane. - Progressively freed from the
sheath 60, theelastic implant 10 shapes and seats (as FIGS. 25B/C and 25D shows), until the trailingstrut 12 unfolds and seats within the anterior commissure (seeFIG. 25E ). The implant can also be positioned or repositioned under image guidance within the left atrium using a catheter-deployed grasping instrument. - 2. Guide Loop Deployment of Unfolded Elastic Implants
-
FIGS. 26 and 27 A to 27I show another embodiment of animplant delivery catheter 58 that can be used to deploy a foldedelastic implant 10 of the type shown in FIGS. 7 to 14 within the left atrium. - In this embodiment, as in the previous embodiment, the
implant delivery catheter 58 includes asheath 60 that constrains theimplant 10 in a collapsed, straightened condition for passage into the left atrium (seeFIG. 26 ). Thesheath 60 is sized and configured to be withdrawn (e.g., by sliding it proximally), to free the implant for expansion within the left atrium, or apush rod 62 can be used to eject the implant from thesheath 60. To create a desired profile, one or both struts can be folded against the body of the implant within thesheath 60. - Unlike the previous embodiment, a metallic, fiber, or
polymer guide wire 64 is looped through thedeployment apertures 50 on thestruts 12 of theimplant 10 prior to the insertion of theimplant 12 into thesheath 60. The legs of the resultingguide wire loop 66 are passed out the proximal end of thesheath 60 for manipulation, as will now be described. - In use, the
implant delivery catheter 58 is introduced trans-septally into the left atrium in the manner previously described. With the distal end of thecatheter 58 positioned above the valve annulus (seeFIG. 27A ), and prior to withdrawal of thesheath 60, both legs of theguide wire loop 66 are advanced distally in tandem through thesheath 60 to advance theloop 60 beyond thedeployment apertures 50 and out the distal end of thesheath 60. Theguide wire loop 66 desirably carries radio-opaque markers 68 to aid in fluoroscopic visualization. Themarkers 68 identify a desired distance between them and the distal end of thesheath 60, marking a space in which theimplant 10 can freely expand without contacting tissue or anatomic structures within the atrium. Guided by themarkers 68, theloop 66 can be dropped into the annulus a desired distance beyond the distal end of thesheath 60, asFIG. 27A shows. - With the
loop 66 positioned in the desired way within the annulus, thesheath 60 can be withdrawn to free theimplant 10 for expansion (seeFIG. 27B ). While tethered to theguide wire loop 66, theimplant 10 opens within the left atrium—first one strut, then the other—as thesheath 60 is withdrawn, asFIGS. 27C and 27D show. - Once the
implant 10 is fully free of thesheath 60 and expanded, both legs of theguide wire loop 66 can be advanced proximally in tandem through the sheath 60 (seeFIG. 27E ). Thewire loop 66 applies force to thestruts 12 and brings them together (seeFIG. 27F ). This places theimplant 10 in a compressed, elastically loaded condition. Proximal advancement of the legs of thewire loop 66 also draws theimplant 10 in this condition snuggly against the distal end of thecatheter 58 for greater control, asFIG. 27F shows. - With the
implant 10 tethered to thecatheter 58 in this condition (seeFIG. 27G ), thecatheter 58 can be advanced under image guidance to place theimplant 10 within the annulus. Manipulation of thecatheter 58 will bring the struts of the implant into desired alignment. Subsequent distal advancement of the legs of the wire loop 66 (seeFIG. 27H ) allows the struts of theimplant 10 to be elastically unloaded and brought into contact with the surrounding tissue. Anchoring structures or mechanisms associated with thestruts 12 can also be placed into desired contact with adjoining tissue below and/or above the plane of the annulus. The legs of thewire loop 66 can be manipulated to pull thestruts 12 together and/or allow them to separate, until the desired orientation and tissue contact in and about the annulus are achieved. - Once desired orientation and tissue contact are achieved for the
implant 10, one leg of thewire loop 66 can be pulled to release the implant from the guide wire 64 (seeFIG. 27I ). Theimplant 10 is allowed to fully unfold and seat within the annulus. - A
guide loop 66 can be used to deploy open annular implants as well as closed annular implants. As shown inFIG. 28A , asingle guide loop 66 can be threaded through an openannular implant 10 of the type shown inFIG. 13B . Or, as shown inFIG. 28B , twoguide wire loops FIGS. 13D and 13E . In this arrangement, the firstguide wire loop 66A can be manipulated to position thestruts 12 of the implant within the annulus, as just described. The secondguide wire loop 66B can be separately manipulated to pull therails 14 together for interlocking, once the struts rest in a desired manner in the commissures. - 3. Deployment of Folded Elastic Implants
-
FIGS. 15A to 15E showelastic implants 10 that can be folded aboutcusps 20. AsFIG. 29 shows, the folding allows theimplant 10 to be conveyed into the left atrium within asheath 60 of animplant delivery catheter 58 with a delivery profile that not only constitutes a side-to-side collapsed condition—which minimizes the delivery profile diameter—but also constitutes a lengthwise folded condition—which minimizes the delivery profile length. -
FIGS. 30A to 30D illustrate the deployment of a symmetrically foldedelastic implant 10 of the type shown inFIGS. 15A and 15B . Theimplant 10 is constrained in a symmetrically folded and collapsed condition within thesheath 60, asFIG. 30A shows. In this condition, thestruts 12 form the leading end of the implant. Apush rod 62 in thecatheter 58 includes agripping mechanism 70 that holds the foldedimplant 10 by thecusps 20. Thepush rod 62 is advanced to expel theimplant 12 from thesheath 60, bothstruts 12 first. - As
FIG. 30B shows, under image guidance, the foldedimplant 10 is aligned with coaptation line generally equidistant from the commissures, with thestruts 12 oriented to face the commissures (thedelivery catheter 58 has been previously introduced trans-septally into the left atrium, as already described). Manipulating thepush rod 62 advances theimplant 10, both struts first, from thesheath 60. Connecting thepush rod 62 to theimplant 10 allows theimplant 10 to be translated and rotated and retracted during deployment. Freed from the sheath 60 (seeFIG. 30B ), theimplant 10 begins to unfold along thecusps 20, and thestruts 12 draw apart toward the commissures. Further advancement of thepush rod 62 frees more of the unfoldingimplant 10 from thesheath 60, until thestruts 12 draw apart sufficiently to contact the commissures (asFIG. 30C shows). Prior to release of thecusps 20 from the grippingmechanism 70, theimplant 10 can be manipulated to assure that anchoring structures or mechanisms associated with the strut are placed into desired contact with adjoining tissue below and/or above the plane of the annulus. The grippingmechanism 70 can then be activated (seeFIG. 30D ), releasing theimplant 10. -
FIGS. 31A to 31E illustrate the deployment of an asymmetrically foldedelastic implant 10 of the type shown inFIGS. 15D and 15E . Theimplant 10 is constrained in an asymmetrically folded and collapsed condition within thesheath 60, asFIG. 31A shows. The grippingmechanism 70 holds one, but not both of thecusps 20. This is because the height of thecusps 20 above therails 14 is also asymmetric. The grippingmechanism 70 will couple to thetaller cusp 20. Thepush rod 62 can be advanced to expel theimplant 10 from thesheath 60. Due to the asymmetry of thecusps 20, one of thestruts 12 is positioned for deployment before theother strut 12. Also due to the asymmetry of thecusps 20, theshorter cusp 20 is positioned for advancement out of thesheath 60 before thetaller cusp 20 is released by the grippingmechanism 70. - As
FIG. 31B shows, under image guidance, the folded and collapsedimplant 10 is aligned with coaptation line near one of the commissures (thedelivery catheter 58 has been previously introduced trans-septally into the left atrium, as already described). Manipulating thepush rod 62 advances theimplant 10 from thesheath 60. The leadingstrut 12 is freed first (seeFIG. 31B ) and placed against the adjacent commissure. Theimplant 10 can be manipulated to assure that anchoring structures or mechanisms associated with the leading strut are placed into desired contact with adjoining tissue below and/or above the plane of the annulus. Further advancement ofpush rod 62 causes theimplant 10 to unfold toward the opposite commissure. Continued advancement of thepush rod 62 frees more of the unfoldingimplant 10 from thesheath 60, until the trailingstrut 12 contacts the opposite commissure (asFIG. 31C shows). Theimplant 10 can be manipulated to assure that anchoring structures or mechanisms associated with the trailingstrut 12 are placed into desired contact with adjoining tissue below and/or above the plane of the annulus. Further advancement of thepush rod 62 frees theshorter cusp 12 from thesheath 60, and theimplant 10 springs open along this side (seeFIG. 31D ). The grippingmechanism 70 can then be activated (seeFIG. 31 ), releasing thetaller cusp 12. Theimplant 10 springs open in this direction. It can be seen that the. asymmetry of theimplant 10 make possible a step-wise deployment of theimplant 10, one component at a time, in the annulus. - 4. Guide Wire Assisted Deployment of Folded Elastic Implants
- The use of one or
more guide loops 66 or tethers to assist in the deployment of unfolded elastic implants has been previously discussed. One ormore guide loops 66 or tethers can likewise be employed to assist in the deployment of folded elastic implants of either symmetric or asymmetric types. - For example, as shown in
FIG. 32 , a metallic, fiber, orpolymer guide wire 64 can be looped through the deployment apertures on the struts of a folded symmetric orasymmetric implant 10 prior to the folding and insertion of theimplant 10 into thesheath 60. The legs of the resultingguide wire loop 66 are passed out the proximal end of thesheath 60 for manipulation. - In use (see
FIG. 33A )—after theimplant delivery catheter 58 is introduced trans-septally into the left atrium in the manner previously described, and prior to activation of thepush rod 62—both legs of theguide wire loop 66 are advanced distally in tandem through thesheath 60 to advance theloop 66 beyond the deployment apertures and out the distal end of thesheath 60. Theloop 66 is placed within the annulus. - The
push rod 62 is manipulated to free the foldedimplant 10 for expansion (seeFIG. 33B ). Theimplant 10 opens while tethered to theguide wire loop 66. Theloop 66 increases in diameter as thestruts 12 expand apart. The perimeter of theloop 66 will orient itself along the greatest dimension of the annulus—which is the distance between the commissures. Theloop 66 thereby orients theimplant 10 with the coaptation line duringimplant 10 expansion. The legs of theloop 66 guide thestruts 12 to the commissures (asFIG. 33C shows). - Tethered to the
catheter 58, theimplant 10 is deployed in the annulus. Theguide wire loop 66 maintains control of the strut spacing within the commissures during implant expansion. - Once desired orientation and tissue contact are achieved for the
implant 10, the grippingmechanism 70 can release theimplant 10. One leg of thewire loop 66 can be pulled to release theimplant 10 from the guide wire (seeFIG. 33D ). Theimplant 10 is allowed to fully unfold and seat within the annulus. - As
FIG. 34 shows, a second guide wire loop 72 can also be passed through apertures on thecusps 20. This guide wire loop 72 can be manipulated independently of the firstguide wire loop 66, to control deployment of the expandingimplant 10 in the septal-to-lateral dimension. Simultaneous, although independent, control of the expandingimplant 10 can be achieved by manipulation of thefirst guide wire 66. - As
FIGS. 35 and 36 A to 36D show, separate metallic, fiber, orpolymer guide wires 92 can be individually threaded (without looping) through small holes on the struts of a folded symmetric orasymmetric implant 10 prior to the folding and insertion of theimplant 10 into the sheath 60 (seeFIG. 35 ). Theseparate guide wires 92 are passed out the proximal end of thesheath 60 for manipulation. - In use (see
FIG. 36A )—after theimplant delivery catheter 58 is introduced trans-septally into the left atrium in the manner previously described, and prior to activation of thepush rod 62—theseparate guide wires 92 are advanced distally in tandem through thesheath 60 and out the distal end of thesheath 60. The ends of thewires 92 are placed within the annulus. - The
push rod 62 is manipulated to free the foldedimplant 10 for expansion (seeFIG. 36B ). Theimplant 10 opens while tethered to theseparate guide wires 92. Theguide wires 92 will orient themselves along the major axis of the annulus—which is the distance between the commissures, to orient theimplant 10 with the coaptation line duringimplant 10 expansion. Theguide wires 92 separately guide therespective struts 12 to the commissures (asFIG. 36C shows). - Tethered to the
catheter 58, theimplant 10 is deployed in the annulus. Theguide wires 92 maintain control of the strut spacing within the commissures during implant expansion. - Once desired orientation and tissue contact are achieved for the
implant 10, the grippingmechanism 70 can release theimplant 10. Theguide wires 92 can be pulled to release theimplant 10 from the guide wires (seeFIG. 36D ). Theimplant 10 is allowed to fully unfold and seat within the annulus. - 5. Other Forms of Assisted Deployment of Folded Elastic Implants
- The foregoing embodiments demonstrate that the unfolding of an
elastic implant 10 can be controlled during deployment in either the major axis dimension, or the minor axis (septal-to-lateral) dimension, or in both dimensions by means of guide wires. Other forms of restraining mechanisms can be used to control the unfolding of theimplant 10. - For example, as shown in
FIG. 37A , the foldedimplant 10 can be restrained within a bag orwrapper 76 as theimplant 10 is advanced from thedelivery sheath 60. The bag orwrapper 76 restricts expansion of theimplant 10 beyond a selected point (e.g., 80% of full deployment), allowing the physician to attend to the important task of seating the struts in the commissures before theimplant 10 fully opens across the annulus. Once theimplant 10 has been seated in the commissures and released from the delivery sheath 60 (seeFIG. 37B ), a ripcord 78 coupled to the bag orwrapper 76 can be pulled, to release the bag orwrapper 76 from the implant 10 (seeFIG. 37C ). Freed from the bag orwrapper 76, theimplant 10 completes its expansion, to achieve final shaping and seating within the annulus. One or more guide wires can be used in combination with the bag orwrapper 76. The bag orwrapper 76 can alternatively be sized and configured to tear away as a result of theimplant 10 expanding beyond a given point, without the use of a ripcord 78 or similar induced tearing mechanism. In another arrangement, theimplant 10 can be enclosed within a shrink-wrap structure having a score line. In these arrangements, the structure is sized and configured to restrain expansion of theimplant 10 until theimplant 10 is advanced outside of the delivery sheath beyond a given point, at which time the score line parts or the material strength of the structure is exceeded, to open and fully release theimplant 10. - III. Plastically Deformable Implants for Reshaping a Heart Valve Annulus and Their Deployment
- As previously described, the
implant 10 may be formed from plastically deformable material (see FIG. 38). Theimplant 10 includes struts and one or more rails, as previously described. Theimplant 10 is deployed by animplant delivery catheter 58 into the left atrium in a normally collapsed condition. In this arrangement, animplant delivery catheter 58 can carry amechanical expansion device 80, such as a scissorjack or the like (seeFIGS. 39A to 39C), to expand the plastically deformable material of theimplant 10 in situ within the annulus. Alternatively, animplant delivery catheter 58 can carry an inflatable body 82 (e.g., balloon) (seeFIGS. 40A to 40C), to expand theimplant 10 within the annulus. During expansion, the plasticallydeformable implant 10 stretches the annulus to achieve a desired major axis size. Once expanded, the plasticallydeformable implant 10 maintains the desired distance, thereby resisting contraction of the annulus. The plasticallydeformable implant 10 may include other structures or mechanisms to further anchor and stabilize theimplant 10 in the heart valve annulus. - IV. Ascertaining Implant Size and Resistance
- The shape and structure of a heart valve such as a mitral valve and the neighboring anatomic structures are generally understood by medical professionals using textbooks of human anatomy along with their knowledge of the site and its disease or injury. Ranges of shapes and dimensions for a given implant are defined by the site to be treated. Precise dimensions for a given patient can be determined by X-ray, MRI, or CT scanning of the site to be treated prior to implantation of an implant.
- A physician may also ascertain the size and resistance for a given implant by the deployment of a
non-compliant balloon gauge 84 in the targeted annulus, as shown inFIG. 41 . Theballoon gauge 84 can carry radio-opaque markers 86 so that dimensions of the annulus can be determined using imaging means and/or other forms of in situ visualization. The compliance and tension forces of the annulus can also be physically measured, by sensing and quantifying the resistance theballoon gauge 84 encounters during expansion in the annulus. Based upon this data, and taking into account the physician's knowledge of the site and its disease or injury, a physician can select a desired size and mechanical properties for the implant. - V. Multi-Functional Implants
- Various embodiments of
implants 10 have described the context of reshaping a heart valve annulus. A givenimplant 10 having technical features suited for this function can also incorporate other technical features well suited for other functions. - By way of illustration,
FIG. 42 shows anannulus remodeling implant 10 in which therails 14 are sized and configured to define a pseudo-annulus. Aneoleaflet element 88 comprising a fabric-covered bridge structure is coupled to the rails. The neoleaflet element is sized and configured to occupy the space of at least a portion of a native heart valve leaflet to provide a one-way valve function. In response to ventricular diastolic pressure, the one-way valve function assumes a valve opened condition within the pseudo-annulus. In response to ventricular systolic pressure, the one-way valve function assumes a valve closed condition within the pseudo-annulus. Theneoleaflet element 88 serves to repair, replace, or supplement a damaged heart valve. -
FIGS. 43 and 44 show anannulus remodeling implant 10 in which therails 14 are sized and configured serve as a pseudo-annulus. Theimplant 10 includes a retainingstructure 90 near or within the pseudo-annulus that is sized and shaped to overlay at least a portion of one or more native valve leaflets. The retainingstructure 90 retains a native valve leaflet, keeping the valve leaflet from a retrograde flow condition, e.g., by being pushed into the atrium, i.e., eversion and/or prolapse. - As further examples of multi-functional implants, FIGS. 45 to 47 shows an
annulus remodeling implant 10 in which the rails further include a framework 38 (as previously described) to help position and secure the device in situ. In FIGS. 45 to 47, theframework 38 also includes aleaflet retaining structure 90, as just described. - While the new devices and methods have been more specifically described in the context of the treatment of a mitral heart valve, it should be understood that other heart valve types can be treated in the same or equivalent fashion. By way of example, and not by limitation, the present systems and methods could be used to prevent or reduce retrograde flow in any heart valve annulus, including the tricuspid valve, the pulmonary valve, or the aortic valve. In addition, other embodiments and uses of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein. The specification and examples should be considered exemplary and merely descriptive of key technical; features and principles, and are not meant to be limiting. The true scope and spirit of the invention are defined by the following claims. As will be easily understood by those of ordinary skill in the art, variations and modifications of each of the disclosed embodiments can be easily made within the scope of this invention as defined by the following claims.
Claims (44)
Priority Applications (22)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/677,104 US20060106456A9 (en) | 2002-10-01 | 2003-10-01 | Devices, systems, and methods for reshaping a heart valve annulus |
US10/846,850 US8784482B2 (en) | 2000-09-20 | 2004-05-14 | Method of reshaping a heart valve annulus using an intravascular device |
US10/894,433 US8956407B2 (en) | 2000-09-20 | 2004-07-19 | Methods for reshaping a heart valve annulus using a tensioning implant |
US11/089,940 US7691144B2 (en) | 2003-10-01 | 2005-03-25 | Devices, systems, and methods for reshaping a heart valve annulus |
US11/089,939 US20050228422A1 (en) | 2002-11-26 | 2005-03-25 | Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools |
US11/089,949 US20050222489A1 (en) | 2003-10-01 | 2005-03-25 | Devices, systems, and methods for reshaping a heart valve annulus, including the use of a bridge implant |
US11/389,819 US20060252984A1 (en) | 2000-09-20 | 2006-03-27 | Devices, systems, and methods for reshaping a heart valve annulus |
US11/903,472 US20080091264A1 (en) | 2002-11-26 | 2007-09-21 | Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools |
US11/980,838 US20080140188A1 (en) | 2001-10-01 | 2007-10-31 | Devices, systems, and methods for reshaping a heart valve annulus |
US12/460,647 US20090287179A1 (en) | 2003-10-01 | 2009-07-22 | Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools |
US12/462,956 US9861475B2 (en) | 2000-09-20 | 2009-08-12 | Devices, systems, and methods for reshaping a heart valve annulus |
US12/657,527 US8187207B2 (en) | 2003-10-01 | 2010-01-22 | Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools |
US12/658,909 US20100161044A1 (en) | 2003-10-01 | 2010-02-17 | Devices, systems, and methods for reshaping a heart valve annulus |
US12/924,219 US8163013B2 (en) | 2001-10-01 | 2010-09-23 | Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools |
US13/272,716 US8979925B2 (en) | 2000-09-20 | 2011-10-13 | Devices, systems, and methods for reshaping a heart valve annulus |
US13/454,767 US8858622B2 (en) | 2000-09-20 | 2012-04-24 | Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools |
US13/482,586 US8690858B2 (en) | 2000-09-20 | 2012-05-29 | Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools |
US14/248,012 US20140222138A1 (en) | 2000-09-20 | 2014-04-08 | Devices, Systems, and Methods for Reshaping a Heart Valve Annulus, Including the Use of Magnetic Tools |
US14/624,131 US20150157459A1 (en) | 2000-09-20 | 2015-02-17 | Devices and Systems for Reshaping a Heart Valve Annulus, Using a Tensioning Implant |
US14/659,157 US9498331B2 (en) | 2000-09-20 | 2015-03-16 | Devices, systems, and methods for reshaping a heart valve annulus |
US14/945,722 US20160067043A1 (en) | 2000-09-20 | 2015-11-19 | Devices, systems, and methods for reshaping a heart valve annulus including the use of magnetic tools |
US15/299,908 US10219905B2 (en) | 2003-10-01 | 2016-10-21 | Devices, systems, and methods for reshaping a heart valve annulus |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2002/031376 WO2003028558A2 (en) | 2001-10-01 | 2002-10-01 | Methods and devices for heart valve treatments |
US42946202P | 2002-11-26 | 2002-11-26 | |
US42944402P | 2002-11-26 | 2002-11-26 | |
US42970902P | 2002-11-26 | 2002-11-26 | |
PCT/US2003/030831 WO2004030569A2 (en) | 2002-10-01 | 2003-10-01 | Devices, systems, and methods for reshaping a heart valve annulus |
US10/677,104 US20060106456A9 (en) | 2002-10-01 | 2003-10-01 | Devices, systems, and methods for reshaping a heart valve annulus |
Related Parent Applications (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/666,617 Continuation-In-Part US6893459B1 (en) | 2000-09-20 | 2000-09-20 | Heart valve annulus device and method of using same |
US09/666,617 Continuation US6893459B1 (en) | 2000-09-20 | 2000-09-20 | Heart valve annulus device and method of using same |
US09666617 Continuation | 2002-10-01 | ||
PCT/US2002/031376 Continuation WO2003028558A2 (en) | 2000-09-20 | 2002-10-01 | Methods and devices for heart valve treatments |
PCT/US2002/031376 Continuation-In-Part WO2003028558A2 (en) | 2000-09-20 | 2002-10-01 | Methods and devices for heart valve treatments |
US10/846,850 Continuation-In-Part US8784482B2 (en) | 2000-09-20 | 2004-05-14 | Method of reshaping a heart valve annulus using an intravascular device |
US10/894,433 Continuation-In-Part US8956407B2 (en) | 2000-09-20 | 2004-07-19 | Methods for reshaping a heart valve annulus using a tensioning implant |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/846,850 Continuation-In-Part US8784482B2 (en) | 2000-09-20 | 2004-05-14 | Method of reshaping a heart valve annulus using an intravascular device |
US10/894,433 Continuation-In-Part US8956407B2 (en) | 2000-09-20 | 2004-07-19 | Methods for reshaping a heart valve annulus using a tensioning implant |
US12/462,956 Continuation US9861475B2 (en) | 2000-09-20 | 2009-08-12 | Devices, systems, and methods for reshaping a heart valve annulus |
Publications (2)
Publication Number | Publication Date |
---|---|
US20040127982A1 US20040127982A1 (en) | 2004-07-01 |
US20060106456A9 true US20060106456A9 (en) | 2006-05-18 |
Family
ID=44585015
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/677,104 Abandoned US20060106456A9 (en) | 2000-09-20 | 2003-10-01 | Devices, systems, and methods for reshaping a heart valve annulus |
US12/462,956 Active 2027-01-31 US9861475B2 (en) | 2000-09-20 | 2009-08-12 | Devices, systems, and methods for reshaping a heart valve annulus |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/462,956 Active 2027-01-31 US9861475B2 (en) | 2000-09-20 | 2009-08-12 | Devices, systems, and methods for reshaping a heart valve annulus |
Country Status (10)
Country | Link |
---|---|
US (2) | US20060106456A9 (en) |
EP (1) | EP1562522B1 (en) |
JP (1) | JP2006501033A (en) |
CN (1) | CN100553590C (en) |
AT (1) | ATE418938T1 (en) |
AU (2) | AU2003277116A1 (en) |
CA (1) | CA2498030A1 (en) |
DE (1) | DE60325634D1 (en) |
HK (1) | HK1082175A1 (en) |
WO (1) | WO2004030569A2 (en) |
Cited By (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050171601A1 (en) * | 2000-10-05 | 2005-08-04 | Cosgrove Delos M. | Minimally-invasive annuloplasty repair segment delivery system |
US20060247672A1 (en) * | 2005-04-27 | 2006-11-02 | Vidlund Robert M | Devices and methods for pericardial access |
US20070208417A1 (en) * | 2006-03-01 | 2007-09-06 | Cook Incorporated | Methods of reducing retrograde flow |
US20080126131A1 (en) * | 2006-07-17 | 2008-05-29 | Walgreen Co. | Predictive Modeling And Risk Stratification Of A Medication Therapy Regimen |
US20080167713A1 (en) * | 2007-01-08 | 2008-07-10 | Bolling Steven F | Reconfiguring Heart Features |
US20090264995A1 (en) * | 2008-04-16 | 2009-10-22 | Subramanian Valavanur A | Transvalvular intraannular band for valve repair |
US20090306622A1 (en) * | 2000-09-20 | 2009-12-10 | Ample Medical, Inc. | Devices, systems, and methods for reshaping a heat valve annulus |
US7666224B2 (en) | 2002-11-12 | 2010-02-23 | Edwards Lifesciences Llc | Devices and methods for heart valve treatment |
US7670368B2 (en) | 2005-02-07 | 2010-03-02 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US7678145B2 (en) | 2002-01-09 | 2010-03-16 | Edwards Lifesciences Llc | Devices and methods for heart valve treatment |
US7682385B2 (en) | 2002-04-03 | 2010-03-23 | Boston Scientific Corporation | Artificial valve |
US20100121433A1 (en) * | 2007-01-08 | 2010-05-13 | Millipede Llc, A Corporation Of Michigan | Reconfiguring heart features |
US20100121435A1 (en) * | 2008-04-16 | 2010-05-13 | Cardiovascular Technologies, Llc | Percutaneous transvalvular intrannular band for mitral valve repair |
US20100121437A1 (en) * | 2008-04-16 | 2010-05-13 | Cardiovascular Technologies, Llc | Transvalvular intraannular band and chordae cutting for ischemic and dilated cardiomyopathy |
US7722666B2 (en) | 2005-04-15 | 2010-05-25 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US20100131057A1 (en) * | 2008-04-16 | 2010-05-27 | Cardiovascular Technologies, Llc | Transvalvular intraannular band for aortic valve repair |
US7776053B2 (en) | 2000-10-26 | 2010-08-17 | Boston Scientific Scimed, Inc. | Implantable valve system |
US7780627B2 (en) | 2002-12-30 | 2010-08-24 | Boston Scientific Scimed, Inc. | Valve treatment catheter and methods |
US7780722B2 (en) | 2005-02-07 | 2010-08-24 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US7799038B2 (en) | 2006-01-20 | 2010-09-21 | Boston Scientific Scimed, Inc. | Translumenal apparatus, system, and method |
US20100249920A1 (en) * | 2007-01-08 | 2010-09-30 | Millipede Llc | Reconfiguring heart features |
US7854761B2 (en) | 2003-12-19 | 2010-12-21 | Boston Scientific Scimed, Inc. | Methods for venous valve replacement with a catheter |
US7854755B2 (en) | 2005-02-01 | 2010-12-21 | Boston Scientific Scimed, Inc. | Vascular catheter, system, and method |
US7867274B2 (en) | 2005-02-23 | 2011-01-11 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US7883539B2 (en) | 1997-01-02 | 2011-02-08 | Edwards Lifesciences Llc | Heart wall tension reduction apparatus and method |
US7892276B2 (en) | 2007-12-21 | 2011-02-22 | Boston Scientific Scimed, Inc. | Valve with delayed leaflet deployment |
US7951189B2 (en) | 2005-09-21 | 2011-05-31 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US7967853B2 (en) | 2007-02-05 | 2011-06-28 | Boston Scientific Scimed, Inc. | Percutaneous valve, system and method |
US8002824B2 (en) | 2004-09-02 | 2011-08-23 | Boston Scientific Scimed, Inc. | Cardiac valve, system, and method |
US8012198B2 (en) | 2005-06-10 | 2011-09-06 | Boston Scientific Scimed, Inc. | Venous valve, system, and method |
US8128681B2 (en) | 2003-12-19 | 2012-03-06 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US8133270B2 (en) | 2007-01-08 | 2012-03-13 | California Institute Of Technology | In-situ formation of a valve |
US8163010B1 (en) | 2008-06-03 | 2012-04-24 | Cardica, Inc. | Staple-based heart valve treatment |
EP2478868A1 (en) | 2011-01-25 | 2012-07-25 | The Provost, Fellows, Foundation Scholars, and the other Members of Board, of the College of the Holy and Undivided Trinity of Queen Elizabeth | Implant device |
US20120191182A1 (en) * | 2006-06-01 | 2012-07-26 | Edwards Lifesciences Corporation | Prosthetic insert for treating a mitral valve |
US8496671B1 (en) | 2010-06-16 | 2013-07-30 | Cardica, Inc. | Mitral valve treatment |
US8828079B2 (en) | 2007-07-26 | 2014-09-09 | Boston Scientific Scimed, Inc. | Circulatory valve, system and method |
US9034033B2 (en) | 2011-10-19 | 2015-05-19 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US9125740B2 (en) | 2011-06-21 | 2015-09-08 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
US9180005B1 (en) | 2014-07-17 | 2015-11-10 | Millipede, Inc. | Adjustable endolumenal mitral valve ring |
US9198757B2 (en) | 2000-10-06 | 2015-12-01 | Edwards Lifesciences, Llc | Methods and devices for improving mitral valve function |
US9421098B2 (en) | 2010-12-23 | 2016-08-23 | Twelve, Inc. | System for mitral valve repair and replacement |
US9579198B2 (en) | 2012-03-01 | 2017-02-28 | Twelve, Inc. | Hydraulic delivery systems for prosthetic heart valve devices and associated methods |
US9655722B2 (en) | 2011-10-19 | 2017-05-23 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US9668859B2 (en) | 2011-08-05 | 2017-06-06 | California Institute Of Technology | Percutaneous heart valve delivery systems |
US9744037B2 (en) | 2013-03-15 | 2017-08-29 | California Institute Of Technology | Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves |
US9763780B2 (en) | 2011-10-19 | 2017-09-19 | Twelve, Inc. | Devices, systems and methods for heart valve replacement |
US9795480B2 (en) | 2010-08-24 | 2017-10-24 | Millipede, Inc. | Reconfiguring tissue features of a heart annulus |
US9848983B2 (en) | 2015-02-13 | 2017-12-26 | Millipede, Inc. | Valve replacement using rotational anchors |
US9901443B2 (en) | 2011-10-19 | 2018-02-27 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US10111747B2 (en) | 2013-05-20 | 2018-10-30 | Twelve, Inc. | Implantable heart valve devices, mitral valve repair devices and associated systems and methods |
US10238490B2 (en) | 2015-08-21 | 2019-03-26 | Twelve, Inc. | Implant heart valve devices, mitral valve repair devices and associated systems and methods |
US10265172B2 (en) | 2016-04-29 | 2019-04-23 | Medtronic Vascular, Inc. | Prosthetic heart valve devices with tethered anchors and associated systems and methods |
US10278819B2 (en) | 2015-06-01 | 2019-05-07 | Edwards Lifesciences Corporation | Cardiac valve repair devices configured for percutaneous delivery |
US10335275B2 (en) | 2015-09-29 | 2019-07-02 | Millipede, Inc. | Methods for delivery of heart valve devices using intravascular ultrasound imaging |
US10433961B2 (en) | 2017-04-18 | 2019-10-08 | Twelve, Inc. | Delivery systems with tethers for prosthetic heart valve devices and associated methods |
US10456259B2 (en) | 2008-04-16 | 2019-10-29 | Heart Repair Technologies, Inc. | Transvalvular intraannular band for mitral valve repair |
US10543088B2 (en) | 2012-09-14 | 2020-01-28 | Boston Scientific Scimed, Inc. | Mitral valve inversion prostheses |
US10548731B2 (en) | 2017-02-10 | 2020-02-04 | Boston Scientific Scimed, Inc. | Implantable device and delivery system for reshaping a heart valve annulus |
US10555813B2 (en) | 2015-11-17 | 2020-02-11 | Boston Scientific Scimed, Inc. | Implantable device and delivery system for reshaping a heart valve annulus |
US10575950B2 (en) | 2017-04-18 | 2020-03-03 | Twelve, Inc. | Hydraulic systems for delivering prosthetic heart valve devices and associated methods |
US10646338B2 (en) | 2017-06-02 | 2020-05-12 | Twelve, Inc. | Delivery systems with telescoping capsules for deploying prosthetic heart valve devices and associated methods |
US20200146854A1 (en) * | 2016-05-16 | 2020-05-14 | Elixir Medical Corporation | Methods and devices for heart valve repair |
US10702378B2 (en) | 2017-04-18 | 2020-07-07 | Twelve, Inc. | Prosthetic heart valve device and associated systems and methods |
US10702380B2 (en) | 2011-10-19 | 2020-07-07 | Twelve, Inc. | Devices, systems and methods for heart valve replacement |
US10709591B2 (en) | 2017-06-06 | 2020-07-14 | Twelve, Inc. | Crimping device and method for loading stents and prosthetic heart valves |
US10729541B2 (en) | 2017-07-06 | 2020-08-04 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
US10786352B2 (en) | 2017-07-06 | 2020-09-29 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
US10792151B2 (en) | 2017-05-11 | 2020-10-06 | Twelve, Inc. | Delivery systems for delivering prosthetic heart valve devices and associated methods |
US10849755B2 (en) | 2012-09-14 | 2020-12-01 | Boston Scientific Scimed, Inc. | Mitral valve inversion prostheses |
US10912546B2 (en) | 2005-04-22 | 2021-02-09 | Laurent Schaller | Catheter-based tissue remodeling devices and methods |
US10940167B2 (en) | 2012-02-10 | 2021-03-09 | Cvdevices, Llc | Methods and uses of biological tissues for various stent and other medical applications |
US11013599B2 (en) | 2008-04-16 | 2021-05-25 | Heart Repair Technologies, Inc. | Percutaneous transvalvular intraannular band for mitral valve repair |
US11033391B2 (en) | 2016-12-22 | 2021-06-15 | Heart Repair Technologies, Inc. | Percutaneous delivery systems for anchoring an implant in a cardiac valve annulus |
US11083579B2 (en) | 2008-04-16 | 2021-08-10 | Heart Repair Technologies, Inc. | Transvalvular intraanular band and chordae cutting for ischemic and dilated cardiomyopathy |
US11202704B2 (en) | 2011-10-19 | 2021-12-21 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US11406495B2 (en) | 2013-02-11 | 2022-08-09 | Cook Medical Technologies Llc | Expandable support frame and medical device |
Families Citing this family (326)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6050936A (en) | 1997-01-02 | 2000-04-18 | Myocor, Inc. | Heart wall tension reduction apparatus |
CA2264561C (en) * | 1997-06-27 | 2013-04-09 | The Trustees Of Columbia University In The City Of New York | Method and apparatus for circulatory valve repair |
FR2768324B1 (en) | 1997-09-12 | 1999-12-10 | Jacques Seguin | SURGICAL INSTRUMENT FOR PERCUTANEOUSLY FIXING TWO AREAS OF SOFT TISSUE, NORMALLY MUTUALLY REMOTE, TO ONE ANOTHER |
US6332893B1 (en) | 1997-12-17 | 2001-12-25 | Myocor, Inc. | Valve to myocardium tension members device and method |
US6260552B1 (en) | 1998-07-29 | 2001-07-17 | Myocor, Inc. | Transventricular implant tools and devices |
US10327743B2 (en) * | 1999-04-09 | 2019-06-25 | Evalve, Inc. | Device and methods for endoscopic annuloplasty |
US6752813B2 (en) | 1999-04-09 | 2004-06-22 | Evalve, Inc. | Methods and devices for capturing and fixing leaflets in valve repair |
US20040044350A1 (en) | 1999-04-09 | 2004-03-04 | Evalve, Inc. | Steerable access sheath and methods of use |
US7666204B2 (en) | 1999-04-09 | 2010-02-23 | Evalve, Inc. | Multi-catheter steerable guiding system and methods of use |
US8216256B2 (en) | 1999-04-09 | 2012-07-10 | Evalve, Inc. | Detachment mechanism for implantable fixation devices |
US7811296B2 (en) | 1999-04-09 | 2010-10-12 | Evalve, Inc. | Fixation devices for variation in engagement of tissue |
DE60045096D1 (en) | 1999-04-09 | 2010-11-25 | Evalve Inc | METHOD AND DEVICE FOR HEART LAPSE REPERATION |
EP1113497A3 (en) * | 1999-12-29 | 2006-01-25 | Texas Instruments Incorporated | Semiconductor package with conductor impedance selected during assembly |
US20050222489A1 (en) | 2003-10-01 | 2005-10-06 | Ample Medical, Inc. | Devices, systems, and methods for reshaping a heart valve annulus, including the use of a bridge implant |
US20080091264A1 (en) | 2002-11-26 | 2008-04-17 | Ample Medical, Inc. | Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools |
US8784482B2 (en) * | 2000-09-20 | 2014-07-22 | Mvrx, Inc. | Method of reshaping a heart valve annulus using an intravascular device |
US6974476B2 (en) * | 2003-05-05 | 2005-12-13 | Rex Medical, L.P. | Percutaneous aortic valve |
US6800090B2 (en) | 2001-05-14 | 2004-10-05 | Cardiac Dimensions, Inc. | Mitral valve therapy device, system and method |
US7635387B2 (en) | 2001-11-01 | 2009-12-22 | Cardiac Dimensions, Inc. | Adjustable height focal tissue deflector |
US6824562B2 (en) | 2002-05-08 | 2004-11-30 | Cardiac Dimensions, Inc. | Body lumen device anchor, device and assembly |
US7311729B2 (en) * | 2002-01-30 | 2007-12-25 | Cardiac Dimensions, Inc. | Device and method for modifying the shape of a body organ |
US6575971B2 (en) * | 2001-11-15 | 2003-06-10 | Quantum Cor, Inc. | Cardiac valve leaflet stapler device and methods thereof |
US6976995B2 (en) | 2002-01-30 | 2005-12-20 | Cardiac Dimensions, Inc. | Fixed length anchor and pull mitral valve device and method |
US7179282B2 (en) | 2001-12-05 | 2007-02-20 | Cardiac Dimensions, Inc. | Device and method for modifying the shape of a body organ |
US6793673B2 (en) * | 2002-12-26 | 2004-09-21 | Cardiac Dimensions, Inc. | System and method to effect mitral valve annulus of a heart |
US20050209690A1 (en) * | 2002-01-30 | 2005-09-22 | Mathis Mark L | Body lumen shaping device with cardiac leads |
US7004958B2 (en) * | 2002-03-06 | 2006-02-28 | Cardiac Dimensions, Inc. | Transvenous staples, assembly and method for mitral valve repair |
CA2950492C (en) | 2002-05-08 | 2018-12-04 | Cardiac Dimensions Pty. Ltd. | Device and method for modifying the shape of a body organ |
US7101395B2 (en) * | 2002-06-12 | 2006-09-05 | Mitral Interventions, Inc. | Method and apparatus for tissue connection |
AU2003277118A1 (en) * | 2002-10-01 | 2004-04-23 | Ample Medical, Inc. | Devices for retaining native heart valve leaflet |
US7316708B2 (en) | 2002-12-05 | 2008-01-08 | Cardiac Dimensions, Inc. | Medical device delivery system |
US7837729B2 (en) | 2002-12-05 | 2010-11-23 | Cardiac Dimensions, Inc. | Percutaneous mitral valve annuloplasty delivery system |
US7314485B2 (en) | 2003-02-03 | 2008-01-01 | Cardiac Dimensions, Inc. | Mitral valve device using conditioned shape memory alloy |
US20040158321A1 (en) * | 2003-02-12 | 2004-08-12 | Cardiac Dimensions, Inc. | Method of implanting a mitral valve therapy device |
US20040220654A1 (en) | 2003-05-02 | 2004-11-04 | Cardiac Dimensions, Inc. | Device and method for modifying the shape of a body organ |
US10631871B2 (en) | 2003-05-19 | 2020-04-28 | Evalve, Inc. | Fixation devices, systems and methods for engaging tissue |
US7887582B2 (en) | 2003-06-05 | 2011-02-15 | Cardiac Dimensions, Inc. | Device and method for modifying the shape of a body organ |
US7351259B2 (en) * | 2003-06-05 | 2008-04-01 | Cardiac Dimensions, Inc. | Device, system and method to affect the mitral valve annulus of a heart |
WO2005002424A2 (en) * | 2003-07-02 | 2005-01-13 | Flexcor, Inc. | Annuloplasty rings and methods for repairing cardiac valves |
ATE442107T1 (en) | 2003-07-21 | 2009-09-15 | Univ Pennsylvania | PERCUTANE HEART VALVE |
US20050137449A1 (en) * | 2003-12-19 | 2005-06-23 | Cardiac Dimensions, Inc. | Tissue shaping device with self-expanding anchors |
US7837728B2 (en) * | 2003-12-19 | 2010-11-23 | Cardiac Dimensions, Inc. | Reduced length tissue shaping device |
US9526616B2 (en) | 2003-12-19 | 2016-12-27 | Cardiac Dimensions Pty. Ltd. | Mitral valve annuloplasty device with twisted anchor |
US7794496B2 (en) | 2003-12-19 | 2010-09-14 | Cardiac Dimensions, Inc. | Tissue shaping device with integral connector and crimp |
US8287584B2 (en) * | 2005-11-14 | 2012-10-16 | Sadra Medical, Inc. | Medical implant deployment tool |
EP1750592B1 (en) | 2004-05-14 | 2016-12-28 | Evalve, Inc. | Locking mechanisms for fixation devices |
CA2748617C (en) | 2004-09-27 | 2014-09-23 | Evalve, Inc. | Methods and devices for tissue grasping and assessment |
US8052592B2 (en) | 2005-09-27 | 2011-11-08 | Evalve, Inc. | Methods and devices for tissue grasping and assessment |
WO2006041505A1 (en) | 2004-10-02 | 2006-04-20 | Huber Christoph Hans | Methods and devices for repair or replacement of heart valves or adjacent tissue without the need for full cardiopulmonary support |
WO2006041877A2 (en) * | 2004-10-05 | 2006-04-20 | Ample Medical, Inc. | Atrioventricular valve annulus repair systems and methods including retro-chordal anchors |
SE0403046D0 (en) | 2004-12-15 | 2004-12-15 | Medtentia Ab | A device and method for improving the function of a heart valve |
DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
EP1855619A4 (en) | 2005-01-20 | 2013-10-02 | Cardiac Dimensions Inc | Tissue shaping device |
US20060173490A1 (en) | 2005-02-01 | 2006-08-03 | Boston Scientific Scimed, Inc. | Filter system and method |
US7878966B2 (en) | 2005-02-04 | 2011-02-01 | Boston Scientific Scimed, Inc. | Ventricular assist and support device |
WO2011034628A1 (en) | 2005-02-07 | 2011-03-24 | Evalve, Inc. | Methods, systems and devices for cardiac valve repair |
CA2597066C (en) | 2005-02-07 | 2014-04-15 | Evalve, Inc. | Methods, systems and devices for cardiac valve repair |
WO2006097931A2 (en) | 2005-03-17 | 2006-09-21 | Valtech Cardio, Ltd. | Mitral valve treatment techniques |
EP1874217A4 (en) * | 2005-04-25 | 2014-11-19 | Evalve Inc | Device and methods for endoscopic annuloplasty |
US7645286B2 (en) | 2005-05-20 | 2010-01-12 | Neotract, Inc. | Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures |
US8333776B2 (en) | 2005-05-20 | 2012-12-18 | Neotract, Inc. | Anchor delivery system |
US9504461B2 (en) | 2005-05-20 | 2016-11-29 | Neotract, Inc. | Anchor delivery system |
US9364212B2 (en) | 2005-05-20 | 2016-06-14 | Neotract, Inc. | Suture anchoring devices and methods for use |
US7758594B2 (en) | 2005-05-20 | 2010-07-20 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
US8668705B2 (en) | 2005-05-20 | 2014-03-11 | Neotract, Inc. | Latching anchor device |
US8529584B2 (en) | 2005-05-20 | 2013-09-10 | Neotract, Inc. | Median lobe band implant apparatus and method |
US8425535B2 (en) | 2005-05-20 | 2013-04-23 | Neotract, Inc. | Multi-actuating trigger anchor delivery system |
US8834492B2 (en) | 2005-05-20 | 2014-09-16 | Neotract, Inc. | Continuous indentation lateral lobe apparatus and method |
US10195014B2 (en) | 2005-05-20 | 2019-02-05 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
US10925587B2 (en) | 2005-05-20 | 2021-02-23 | Neotract, Inc. | Anchor delivery system |
US8394113B2 (en) | 2005-05-20 | 2013-03-12 | Neotract, Inc. | Coiled anchor device |
US8628542B2 (en) | 2005-05-20 | 2014-01-14 | Neotract, Inc. | Median lobe destruction apparatus and method |
US7896891B2 (en) | 2005-05-20 | 2011-03-01 | Neotract, Inc. | Apparatus and method for manipulating or retracting tissue and anatomical structure |
US9149266B2 (en) | 2005-05-20 | 2015-10-06 | Neotract, Inc. | Deforming anchor device |
US9549739B2 (en) | 2005-05-20 | 2017-01-24 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
US8603106B2 (en) | 2005-05-20 | 2013-12-10 | Neotract, Inc. | Integrated handle assembly for anchor delivery system |
US8945152B2 (en) | 2005-05-20 | 2015-02-03 | Neotract, Inc. | Multi-actuating trigger anchor delivery system |
US7616122B2 (en) | 2005-06-20 | 2009-11-10 | Biovigil, Llc | Hand cleanliness |
US8502681B2 (en) | 2005-06-20 | 2013-08-06 | Biovigil, Llc | Hand cleanliness |
US8951285B2 (en) | 2005-07-05 | 2015-02-10 | Mitralign, Inc. | Tissue anchor, anchoring system and methods of using the same |
CN102113923B (en) * | 2005-09-07 | 2014-05-07 | 梅德坦提亚国际有限公司 | A device for improving the function of a heart valve |
US7530253B2 (en) * | 2005-09-09 | 2009-05-12 | Edwards Lifesciences Corporation | Prosthetic valve crimping device |
US8092520B2 (en) | 2005-11-10 | 2012-01-10 | CardiAQ Technologies, Inc. | Vascular prosthesis connecting stent |
US8585594B2 (en) * | 2006-05-24 | 2013-11-19 | Phoenix Biomedical, Inc. | Methods of assessing inner surfaces of body lumens or organs |
US20110276127A1 (en) * | 2006-05-24 | 2011-11-10 | Forster David C | Multiple inflation of an expandable member as a precursor to an implant procedure |
US11285005B2 (en) | 2006-07-17 | 2022-03-29 | Cardiac Dimensions Pty. Ltd. | Mitral valve annuloplasty device with twisted anchor |
US20090306768A1 (en) | 2006-07-28 | 2009-12-10 | Cardiaq Valve Technologies, Inc. | Percutaneous valve prosthesis and system and method for implanting same |
US7854849B2 (en) * | 2006-10-10 | 2010-12-21 | Multiphase Systems Integration | Compact multiphase inline bulk water separation method and system for hydrocarbon production |
SE530568C2 (en) | 2006-11-13 | 2008-07-08 | Medtentia Ab | Medical device for improving function of heart valve, has flange unit connected to loop-shaped support and provided to be arranged against annulus when loop shaped support abut heart valve |
US9883943B2 (en) | 2006-12-05 | 2018-02-06 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US11259924B2 (en) | 2006-12-05 | 2022-03-01 | Valtech Cardio Ltd. | Implantation of repair devices in the heart |
EP2088965B1 (en) | 2006-12-05 | 2012-11-28 | Valtech Cardio, Ltd. | Segmented ring placement |
US7753949B2 (en) * | 2007-02-23 | 2010-07-13 | The Trustees Of The University Of Pennsylvania | Valve prosthesis systems and methods |
US8070802B2 (en) | 2007-02-23 | 2011-12-06 | The Trustees Of The University Of Pennsylvania | Mitral valve system |
US11660190B2 (en) | 2007-03-13 | 2023-05-30 | Edwards Lifesciences Corporation | Tissue anchors, systems and methods, and devices |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US8529620B2 (en) * | 2007-05-01 | 2013-09-10 | Ottavio Alfieri | Inwardly-bowed tricuspid annuloplasty ring |
US20090222081A1 (en) * | 2008-01-24 | 2009-09-03 | Coherex Medical, Inc. | Methods and apparatus for reducing valve prolapse |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
WO2011104269A1 (en) | 2008-02-26 | 2011-09-01 | Jenavalve Technology Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US8382829B1 (en) | 2008-03-10 | 2013-02-26 | Mitralign, Inc. | Method to reduce mitral regurgitation by cinching the commissure of the mitral valve |
US7976578B2 (en) * | 2008-06-04 | 2011-07-12 | James Marvel | Buffer for a human joint and method of arthroscopically inserting |
CA2728078A1 (en) | 2008-06-16 | 2010-01-14 | Valtech Cardio, Ltd. | Annuloplasty devices and methods of delivery therefor |
US8323335B2 (en) * | 2008-06-20 | 2012-12-04 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic valves and methods for using |
EP2344048B1 (en) | 2008-07-30 | 2016-09-07 | Neotract, Inc. | Slotted anchor device |
US8006594B2 (en) * | 2008-08-11 | 2011-08-30 | Cardiac Dimensions, Inc. | Catheter cutting tool |
US8652202B2 (en) | 2008-08-22 | 2014-02-18 | Edwards Lifesciences Corporation | Prosthetic heart valve and delivery apparatus |
EP2358308B1 (en) * | 2008-09-15 | 2019-11-27 | Medtronic, Inc. | Tools for remodeling tissue |
EP2901966B1 (en) | 2008-09-29 | 2016-06-29 | Edwards Lifesciences CardiAQ LLC | Heart valve |
JP2012505050A (en) * | 2008-10-10 | 2012-03-01 | インターバルブ, インコーポレイテッド | Valvuloplasty catheter and method |
US8545553B2 (en) | 2009-05-04 | 2013-10-01 | Valtech Cardio, Ltd. | Over-wire rotation tool |
US8940044B2 (en) | 2011-06-23 | 2015-01-27 | Valtech Cardio, Ltd. | Closure element for use with an annuloplasty structure |
EP2379008B1 (en) | 2008-12-22 | 2021-02-17 | Valtech Cardio, Ltd. | Adjustable annuloplasty devices |
US8241351B2 (en) | 2008-12-22 | 2012-08-14 | Valtech Cardio, Ltd. | Adjustable partial annuloplasty ring and mechanism therefor |
US9011530B2 (en) | 2008-12-22 | 2015-04-21 | Valtech Cardio, Ltd. | Partially-adjustable annuloplasty structure |
US10517719B2 (en) | 2008-12-22 | 2019-12-31 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US8715342B2 (en) | 2009-05-07 | 2014-05-06 | Valtech Cardio, Ltd. | Annuloplasty ring with intra-ring anchoring |
US8147542B2 (en) | 2008-12-22 | 2012-04-03 | Valtech Cardio, Ltd. | Adjustable repair chords and spool mechanism therefor |
US20100174363A1 (en) * | 2009-01-07 | 2010-07-08 | Endovalve, Inc. | One Piece Prosthetic Valve Support Structure and Related Assemblies |
US20100179565A1 (en) * | 2009-01-13 | 2010-07-15 | Medtronic Vascular, Inc. | Rail for Delivering an Endovascular Stapler |
US8353956B2 (en) | 2009-02-17 | 2013-01-15 | Valtech Cardio, Ltd. | Actively-engageable movement-restriction mechanism for use with an annuloplasty structure |
JP2012520716A (en) | 2009-03-17 | 2012-09-10 | ミトラシスト メディカル リミテッド | Artificial valve having a folding valve and its delivery method |
CN101919750A (en) | 2009-03-30 | 2010-12-22 | 卡迪万蒂奇医药公司 | There is not the implantation method of sewing up cusps of pulmonary valve or mitral valve |
CA2756049C (en) | 2009-04-15 | 2017-05-02 | Impala, Inc. | Vascular implant and delivery system |
US9968452B2 (en) | 2009-05-04 | 2018-05-15 | Valtech Cardio, Ltd. | Annuloplasty ring delivery cathethers |
EP3042615A1 (en) | 2009-09-15 | 2016-07-13 | Evalve, Inc. | Methods, systems and devices for cardiac valve repair |
AU2010306762C1 (en) * | 2009-10-14 | 2016-04-21 | Heart Repair Technologies, Inc. | Percutaneous transvalvular intraannular band for mitral valve repair |
US9180007B2 (en) | 2009-10-29 | 2015-11-10 | Valtech Cardio, Ltd. | Apparatus and method for guide-wire based advancement of an adjustable implant |
US10098737B2 (en) | 2009-10-29 | 2018-10-16 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
US9011520B2 (en) | 2009-10-29 | 2015-04-21 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
EP2506777B1 (en) | 2009-12-02 | 2020-11-25 | Valtech Cardio, Ltd. | Combination of spool assembly coupled to a helical anchor and delivery tool for implantation thereof |
KR101231140B1 (en) * | 2011-08-12 | 2013-02-07 | 부산대학교 산학협력단 | Appartus for cerclage annuloplasty procedure |
US8449599B2 (en) | 2009-12-04 | 2013-05-28 | Edwards Lifesciences Corporation | Prosthetic valve for replacing mitral valve |
US8870950B2 (en) | 2009-12-08 | 2014-10-28 | Mitral Tech Ltd. | Rotation-based anchoring of an implant |
US10058323B2 (en) | 2010-01-22 | 2018-08-28 | 4 Tech Inc. | Tricuspid valve repair using tension |
US9307980B2 (en) | 2010-01-22 | 2016-04-12 | 4Tech Inc. | Tricuspid valve repair using tension |
US8475525B2 (en) | 2010-01-22 | 2013-07-02 | 4Tech Inc. | Tricuspid valve repair using tension |
US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
JP2013526388A (en) | 2010-05-25 | 2013-06-24 | イエナバルブ テクノロジー インク | Artificial heart valve, and transcatheter delivery prosthesis comprising an artificial heart valve and a stent |
WO2011163275A2 (en) | 2010-06-21 | 2011-12-29 | Cardiaq Valve Technologies, Inc. | Replacement heart valve |
DE112011102305T5 (en) | 2010-07-09 | 2013-05-16 | Highlife Sas | Transcatheter atrioventricular valve prosthesis |
US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
WO2012012761A2 (en) | 2010-07-23 | 2012-01-26 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic valves |
EP3001978B2 (en) | 2010-09-23 | 2023-03-01 | Edwards Lifesciences CardiAQ LLC | Replacement heart valve delivery device |
WO2012068541A2 (en) | 2010-11-18 | 2012-05-24 | Pavilion Medical Innovations | Tissue restraining devices and methods of use |
US9198756B2 (en) | 2010-11-18 | 2015-12-01 | Pavilion Medical Innovations, Llc | Tissue restraining devices and methods of use |
JP5695213B2 (en) * | 2011-01-04 | 2015-04-01 | ザ クリーブランド クリニック ファウンデーションThe Cleveland ClinicFoundation | Apparatus and method for treating a heart valve with regurgitation |
WO2012094406A1 (en) * | 2011-01-04 | 2012-07-12 | The Cleveland Clinic Foundation | Apparatus and method for treating a regurgitant heart valve |
WO2012103173A2 (en) * | 2011-01-25 | 2012-08-02 | Emory University | Devices and methods for surgical and percutaneous repair of heart valve lesions |
US9161749B2 (en) | 2011-04-14 | 2015-10-20 | Neotract, Inc. | Method and apparatus for treating sexual dysfunction |
US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
US9918840B2 (en) | 2011-06-23 | 2018-03-20 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
US10792152B2 (en) | 2011-06-23 | 2020-10-06 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
US8945177B2 (en) | 2011-09-13 | 2015-02-03 | Abbott Cardiovascular Systems Inc. | Gripper pusher mechanism for tissue apposition systems |
US8858623B2 (en) | 2011-11-04 | 2014-10-14 | Valtech Cardio, Ltd. | Implant having multiple rotational assemblies |
EP3970627B1 (en) | 2011-11-08 | 2023-12-20 | Edwards Lifesciences Innovation (Israel) Ltd. | Controlled steering functionality for implant-delivery tool |
US10143553B2 (en) | 2011-12-12 | 2018-12-04 | Cardiac Implants, Llc | Heart valve repair device |
US9078747B2 (en) | 2011-12-21 | 2015-07-14 | Edwards Lifesciences Corporation | Anchoring device for replacing or repairing a heart valve |
EP2620125B1 (en) | 2012-01-24 | 2017-10-11 | Medtentia International Ltd Oy | An arrangement, a loop-shaped support, a prosthetic heart valve and a method of repairing or replacing a native heart valve |
CA2863169C (en) * | 2012-01-31 | 2020-12-15 | Mitral Valve Technologies Sa | Mitral valve docking devices, systems and methods |
JP6182552B2 (en) | 2012-03-06 | 2017-08-16 | ハイライフ エスエーエス | Treatment catheter member with surrounding function |
ES2675936T3 (en) | 2012-03-23 | 2018-07-13 | Sorin Group Italia S.R.L. | Folding valve prosthesis |
US10292801B2 (en) | 2012-03-29 | 2019-05-21 | Neotract, Inc. | System for delivering anchors for treating incontinence |
US9427315B2 (en) | 2012-04-19 | 2016-08-30 | Caisson Interventional, LLC | Valve replacement systems and methods |
US9011515B2 (en) | 2012-04-19 | 2015-04-21 | Caisson Interventional, LLC | Heart valve assembly systems and methods |
US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
DE102012010798A1 (en) * | 2012-06-01 | 2013-12-05 | Universität Duisburg-Essen | Implantable device for improving or eliminating heart valve insufficiency |
US10130353B2 (en) | 2012-06-29 | 2018-11-20 | Neotract, Inc. | Flexible system for delivering an anchor |
EP2695586B1 (en) | 2012-08-10 | 2019-05-08 | Sorin Group Italia S.r.l. | A valve prosthesis and kit |
CA2885354A1 (en) | 2012-09-29 | 2014-04-03 | Mitralign, Inc. | Plication lock delivery system and method of use thereof |
WO2014064695A2 (en) | 2012-10-23 | 2014-05-01 | Valtech Cardio, Ltd. | Percutaneous tissue anchor techniques |
EP3517052A1 (en) | 2012-10-23 | 2019-07-31 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
EP2730252A1 (en) * | 2012-11-07 | 2014-05-14 | Medtentia International Ltd Oy | Medical device for a cardiac valve implant, and a metod of manufacturing the medical device |
EP4162902A1 (en) | 2012-11-21 | 2023-04-12 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic heart valves |
WO2014087402A1 (en) | 2012-12-06 | 2014-06-12 | Valtech Cardio, Ltd. | Techniques for guide-wire based advancement of a tool |
EP2943132B1 (en) | 2013-01-09 | 2018-03-28 | 4Tech Inc. | Soft tissue anchors |
ITRM20130016A1 (en) | 2013-01-10 | 2014-07-11 | Jacob Zeitani | PLASTIC DEVICE FOR THE MITRAL VALVE. |
WO2018055629A1 (en) * | 2016-09-26 | 2018-03-29 | Innercore Medical Ltd. | Mitral valve repair device and method |
WO2014115149A2 (en) | 2013-01-24 | 2014-07-31 | Mitraltech Ltd. | Ventricularly-anchored prosthetic valves |
EP2961351B1 (en) | 2013-02-26 | 2018-11-28 | Mitralign, Inc. | Devices for percutaneous tricuspid valve repair |
WO2014136056A1 (en) * | 2013-03-04 | 2014-09-12 | Medical Research, Infrastructure And Health Services Fund Of The Tel-Aviv Medical Center | Cardiac valve commissure brace |
US20140277427A1 (en) | 2013-03-14 | 2014-09-18 | Cardiaq Valve Technologies, Inc. | Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery |
US11259923B2 (en) | 2013-03-14 | 2022-03-01 | Jc Medical, Inc. | Methods and devices for delivery of a prosthetic valve |
US11406497B2 (en) | 2013-03-14 | 2022-08-09 | Jc Medical, Inc. | Heart valve prosthesis |
WO2014141239A1 (en) | 2013-03-14 | 2014-09-18 | 4Tech Inc. | Stent with tether interface |
US10449333B2 (en) | 2013-03-14 | 2019-10-22 | Valtech Cardio, Ltd. | Guidewire feeder |
EP2967810B1 (en) | 2013-03-14 | 2020-04-22 | Suzhou Jiecheng Medical Technology Co., Ltd. | Embolic protection devices |
US9730791B2 (en) | 2013-03-14 | 2017-08-15 | Edwards Lifesciences Cardiaq Llc | Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery |
US9724195B2 (en) | 2013-03-15 | 2017-08-08 | Mitralign, Inc. | Translation catheters and systems |
MX2015012506A (en) * | 2013-03-15 | 2016-03-16 | Fabian Hermann Urban Füglister | Tongue deformation implant. |
US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
US10524904B2 (en) * | 2013-07-11 | 2020-01-07 | Medtronic, Inc. | Valve positioning device |
US9895219B2 (en) * | 2013-07-31 | 2018-02-20 | Medtronic Vascular Galway | Mitral valve prosthesis for transcatheter valve implantation |
EP2835112B1 (en) | 2013-08-08 | 2021-01-27 | Sorin Group Italia S.r.l. | Heart valve prosthesis |
JP6563394B2 (en) | 2013-08-30 | 2019-08-21 | イェーナヴァルヴ テクノロジー インコーポレイテッド | Radially foldable frame for an artificial valve and method for manufacturing the frame |
US10070857B2 (en) | 2013-08-31 | 2018-09-11 | Mitralign, Inc. | Devices and methods for locating and implanting tissue anchors at mitral valve commissure |
WO2015048738A1 (en) * | 2013-09-30 | 2015-04-02 | The Cleveland Clinic Foundation | Apparatus and method for treating a regurgitant heart valve |
WO2015059699A2 (en) | 2013-10-23 | 2015-04-30 | Valtech Cardio, Ltd. | Anchor magazine |
US9050188B2 (en) | 2013-10-23 | 2015-06-09 | Caisson Interventional, LLC | Methods and systems for heart valve therapy |
US10052095B2 (en) | 2013-10-30 | 2018-08-21 | 4Tech Inc. | Multiple anchoring-point tension system |
US10022114B2 (en) | 2013-10-30 | 2018-07-17 | 4Tech Inc. | Percutaneous tether locking |
US9610162B2 (en) | 2013-12-26 | 2017-04-04 | Valtech Cardio, Ltd. | Implantation of flexible implant |
CN106170269B (en) | 2014-02-21 | 2019-01-11 | 爱德华兹生命科学卡迪尔克有限责任公司 | The delivery apparatus of controlled deployment for valve substitutes |
US9572666B2 (en) | 2014-03-17 | 2017-02-21 | Evalve, Inc. | Mitral valve fixation device removal devices and methods |
US10390943B2 (en) | 2014-03-17 | 2019-08-27 | Evalve, Inc. | Double orifice device for transcatheter mitral valve replacement |
US9763778B2 (en) * | 2014-03-18 | 2017-09-19 | St. Jude Medical, Cardiology Division, Inc. | Aortic insufficiency valve percutaneous valve anchoring |
USRE49792E1 (en) | 2014-05-14 | 2024-01-09 | Corcym S.R.L. | Implant device and implantation kit |
WO2015179423A1 (en) | 2014-05-19 | 2015-11-26 | Cardiaq Valve Technologies, Inc. | Replacement mitral valve with annular flap |
US9974647B2 (en) | 2014-06-12 | 2018-05-22 | Caisson Interventional, LLC | Two stage anchor and mitral valve assembly |
CN106573129B (en) | 2014-06-19 | 2019-09-24 | 4科技有限公司 | Heart tissue is tightened |
US10687943B2 (en) | 2014-07-03 | 2020-06-23 | Medtentia International Ltd Oy | Annuloplasty system |
US10195030B2 (en) | 2014-10-14 | 2019-02-05 | Valtech Cardio, Ltd. | Leaflet-restraining techniques |
FR3027212A1 (en) * | 2014-10-16 | 2016-04-22 | Seguin Jacques | INTERVALVULAR IMPLANT FOR MITRAL VALVE |
US9750605B2 (en) | 2014-10-23 | 2017-09-05 | Caisson Interventional, LLC | Systems and methods for heart valve therapy |
US9750607B2 (en) | 2014-10-23 | 2017-09-05 | Caisson Interventional, LLC | Systems and methods for heart valve therapy |
CN106999178B (en) | 2014-12-02 | 2019-12-24 | 4科技有限公司 | Eccentric tissue anchor |
WO2016090308A1 (en) | 2014-12-04 | 2016-06-09 | Edwards Lifesciences Corporation | Percutaneous clip for repairing a heart valve |
US10188392B2 (en) | 2014-12-19 | 2019-01-29 | Abbott Cardiovascular Systems, Inc. | Grasping for tissue repair |
WO2016125160A1 (en) | 2015-02-05 | 2016-08-11 | Mitraltech Ltd. | Prosthetic valve with axially-sliding frames |
US20160256269A1 (en) | 2015-03-05 | 2016-09-08 | Mitralign, Inc. | Devices for treating paravalvular leakage and methods use thereof |
US10524912B2 (en) | 2015-04-02 | 2020-01-07 | Abbott Cardiovascular Systems, Inc. | Tissue fixation devices and methods |
SG10202010021SA (en) | 2015-04-30 | 2020-11-27 | Valtech Cardio Ltd | Annuloplasty technologies |
US10376363B2 (en) | 2015-04-30 | 2019-08-13 | Edwards Lifesciences Cardiaq Llc | Replacement mitral valve, delivery system for replacement mitral valve and methods of use |
EP3632378B1 (en) | 2015-05-01 | 2024-05-29 | JenaValve Technology, Inc. | Device with reduced pacemaker rate in heart valve replacement |
EP3738551A1 (en) | 2015-05-14 | 2020-11-18 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
US10376673B2 (en) | 2015-06-19 | 2019-08-13 | Evalve, Inc. | Catheter guiding system and methods |
US10226335B2 (en) | 2015-06-22 | 2019-03-12 | Edwards Lifesciences Cardiaq Llc | Actively controllable heart valve implant and method of controlling same |
US10092400B2 (en) | 2015-06-23 | 2018-10-09 | Edwards Lifesciences Cardiaq Llc | Systems and methods for anchoring and sealing a prosthetic heart valve |
US10238494B2 (en) | 2015-06-29 | 2019-03-26 | Evalve, Inc. | Self-aligning radiopaque ring |
US10667815B2 (en) | 2015-07-21 | 2020-06-02 | Evalve, Inc. | Tissue grasping devices and related methods |
US10413408B2 (en) | 2015-08-06 | 2019-09-17 | Evalve, Inc. | Delivery catheter systems, methods, and devices |
US10575951B2 (en) | 2015-08-26 | 2020-03-03 | Edwards Lifesciences Cardiaq Llc | Delivery device and methods of use for transapical delivery of replacement mitral valve |
US10117744B2 (en) | 2015-08-26 | 2018-11-06 | Edwards Lifesciences Cardiaq Llc | Replacement heart valves and methods of delivery |
US10350066B2 (en) | 2015-08-28 | 2019-07-16 | Edwards Lifesciences Cardiaq Llc | Steerable delivery system for replacement mitral valve and methods of use |
US10765517B2 (en) | 2015-10-01 | 2020-09-08 | Neochord, Inc. | Ringless web for repair of heart valves |
US10238495B2 (en) | 2015-10-09 | 2019-03-26 | Evalve, Inc. | Delivery catheter handle and methods of use |
WO2017100785A1 (en) | 2015-12-10 | 2017-06-15 | Mvrx, Inc. | Devices, systems, and methods for reshaping a heart valve annulus |
EP3960127A1 (en) | 2015-12-30 | 2022-03-02 | Caisson Interventional, LLC | Systems and methods for heart valve therapy |
WO2017117370A2 (en) | 2015-12-30 | 2017-07-06 | Mitralign, Inc. | System and method for reducing tricuspid regurgitation |
US10751182B2 (en) | 2015-12-30 | 2020-08-25 | Edwards Lifesciences Corporation | System and method for reshaping right heart |
CN108882981B (en) | 2016-01-29 | 2021-08-10 | 内奥瓦斯克迪亚拉公司 | Prosthetic valve for preventing outflow obstruction |
US10531866B2 (en) | 2016-02-16 | 2020-01-14 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
US10357365B2 (en) * | 2016-03-07 | 2019-07-23 | Serca Biomedical, LLC | Annuloplasty repair devices, systems and methods |
US11219746B2 (en) | 2016-03-21 | 2022-01-11 | Edwards Lifesciences Corporation | Multi-direction steerable handles for steering catheters |
US10835714B2 (en) | 2016-03-21 | 2020-11-17 | Edwards Lifesciences Corporation | Multi-direction steerable handles for steering catheters |
US10799676B2 (en) | 2016-03-21 | 2020-10-13 | Edwards Lifesciences Corporation | Multi-direction steerable handles for steering catheters |
US10799675B2 (en) | 2016-03-21 | 2020-10-13 | Edwards Lifesciences Corporation | Cam controlled multi-direction steerable handles |
US10799677B2 (en) | 2016-03-21 | 2020-10-13 | Edwards Lifesciences Corporation | Multi-direction steerable handles for steering catheters |
CN105726072B (en) * | 2016-04-14 | 2018-02-27 | 江苏大学 | A kind of bicuspid valve air bag closure plate occluder and method for implantation being implanted into through the apex of the heart |
CN109475419B (en) | 2016-05-13 | 2021-11-09 | 耶拿阀门科技股份有限公司 | Heart valve prosthesis delivery systems and methods for delivering heart valve prostheses through guide sheaths and loading systems |
WO2019222694A1 (en) * | 2018-05-18 | 2019-11-21 | Elixir Medical Corporation | Methods and devices for heart valve repair |
EP3457948B1 (en) | 2016-05-20 | 2020-07-01 | Vivasure Medical Limited | Vascular closure device |
US10702274B2 (en) | 2016-05-26 | 2020-07-07 | Edwards Lifesciences Corporation | Method and system for closing left atrial appendage |
US20170354500A1 (en) * | 2016-06-08 | 2017-12-14 | Cook Medical Technologies Llc | Mitral prolapse valve restrictor |
US10736632B2 (en) | 2016-07-06 | 2020-08-11 | Evalve, Inc. | Methods and devices for valve clip excision |
US10973638B2 (en) | 2016-07-07 | 2021-04-13 | Edwards Lifesciences Corporation | Device and method for treating vascular insufficiency |
GB201611910D0 (en) | 2016-07-08 | 2016-08-24 | Valtech Cardio Ltd | Adjustable annuloplasty device with alternating peaks and troughs |
CN114587712A (en) | 2016-08-10 | 2022-06-07 | 卡迪尔维尔福股份有限公司 | Prosthetic valve with coaxial frame |
US11071564B2 (en) | 2016-10-05 | 2021-07-27 | Evalve, Inc. | Cardiac valve cutting device |
CN106618798B (en) * | 2016-10-24 | 2019-10-11 | 宁波健世生物科技有限公司 | A kind of heart valve prosthesis and its conveying and method for releasing fixed by interventricular septum |
AU2016427851A1 (en) * | 2016-10-28 | 2019-06-06 | Coramaze Technologies Gmbh | Heart implant |
US10653862B2 (en) | 2016-11-07 | 2020-05-19 | Edwards Lifesciences Corporation | Apparatus for the introduction and manipulation of multiple telescoping catheters |
US10363138B2 (en) | 2016-11-09 | 2019-07-30 | Evalve, Inc. | Devices for adjusting the curvature of cardiac valve structures |
US10398553B2 (en) | 2016-11-11 | 2019-09-03 | Evalve, Inc. | Opposing disk device for grasping cardiac valve tissue |
US10426616B2 (en) | 2016-11-17 | 2019-10-01 | Evalve, Inc. | Cardiac implant delivery system |
WO2018090148A1 (en) | 2016-11-21 | 2018-05-24 | Neovasc Tiara Inc. | Methods and systems for rapid retraction of a transcatheter heart valve delivery system |
US10779837B2 (en) | 2016-12-08 | 2020-09-22 | Evalve, Inc. | Adjustable arm device for grasping tissues |
US10314586B2 (en) | 2016-12-13 | 2019-06-11 | Evalve, Inc. | Rotatable device and method for fixing tricuspid valve tissue |
US10905554B2 (en) | 2017-01-05 | 2021-02-02 | Edwards Lifesciences Corporation | Heart valve coaptation device |
JP7094965B2 (en) | 2017-01-27 | 2022-07-04 | イエナバルブ テクノロジー インク | Heart valve imitation |
US10675017B2 (en) | 2017-02-07 | 2020-06-09 | Edwards Lifesciences Corporation | Transcatheter heart valve leaflet plication |
US10390953B2 (en) | 2017-03-08 | 2019-08-27 | Cardiac Dimensions Pty. Ltd. | Methods and devices for reducing paravalvular leakage |
EP3592288B1 (en) * | 2017-03-27 | 2021-09-01 | TruLeaf Medical Ltd. | Docking elements |
US11224511B2 (en) | 2017-04-18 | 2022-01-18 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
EP4011331A1 (en) | 2017-04-18 | 2022-06-15 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
US11045627B2 (en) | 2017-04-18 | 2021-06-29 | Edwards Lifesciences Corporation | Catheter system with linear actuation control mechanism |
US10799312B2 (en) | 2017-04-28 | 2020-10-13 | Edwards Lifesciences Corporation | Medical device stabilizing apparatus and method of use |
US10959846B2 (en) | 2017-05-10 | 2021-03-30 | Edwards Lifesciences Corporation | Mitral valve spacer device |
US10842619B2 (en) | 2017-05-12 | 2020-11-24 | Edwards Lifesciences Corporation | Prosthetic heart valve docking assembly |
WO2018209313A1 (en) | 2017-05-12 | 2018-11-15 | Evalve, Inc. | Long arm valve repair clip |
US10517598B2 (en) * | 2017-06-07 | 2019-12-31 | Evalve, Inc. | Tissue tensioning device for cardiac valve repair |
ES2923913T3 (en) | 2017-07-06 | 2022-10-03 | Edwards Lifesciences Corp | Steerable rail supply system |
US11069220B2 (en) | 2017-07-10 | 2021-07-20 | Biovigil Hygiene Technologies, Llc | Hand cleanliness monitoring |
CA3073834A1 (en) | 2017-08-25 | 2019-02-28 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
US11051940B2 (en) | 2017-09-07 | 2021-07-06 | Edwards Lifesciences Corporation | Prosthetic spacer device for heart valve |
US11065117B2 (en) | 2017-09-08 | 2021-07-20 | Edwards Lifesciences Corporation | Axisymmetric adjustable device for treating mitral regurgitation |
US11110251B2 (en) | 2017-09-19 | 2021-09-07 | Edwards Lifesciences Corporation | Multi-direction steerable handles for steering catheters |
US10835221B2 (en) | 2017-11-02 | 2020-11-17 | Valtech Cardio, Ltd. | Implant-cinching devices and systems |
US11135062B2 (en) | 2017-11-20 | 2021-10-05 | Valtech Cardio Ltd. | Cinching of dilated heart muscle |
WO2019126718A1 (en) | 2017-12-23 | 2019-06-27 | Neotract, Inc. | Expandable tissue engagement apparatus and method |
CN111601572A (en) | 2018-01-07 | 2020-08-28 | 苏州杰成医疗科技有限公司 | Prosthetic heart valve delivery system |
CA3083605C (en) | 2018-01-07 | 2024-02-27 | Suzhou Jiecheng Medical Technology Co., Ltd. | Heart valve prosthesis and delivery |
US10105222B1 (en) | 2018-01-09 | 2018-10-23 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10159570B1 (en) | 2018-01-09 | 2018-12-25 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
CA3086678A1 (en) | 2018-01-09 | 2019-07-18 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10973639B2 (en) | 2018-01-09 | 2021-04-13 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10076415B1 (en) | 2018-01-09 | 2018-09-18 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10245144B1 (en) | 2018-01-09 | 2019-04-02 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10238493B1 (en) | 2018-01-09 | 2019-03-26 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10507109B2 (en) | 2018-01-09 | 2019-12-17 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10136993B1 (en) | 2018-01-09 | 2018-11-27 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10231837B1 (en) | 2018-01-09 | 2019-03-19 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10111751B1 (en) | 2018-01-09 | 2018-10-30 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10123873B1 (en) | 2018-01-09 | 2018-11-13 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
CA3086884A1 (en) | 2018-01-24 | 2019-08-01 | Valtech Cardio, Ltd. | Contraction of an annuloplasty structure |
EP3743014B1 (en) | 2018-01-26 | 2023-07-19 | Edwards Lifesciences Innovation (Israel) Ltd. | Techniques for facilitating heart valve tethering and chord replacement |
US11051934B2 (en) | 2018-02-28 | 2021-07-06 | Edwards Lifesciences Corporation | Prosthetic mitral valve with improved anchors and seal |
US11285003B2 (en) | 2018-03-20 | 2022-03-29 | Medtronic Vascular, Inc. | Prolapse prevention device and methods of use thereof |
US11026791B2 (en) | 2018-03-20 | 2021-06-08 | Medtronic Vascular, Inc. | Flexible canopy valve repair systems and methods of use |
US11389297B2 (en) | 2018-04-12 | 2022-07-19 | Edwards Lifesciences Corporation | Mitral valve spacer device |
US11207181B2 (en) | 2018-04-18 | 2021-12-28 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
US11504231B2 (en) | 2018-05-23 | 2022-11-22 | Corcym S.R.L. | Cardiac valve prosthesis |
CA3106104A1 (en) | 2018-07-12 | 2020-01-16 | Valtech Cardio, Ltd. | Annuloplasty systems and locking tools therefor |
US10945844B2 (en) | 2018-10-10 | 2021-03-16 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
US11737872B2 (en) | 2018-11-08 | 2023-08-29 | Neovasc Tiara Inc. | Ventricular deployment of a transcatheter mitral valve prosthesis |
AU2018449153A1 (en) * | 2018-11-14 | 2021-07-01 | Half Moon Medical, Inc. | Leaflet extension for cardiac valve leaflet |
CN113677298A (en) | 2019-02-06 | 2021-11-19 | Inqb8医疗科技有限责任公司 | Intracardiac left atrium and dual support system |
BR122021018576A2 (en) | 2019-02-14 | 2021-10-13 | Edwards Lifesciences Corporation | VALVE REPAIR DEVICE FOR REPAIRING A PATIENT'S NATIVE VALVE AND VALVE REPAIR SYSTEM |
CA3135753C (en) | 2019-04-01 | 2023-10-24 | Neovasc Tiara Inc. | Controllably deployable prosthetic valve |
EP3952792A4 (en) | 2019-04-10 | 2023-01-04 | Neovasc Tiara Inc. | Prosthetic valve with natural blood flow |
AU2020279750B2 (en) | 2019-05-20 | 2023-07-13 | Neovasc Tiara Inc. | Introducer with hemostasis mechanism |
AU2020295566B2 (en) | 2019-06-20 | 2023-07-20 | Neovasc Tiara Inc. | Low profile prosthetic mitral valve |
AU2020375903A1 (en) | 2019-10-29 | 2021-12-23 | Edwards Lifesciences Innovation (Israel) Ltd. | Annuloplasty and tissue anchor technologies |
AU2021320088B2 (en) | 2020-08-03 | 2022-06-23 | Teleflex Life Sciences Llc | Handle and cartridge system for medical interventions |
JP2023554000A (en) | 2020-12-14 | 2023-12-26 | カーディアック・ディメンションズ・プロプライエタリー・リミテッド | Modular preloaded medical implants and delivery systems |
Citations (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US191528A (en) * | 1877-06-05 | Improvement in check-row attachments to seed-planters | ||
US4056854A (en) * | 1976-09-28 | 1977-11-08 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Aortic heart valve catheter |
US4275469A (en) * | 1979-12-13 | 1981-06-30 | Shelhigh Inc. | Prosthetic heart valve |
US4994069A (en) * | 1988-11-02 | 1991-02-19 | Target Therapeutics | Vaso-occlusion coil and method |
US5360444A (en) * | 1991-03-19 | 1994-11-01 | Kenji Kusuhara | Occluder supporter and a method of attachment thereof |
US5370685A (en) * | 1991-07-16 | 1994-12-06 | Stanford Surgical Technologies, Inc. | Endovascular aortic valve replacement |
US5545241A (en) * | 1995-01-17 | 1996-08-13 | Donaldson Company, Inc. | Air cleaner |
US5716397A (en) * | 1996-12-06 | 1998-02-10 | Medtronic, Inc. | Annuloplasty device with removable stiffening element |
US5776189A (en) * | 1997-03-05 | 1998-07-07 | Khalid; Naqeeb | Cardiac valvular support prosthesis |
US5792155A (en) * | 1991-07-16 | 1998-08-11 | Van Cleef; Jean-Francois | Process for partially or totally flattening a vein |
US5855601A (en) * | 1996-06-21 | 1999-01-05 | The Trustees Of Columbia University In The City Of New York | Artificial heart valve and method and device for implanting the same |
US5961440A (en) * | 1997-01-02 | 1999-10-05 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US6050936A (en) * | 1997-01-02 | 2000-04-18 | Myocor, Inc. | Heart wall tension reduction apparatus |
US6077214A (en) * | 1998-07-29 | 2000-06-20 | Myocor, Inc. | Stress reduction apparatus and method |
US6102932A (en) * | 1998-12-15 | 2000-08-15 | Micrus Corporation | Intravascular device push wire delivery system |
US6149695A (en) * | 1998-03-09 | 2000-11-21 | Adia; Moosa Mahomed | Abrasive body |
US6183411B1 (en) * | 1998-09-21 | 2001-02-06 | Myocor, Inc. | External stress reduction device and method |
US6210432B1 (en) * | 1999-06-29 | 2001-04-03 | Jan Otto Solem | Device and method for treatment of mitral insufficiency |
US6260552B1 (en) * | 1998-07-29 | 2001-07-17 | Myocor, Inc. | Transventricular implant tools and devices |
US20010010017A1 (en) * | 1996-12-31 | 2001-07-26 | Brice Letac | Alve prosthesis for implantation in body channels |
US6287339B1 (en) * | 1999-05-27 | 2001-09-11 | Sulzer Carbomedics Inc. | Sutureless heart valve prosthesis |
US20010021872A1 (en) * | 1999-12-31 | 2001-09-13 | Bailey Steven R. | Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof |
US6299637B1 (en) * | 1999-08-20 | 2001-10-09 | Samuel M. Shaolian | Transluminally implantable venous valve |
US6312464B1 (en) * | 1999-04-28 | 2001-11-06 | NAVIA JOSé L. | Method of implanting a stentless cardiac valve prosthesis |
US6312465B1 (en) * | 1999-07-23 | 2001-11-06 | Sulzer Carbomedics Inc. | Heart valve prosthesis with a resiliently deformable retaining member |
US20010051824A1 (en) * | 2000-04-07 | 2001-12-13 | Hopkins Richard A. | Cardiac valve replacement |
US6332893B1 (en) * | 1997-12-17 | 2001-12-25 | Myocor, Inc. | Valve to myocardium tension members device and method |
US6338470B1 (en) * | 2000-12-05 | 2002-01-15 | Kevin L. Steely | Powered lift for raising a two-wheeled vehicle |
US6338740B1 (en) * | 1999-01-26 | 2002-01-15 | Edwards Lifesciences Corporation | Flexible heart valve leaflets |
US20020032481A1 (en) * | 2000-09-12 | 2002-03-14 | Shlomo Gabbay | Heart valve prosthesis and sutureless implantation of a heart valve prosthesis |
US20020065554A1 (en) * | 2000-10-25 | 2002-05-30 | Streeter Richard B. | Mitral shield |
US6419695B1 (en) * | 2000-05-22 | 2002-07-16 | Shlomo Gabbay | Cardiac prosthesis for helping improve operation of a heart valve |
US6419696B1 (en) * | 2000-07-06 | 2002-07-16 | Paul A. Spence | Annuloplasty devices and related heart valve repair methods |
US20020094573A1 (en) * | 1999-10-19 | 2002-07-18 | Eugene Bell | Cardiovascular components for transplantation and methods of making thereof |
US6440164B1 (en) * | 1999-10-21 | 2002-08-27 | Scimed Life Systems, Inc. | Implantable prosthetic valve |
US20020123802A1 (en) * | 2000-02-02 | 2002-09-05 | Snyders Robert V. | Artificial heart valve, implantation instrument and method therefor |
US20020129820A1 (en) * | 2001-03-15 | 2002-09-19 | Medtronic, Inc | Annuloplasty band and method |
US6454799B1 (en) * | 2000-04-06 | 2002-09-24 | Edwards Lifesciences Corporation | Minimally-invasive heart valves and methods of use |
US20020138138A1 (en) * | 2001-03-23 | 2002-09-26 | Jibin Yang | Rolled minimally-invasive heart valves and methods of use |
US6503272B2 (en) * | 2001-03-21 | 2003-01-07 | Cordis Corporation | Stent-based venous valves |
US6537198B1 (en) * | 2000-03-21 | 2003-03-25 | Myocor, Inc. | Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly |
US6629534B1 (en) * | 1999-04-09 | 2003-10-07 | Evalve, Inc. | Methods and apparatus for cardiac valve repair |
US20030191528A1 (en) * | 2000-06-02 | 2003-10-09 | Quijano Rodolfo C. | Expandable medical implant and percutaneous delivery |
US20030233022A1 (en) * | 2002-06-12 | 2003-12-18 | Vidlund Robert M. | Devices and methods for heart valve treatment |
US6676699B2 (en) * | 2002-04-26 | 2004-01-13 | Medtronic Ave, Inc | Stent graft with integrated valve device and method |
US6702826B2 (en) * | 2000-06-23 | 2004-03-09 | Viacor, Inc. | Automated annular plication for mitral valve repair |
US6764510B2 (en) * | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
US20040148019A1 (en) * | 2002-11-12 | 2004-07-29 | Vidlund Robert M. | Devices and methods for heart valve treatment |
US20040162610A1 (en) * | 2001-12-26 | 2004-08-19 | Tradinco Ab | Mitral and tricuspid vlave repair |
US6893459B1 (en) * | 2000-09-20 | 2005-05-17 | Ample Medical, Inc. | Heart valve annulus device and method of using same |
US6913608B2 (en) * | 2000-10-23 | 2005-07-05 | Viacor, Inc. | Automated annular plication for mitral valve repair |
US6945978B1 (en) * | 2002-11-15 | 2005-09-20 | Advanced Cardiovascular Systems, Inc. | Heart valve catheter |
US7004176B2 (en) * | 2003-10-17 | 2006-02-28 | Edwards Lifesciences Ag | Heart valve leaflet locator |
US20060241745A1 (en) * | 2005-04-21 | 2006-10-26 | Solem Jan O | Blood flow controlling apparatus |
US7166126B2 (en) * | 2000-02-02 | 2007-01-23 | Paul A. Spence | Heart valve repair apparatus and methods |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4491986A (en) * | 1976-05-12 | 1985-01-08 | Shlomo Gabbay | Heart valve |
US5830224A (en) | 1996-03-15 | 1998-11-03 | Beth Israel Deaconess Medical Center | Catheter apparatus and methodology for generating a fistula on-demand between closely associated blood vessels at a pre-chosen anatomic site in-vivo |
US6045497A (en) | 1997-01-02 | 2000-04-04 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US7452371B2 (en) * | 1999-06-02 | 2008-11-18 | Cook Incorporated | Implantable vascular device |
US6626899B2 (en) * | 1999-06-25 | 2003-09-30 | Nidus Medical, Llc | Apparatus and methods for treating tissue |
US6402781B1 (en) | 2000-01-31 | 2002-06-11 | Mitralife | Percutaneous mitral annuloplasty and cardiac reinforcement |
WO2004030568A2 (en) * | 2002-10-01 | 2004-04-15 | Ample Medical, Inc. | Device and method for repairing a native heart valve leaflet |
US6602288B1 (en) * | 2000-10-05 | 2003-08-05 | Edwards Lifesciences Corporation | Minimally-invasive annuloplasty repair segment delivery template, system and method of use |
US6723038B1 (en) | 2000-10-06 | 2004-04-20 | Myocor, Inc. | Methods and devices for improving mitral valve function |
US6616684B1 (en) | 2000-10-06 | 2003-09-09 | Myocor, Inc. | Endovascular splinting devices and methods |
EP1367962A4 (en) | 2001-02-05 | 2008-10-01 | Viacor Inc | Method and apparatus for improving mitral valve function |
AU2002362442B2 (en) * | 2001-10-01 | 2008-08-07 | Ample Medical, Inc. | Methods and devices for heart valve treatments |
AU2003277118A1 (en) * | 2002-10-01 | 2004-04-23 | Ample Medical, Inc. | Devices for retaining native heart valve leaflet |
DE60325634D1 (en) * | 2002-10-01 | 2009-02-12 | Ample Medical Inc | DEVICES AND SYSTEMS FOR FORMING A HEADLAP ANNULUS |
WO2005002424A2 (en) * | 2003-07-02 | 2005-01-13 | Flexcor, Inc. | Annuloplasty rings and methods for repairing cardiac valves |
CA2597066C (en) * | 2005-02-07 | 2014-04-15 | Evalve, Inc. | Methods, systems and devices for cardiac valve repair |
WO2008029296A2 (en) * | 2006-02-16 | 2008-03-13 | Endocor Pte Ltd. | Minimally invasive heart valve replacement |
-
2003
- 2003-10-01 DE DE60325634T patent/DE60325634D1/en not_active Expired - Lifetime
- 2003-10-01 CA CA002498030A patent/CA2498030A1/en not_active Abandoned
- 2003-10-01 AT AT03799343T patent/ATE418938T1/en not_active IP Right Cessation
- 2003-10-01 CN CNB2003801008335A patent/CN100553590C/en not_active Expired - Fee Related
- 2003-10-01 AU AU2003277116A patent/AU2003277116A1/en not_active Abandoned
- 2003-10-01 US US10/677,104 patent/US20060106456A9/en not_active Abandoned
- 2003-10-01 EP EP03799343A patent/EP1562522B1/en not_active Expired - Lifetime
- 2003-10-01 JP JP2004541902A patent/JP2006501033A/en active Pending
- 2003-10-01 WO PCT/US2003/030831 patent/WO2004030569A2/en active Application Filing
-
2006
- 2006-02-17 HK HK06102076.7A patent/HK1082175A1/en not_active IP Right Cessation
-
2009
- 2009-08-07 AU AU2009208049A patent/AU2009208049A1/en not_active Abandoned
- 2009-08-12 US US12/462,956 patent/US9861475B2/en active Active
Patent Citations (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US191528A (en) * | 1877-06-05 | Improvement in check-row attachments to seed-planters | ||
US4056854A (en) * | 1976-09-28 | 1977-11-08 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Aortic heart valve catheter |
US4275469A (en) * | 1979-12-13 | 1981-06-30 | Shelhigh Inc. | Prosthetic heart valve |
US4994069A (en) * | 1988-11-02 | 1991-02-19 | Target Therapeutics | Vaso-occlusion coil and method |
US5360444A (en) * | 1991-03-19 | 1994-11-01 | Kenji Kusuhara | Occluder supporter and a method of attachment thereof |
US5370685A (en) * | 1991-07-16 | 1994-12-06 | Stanford Surgical Technologies, Inc. | Endovascular aortic valve replacement |
US6338735B1 (en) * | 1991-07-16 | 2002-01-15 | John H. Stevens | Methods for removing embolic material in blood flowing through a patient's ascending aorta |
US5792155A (en) * | 1991-07-16 | 1998-08-11 | Van Cleef; Jean-Francois | Process for partially or totally flattening a vein |
US5545241A (en) * | 1995-01-17 | 1996-08-13 | Donaldson Company, Inc. | Air cleaner |
US5545241B1 (en) * | 1995-01-17 | 1999-09-28 | Donaldson Co Inc | Air cleaner |
US5855601A (en) * | 1996-06-21 | 1999-01-05 | The Trustees Of Columbia University In The City Of New York | Artificial heart valve and method and device for implanting the same |
US5716397A (en) * | 1996-12-06 | 1998-02-10 | Medtronic, Inc. | Annuloplasty device with removable stiffening element |
US20010010017A1 (en) * | 1996-12-31 | 2001-07-26 | Brice Letac | Alve prosthesis for implantation in body channels |
US20030014104A1 (en) * | 1996-12-31 | 2003-01-16 | Alain Cribier | Value prosthesis for implantation in body channels |
US6050936A (en) * | 1997-01-02 | 2000-04-18 | Myocor, Inc. | Heart wall tension reduction apparatus |
US5961440A (en) * | 1997-01-02 | 1999-10-05 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US6165119A (en) * | 1997-01-02 | 2000-12-26 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US5776189A (en) * | 1997-03-05 | 1998-07-07 | Khalid; Naqeeb | Cardiac valvular support prosthesis |
US6332893B1 (en) * | 1997-12-17 | 2001-12-25 | Myocor, Inc. | Valve to myocardium tension members device and method |
US6149695A (en) * | 1998-03-09 | 2000-11-21 | Adia; Moosa Mahomed | Abrasive body |
US6260552B1 (en) * | 1998-07-29 | 2001-07-17 | Myocor, Inc. | Transventricular implant tools and devices |
US6077214A (en) * | 1998-07-29 | 2000-06-20 | Myocor, Inc. | Stress reduction apparatus and method |
US6183411B1 (en) * | 1998-09-21 | 2001-02-06 | Myocor, Inc. | External stress reduction device and method |
US6102932A (en) * | 1998-12-15 | 2000-08-15 | Micrus Corporation | Intravascular device push wire delivery system |
US6338740B1 (en) * | 1999-01-26 | 2002-01-15 | Edwards Lifesciences Corporation | Flexible heart valve leaflets |
US6629534B1 (en) * | 1999-04-09 | 2003-10-07 | Evalve, Inc. | Methods and apparatus for cardiac valve repair |
US6312464B1 (en) * | 1999-04-28 | 2001-11-06 | NAVIA JOSé L. | Method of implanting a stentless cardiac valve prosthesis |
US6287339B1 (en) * | 1999-05-27 | 2001-09-11 | Sulzer Carbomedics Inc. | Sutureless heart valve prosthesis |
US6210432B1 (en) * | 1999-06-29 | 2001-04-03 | Jan Otto Solem | Device and method for treatment of mitral insufficiency |
US6312465B1 (en) * | 1999-07-23 | 2001-11-06 | Sulzer Carbomedics Inc. | Heart valve prosthesis with a resiliently deformable retaining member |
US6299637B1 (en) * | 1999-08-20 | 2001-10-09 | Samuel M. Shaolian | Transluminally implantable venous valve |
US20020094573A1 (en) * | 1999-10-19 | 2002-07-18 | Eugene Bell | Cardiovascular components for transplantation and methods of making thereof |
US6685739B2 (en) * | 1999-10-21 | 2004-02-03 | Scimed Life Systems, Inc. | Implantable prosthetic valve |
US6440164B1 (en) * | 1999-10-21 | 2002-08-27 | Scimed Life Systems, Inc. | Implantable prosthetic valve |
US6458153B1 (en) * | 1999-12-31 | 2002-10-01 | Abps Venture One, Ltd. | Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof |
US20010021872A1 (en) * | 1999-12-31 | 2001-09-13 | Bailey Steven R. | Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof |
US7166126B2 (en) * | 2000-02-02 | 2007-01-23 | Paul A. Spence | Heart valve repair apparatus and methods |
US20020123802A1 (en) * | 2000-02-02 | 2002-09-05 | Snyders Robert V. | Artificial heart valve, implantation instrument and method therefor |
US6537198B1 (en) * | 2000-03-21 | 2003-03-25 | Myocor, Inc. | Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly |
US6454799B1 (en) * | 2000-04-06 | 2002-09-24 | Edwards Lifesciences Corporation | Minimally-invasive heart valves and methods of use |
US20010051824A1 (en) * | 2000-04-07 | 2001-12-13 | Hopkins Richard A. | Cardiac valve replacement |
US6419695B1 (en) * | 2000-05-22 | 2002-07-16 | Shlomo Gabbay | Cardiac prosthesis for helping improve operation of a heart valve |
US20030191528A1 (en) * | 2000-06-02 | 2003-10-09 | Quijano Rodolfo C. | Expandable medical implant and percutaneous delivery |
US6702826B2 (en) * | 2000-06-23 | 2004-03-09 | Viacor, Inc. | Automated annular plication for mitral valve repair |
US6419696B1 (en) * | 2000-07-06 | 2002-07-16 | Paul A. Spence | Annuloplasty devices and related heart valve repair methods |
US20020032481A1 (en) * | 2000-09-12 | 2002-03-14 | Shlomo Gabbay | Heart valve prosthesis and sutureless implantation of a heart valve prosthesis |
US20030040792A1 (en) * | 2000-09-12 | 2003-02-27 | Shlomo Gabbay | Heart valve prosthesis and sutureless implantation of a heart valve prosthesis |
US6893459B1 (en) * | 2000-09-20 | 2005-05-17 | Ample Medical, Inc. | Heart valve annulus device and method of using same |
US6913608B2 (en) * | 2000-10-23 | 2005-07-05 | Viacor, Inc. | Automated annular plication for mitral valve repair |
US20020065554A1 (en) * | 2000-10-25 | 2002-05-30 | Streeter Richard B. | Mitral shield |
US7070618B2 (en) * | 2000-10-25 | 2006-07-04 | Viacor, Inc. | Mitral shield |
US6338470B1 (en) * | 2000-12-05 | 2002-01-15 | Kevin L. Steely | Powered lift for raising a two-wheeled vehicle |
US20020129820A1 (en) * | 2001-03-15 | 2002-09-19 | Medtronic, Inc | Annuloplasty band and method |
US6503272B2 (en) * | 2001-03-21 | 2003-01-07 | Cordis Corporation | Stent-based venous valves |
US20020138138A1 (en) * | 2001-03-23 | 2002-09-26 | Jibin Yang | Rolled minimally-invasive heart valves and methods of use |
US20040162610A1 (en) * | 2001-12-26 | 2004-08-19 | Tradinco Ab | Mitral and tricuspid vlave repair |
US6764510B2 (en) * | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
US7077862B2 (en) * | 2002-01-09 | 2006-07-18 | Myocor, Inc. | Devices and methods for heart valve treatment |
US6676699B2 (en) * | 2002-04-26 | 2004-01-13 | Medtronic Ave, Inc | Stent graft with integrated valve device and method |
US20030233022A1 (en) * | 2002-06-12 | 2003-12-18 | Vidlund Robert M. | Devices and methods for heart valve treatment |
US20040148019A1 (en) * | 2002-11-12 | 2004-07-29 | Vidlund Robert M. | Devices and methods for heart valve treatment |
US6945978B1 (en) * | 2002-11-15 | 2005-09-20 | Advanced Cardiovascular Systems, Inc. | Heart valve catheter |
US7004176B2 (en) * | 2003-10-17 | 2006-02-28 | Edwards Lifesciences Ag | Heart valve leaflet locator |
US20060241745A1 (en) * | 2005-04-21 | 2006-10-26 | Solem Jan O | Blood flow controlling apparatus |
Cited By (175)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7883539B2 (en) | 1997-01-02 | 2011-02-08 | Edwards Lifesciences Llc | Heart wall tension reduction apparatus and method |
US8267852B2 (en) | 1997-01-02 | 2012-09-18 | Edwards Lifesciences, Llc | Heart wall tension reduction apparatus and method |
US8460173B2 (en) | 1997-01-02 | 2013-06-11 | Edwards Lifesciences, Llc | Heart wall tension reduction apparatus and method |
US9861475B2 (en) * | 2000-09-20 | 2018-01-09 | Mvrx Inc. | Devices, systems, and methods for reshaping a heart valve annulus |
US20090306622A1 (en) * | 2000-09-20 | 2009-12-10 | Ample Medical, Inc. | Devices, systems, and methods for reshaping a heat valve annulus |
US7931684B2 (en) * | 2000-10-05 | 2011-04-26 | Edwards Lifesciences Corporation | Minimally-invasive annuloplasty repair segment delivery system |
US20050171601A1 (en) * | 2000-10-05 | 2005-08-04 | Cosgrove Delos M. | Minimally-invasive annuloplasty repair segment delivery system |
US9198757B2 (en) | 2000-10-06 | 2015-12-01 | Edwards Lifesciences, Llc | Methods and devices for improving mitral valve function |
US7776053B2 (en) | 2000-10-26 | 2010-08-17 | Boston Scientific Scimed, Inc. | Implantable valve system |
US8070805B2 (en) | 2002-01-09 | 2011-12-06 | Edwards Lifesciences Llc | Devices and methods for heart valve treatment |
US8506624B2 (en) | 2002-01-09 | 2013-08-13 | Edwards Lifesciences, Llc | Devices and methods for heart valve treatment |
US7678145B2 (en) | 2002-01-09 | 2010-03-16 | Edwards Lifesciences Llc | Devices and methods for heart valve treatment |
US7682385B2 (en) | 2002-04-03 | 2010-03-23 | Boston Scientific Corporation | Artificial valve |
US7666224B2 (en) | 2002-11-12 | 2010-02-23 | Edwards Lifesciences Llc | Devices and methods for heart valve treatment |
US7780627B2 (en) | 2002-12-30 | 2010-08-24 | Boston Scientific Scimed, Inc. | Valve treatment catheter and methods |
US8721717B2 (en) | 2003-12-19 | 2014-05-13 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US7854761B2 (en) | 2003-12-19 | 2010-12-21 | Boston Scientific Scimed, Inc. | Methods for venous valve replacement with a catheter |
US9301843B2 (en) | 2003-12-19 | 2016-04-05 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US8128681B2 (en) | 2003-12-19 | 2012-03-06 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US10869764B2 (en) | 2003-12-19 | 2020-12-22 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US8002824B2 (en) | 2004-09-02 | 2011-08-23 | Boston Scientific Scimed, Inc. | Cardiac valve, system, and method |
US8932349B2 (en) | 2004-09-02 | 2015-01-13 | Boston Scientific Scimed, Inc. | Cardiac valve, system, and method |
US9918834B2 (en) | 2004-09-02 | 2018-03-20 | Boston Scientific Scimed, Inc. | Cardiac valve, system and method |
US7854755B2 (en) | 2005-02-01 | 2010-12-21 | Boston Scientific Scimed, Inc. | Vascular catheter, system, and method |
US7780722B2 (en) | 2005-02-07 | 2010-08-24 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US7670368B2 (en) | 2005-02-07 | 2010-03-02 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US9808341B2 (en) | 2005-02-23 | 2017-11-07 | Boston Scientific Scimed Inc. | Valve apparatus, system and method |
US9370419B2 (en) | 2005-02-23 | 2016-06-21 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US7867274B2 (en) | 2005-02-23 | 2011-01-11 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US8512399B2 (en) | 2005-04-15 | 2013-08-20 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US7722666B2 (en) | 2005-04-15 | 2010-05-25 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US9861473B2 (en) | 2005-04-15 | 2018-01-09 | Boston Scientific Scimed Inc. | Valve apparatus, system and method |
US10912546B2 (en) | 2005-04-22 | 2021-02-09 | Laurent Schaller | Catheter-based tissue remodeling devices and methods |
US10966696B2 (en) | 2005-04-22 | 2021-04-06 | Laurent Schaller | Catheter-based tissue remodeling devices and methods |
US20060247672A1 (en) * | 2005-04-27 | 2006-11-02 | Vidlund Robert M | Devices and methods for pericardial access |
US11337812B2 (en) | 2005-06-10 | 2022-05-24 | Boston Scientific Scimed, Inc. | Venous valve, system and method |
US9028542B2 (en) | 2005-06-10 | 2015-05-12 | Boston Scientific Scimed, Inc. | Venous valve, system, and method |
US8012198B2 (en) | 2005-06-10 | 2011-09-06 | Boston Scientific Scimed, Inc. | Venous valve, system, and method |
US9474609B2 (en) | 2005-09-21 | 2016-10-25 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US8672997B2 (en) | 2005-09-21 | 2014-03-18 | Boston Scientific Scimed, Inc. | Valve with sinus |
US8460365B2 (en) | 2005-09-21 | 2013-06-11 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US10548734B2 (en) | 2005-09-21 | 2020-02-04 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US7951189B2 (en) | 2005-09-21 | 2011-05-31 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US7799038B2 (en) | 2006-01-20 | 2010-09-21 | Boston Scientific Scimed, Inc. | Translumenal apparatus, system, and method |
US9101468B2 (en) | 2006-03-01 | 2015-08-11 | Cook Medical Technologies Llc | Methods of reducing retrograde flow |
US7648527B2 (en) | 2006-03-01 | 2010-01-19 | Cook Incorporated | Methods of reducing retrograde flow |
US20070208417A1 (en) * | 2006-03-01 | 2007-09-06 | Cook Incorporated | Methods of reducing retrograde flow |
US20100131053A1 (en) * | 2006-03-01 | 2010-05-27 | Cook Incorporated | Methods of reducing retrograde flow |
US8323332B2 (en) | 2006-03-01 | 2012-12-04 | Cook Medical Technologies Llc | Methods of reducing retrograde flow |
US20120191182A1 (en) * | 2006-06-01 | 2012-07-26 | Edwards Lifesciences Corporation | Prosthetic insert for treating a mitral valve |
US8968395B2 (en) * | 2006-06-01 | 2015-03-03 | Edwards Lifesciences Corporation | Prosthetic insert for treating a mitral valve |
US20080126131A1 (en) * | 2006-07-17 | 2008-05-29 | Walgreen Co. | Predictive Modeling And Risk Stratification Of A Medication Therapy Regimen |
US20100249920A1 (en) * | 2007-01-08 | 2010-09-30 | Millipede Llc | Reconfiguring heart features |
US9192471B2 (en) * | 2007-01-08 | 2015-11-24 | Millipede, Inc. | Device for translumenal reshaping of a mitral valve annulus |
US8133270B2 (en) | 2007-01-08 | 2012-03-13 | California Institute Of Technology | In-situ formation of a valve |
US20090182419A1 (en) * | 2007-01-08 | 2009-07-16 | Millipede Llc | Reconfiguring heart features |
US8348999B2 (en) | 2007-01-08 | 2013-01-08 | California Institute Of Technology | In-situ formation of a valve |
US20080167713A1 (en) * | 2007-01-08 | 2008-07-10 | Bolling Steven F | Reconfiguring Heart Features |
US20100121433A1 (en) * | 2007-01-08 | 2010-05-13 | Millipede Llc, A Corporation Of Michigan | Reconfiguring heart features |
US11504239B2 (en) | 2007-02-05 | 2022-11-22 | Boston Scientific Scimed, Inc. | Percutaneous valve, system and method |
US8470023B2 (en) | 2007-02-05 | 2013-06-25 | Boston Scientific Scimed, Inc. | Percutaneous valve, system, and method |
US10226344B2 (en) | 2007-02-05 | 2019-03-12 | Boston Scientific Scimed, Inc. | Percutaneous valve, system and method |
US9421083B2 (en) | 2007-02-05 | 2016-08-23 | Boston Scientific Scimed Inc. | Percutaneous valve, system and method |
US7967853B2 (en) | 2007-02-05 | 2011-06-28 | Boston Scientific Scimed, Inc. | Percutaneous valve, system and method |
US8828079B2 (en) | 2007-07-26 | 2014-09-09 | Boston Scientific Scimed, Inc. | Circulatory valve, system and method |
US8414641B2 (en) | 2007-12-21 | 2013-04-09 | Boston Scientific Scimed, Inc. | Valve with delayed leaflet deployment |
US8137394B2 (en) | 2007-12-21 | 2012-03-20 | Boston Scientific Scimed, Inc. | Valve with delayed leaflet deployment |
US7892276B2 (en) | 2007-12-21 | 2011-02-22 | Boston Scientific Scimed, Inc. | Valve with delayed leaflet deployment |
US9168137B2 (en) | 2008-04-16 | 2015-10-27 | Heart Repair Technologies, Inc. | Transvalvular intraannular band for aortic valve repair |
US10456259B2 (en) | 2008-04-16 | 2019-10-29 | Heart Repair Technologies, Inc. | Transvalvular intraannular band for mitral valve repair |
US20090264995A1 (en) * | 2008-04-16 | 2009-10-22 | Subramanian Valavanur A | Transvalvular intraannular band for valve repair |
US20100076550A1 (en) * | 2008-04-16 | 2010-03-25 | Cardiovascular Technologies, Llc | Transvalvular intraannular band for valve repair |
US20100121435A1 (en) * | 2008-04-16 | 2010-05-13 | Cardiovascular Technologies, Llc | Percutaneous transvalvular intrannular band for mitral valve repair |
US11013599B2 (en) | 2008-04-16 | 2021-05-25 | Heart Repair Technologies, Inc. | Percutaneous transvalvular intraannular band for mitral valve repair |
US11083579B2 (en) | 2008-04-16 | 2021-08-10 | Heart Repair Technologies, Inc. | Transvalvular intraanular band and chordae cutting for ischemic and dilated cardiomyopathy |
US20100121437A1 (en) * | 2008-04-16 | 2010-05-13 | Cardiovascular Technologies, Llc | Transvalvular intraannular band and chordae cutting for ischemic and dilated cardiomyopathy |
US8961597B2 (en) | 2008-04-16 | 2015-02-24 | Heart Repair Technologies, Inc. | Percutaneous transvalvular intraannular band for mitral valve repair |
US8262725B2 (en) | 2008-04-16 | 2012-09-11 | Cardiovascular Technologies, Llc | Transvalvular intraannular band for valve repair |
US9468526B2 (en) | 2008-04-16 | 2016-10-18 | Heart Repair Technologies, Inc. | Percutaneous transvalvular intraannular band for mitral valve repair |
US8956406B2 (en) | 2008-04-16 | 2015-02-17 | Heart Repair Technologies, Inc. | Transvalvular intraanular band and chordae cutting for ischemic and dilated cardiomyopathy |
US10219903B2 (en) | 2008-04-16 | 2019-03-05 | Heart Repair Technologies, Inc. | Transvalvular intraanular band and chordae cutting for ischemic and dilated cardiomyopathy |
US8480732B2 (en) | 2008-04-16 | 2013-07-09 | Heart Repair Technologies, Inc. | Transvalvular intraannular band for valve repair |
US20100131057A1 (en) * | 2008-04-16 | 2010-05-27 | Cardiovascular Technologies, Llc | Transvalvular intraannular band for aortic valve repair |
US10238488B2 (en) | 2008-04-16 | 2019-03-26 | Heart Repair Technologies, Inc. | Percutaneous transvalvular intraannular band for mitral valve repair |
US9585753B2 (en) | 2008-04-16 | 2017-03-07 | Heart Repair Technologies, Inc. | Transvalvular intraannular band for valve repair |
US9615925B2 (en) | 2008-04-16 | 2017-04-11 | Heart Repair Technologies, Inc. | Transvalvular intraanular band for ischemic and dilated cardiomyopathy |
US8163010B1 (en) | 2008-06-03 | 2012-04-24 | Cardica, Inc. | Staple-based heart valve treatment |
US8888794B2 (en) | 2010-06-16 | 2014-11-18 | Cardica, Inc. | Mitral valve treatment |
US8496671B1 (en) | 2010-06-16 | 2013-07-30 | Cardica, Inc. | Mitral valve treatment |
US9795480B2 (en) | 2010-08-24 | 2017-10-24 | Millipede, Inc. | Reconfiguring tissue features of a heart annulus |
US10517725B2 (en) | 2010-12-23 | 2019-12-31 | Twelve, Inc. | System for mitral valve repair and replacement |
US11571303B2 (en) | 2010-12-23 | 2023-02-07 | Twelve, Inc. | System for mitral valve repair and replacement |
US9770331B2 (en) | 2010-12-23 | 2017-09-26 | Twelve, Inc. | System for mitral valve repair and replacement |
US9421098B2 (en) | 2010-12-23 | 2016-08-23 | Twelve, Inc. | System for mitral valve repair and replacement |
EP2478868A1 (en) | 2011-01-25 | 2012-07-25 | The Provost, Fellows, Foundation Scholars, and the other Members of Board, of the College of the Holy and Undivided Trinity of Queen Elizabeth | Implant device |
WO2012101190A1 (en) | 2011-01-25 | 2012-08-02 | The Provost, Fellows, Foundation Scholars, And The Other Members Of Board, Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | Implant device |
US10028827B2 (en) | 2011-06-21 | 2018-07-24 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
US10751173B2 (en) | 2011-06-21 | 2020-08-25 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
US9125740B2 (en) | 2011-06-21 | 2015-09-08 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
US9572662B2 (en) | 2011-06-21 | 2017-02-21 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
US9579196B2 (en) | 2011-06-21 | 2017-02-28 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
US9585751B2 (en) | 2011-06-21 | 2017-03-07 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
US10034750B2 (en) | 2011-06-21 | 2018-07-31 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
US11712334B2 (en) | 2011-06-21 | 2023-08-01 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
US11523900B2 (en) | 2011-06-21 | 2022-12-13 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
US9668859B2 (en) | 2011-08-05 | 2017-06-06 | California Institute Of Technology | Percutaneous heart valve delivery systems |
US11202704B2 (en) | 2011-10-19 | 2021-12-21 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US9295552B2 (en) | 2011-10-19 | 2016-03-29 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US9655722B2 (en) | 2011-10-19 | 2017-05-23 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US11826249B2 (en) | 2011-10-19 | 2023-11-28 | Twelve, Inc. | Devices, systems and methods for heart valve replacement |
US10052204B2 (en) | 2011-10-19 | 2018-08-21 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US9901443B2 (en) | 2011-10-19 | 2018-02-27 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US11617648B2 (en) | 2011-10-19 | 2023-04-04 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US11497603B2 (en) | 2011-10-19 | 2022-11-15 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US10702380B2 (en) | 2011-10-19 | 2020-07-07 | Twelve, Inc. | Devices, systems and methods for heart valve replacement |
US10299927B2 (en) | 2011-10-19 | 2019-05-28 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US10299917B2 (en) | 2011-10-19 | 2019-05-28 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US10945835B2 (en) | 2011-10-19 | 2021-03-16 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US10335278B2 (en) | 2011-10-19 | 2019-07-02 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US9039757B2 (en) | 2011-10-19 | 2015-05-26 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US10016271B2 (en) | 2011-10-19 | 2018-07-10 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US9763780B2 (en) | 2011-10-19 | 2017-09-19 | Twelve, Inc. | Devices, systems and methods for heart valve replacement |
US9034032B2 (en) | 2011-10-19 | 2015-05-19 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US9034033B2 (en) | 2011-10-19 | 2015-05-19 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US11628063B2 (en) | 2011-10-19 | 2023-04-18 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US11197758B2 (en) | 2011-10-19 | 2021-12-14 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US10940167B2 (en) | 2012-02-10 | 2021-03-09 | Cvdevices, Llc | Methods and uses of biological tissues for various stent and other medical applications |
US11129714B2 (en) | 2012-03-01 | 2021-09-28 | Twelve, Inc. | Hydraulic delivery systems for prosthetic heart valve devices and associated methods |
US9579198B2 (en) | 2012-03-01 | 2017-02-28 | Twelve, Inc. | Hydraulic delivery systems for prosthetic heart valve devices and associated methods |
US10258468B2 (en) | 2012-03-01 | 2019-04-16 | Twelve, Inc. | Hydraulic delivery systems for prosthetic heart valve devices and associated methods |
US10543088B2 (en) | 2012-09-14 | 2020-01-28 | Boston Scientific Scimed, Inc. | Mitral valve inversion prostheses |
US10849755B2 (en) | 2012-09-14 | 2020-12-01 | Boston Scientific Scimed, Inc. | Mitral valve inversion prostheses |
US11406495B2 (en) | 2013-02-11 | 2022-08-09 | Cook Medical Technologies Llc | Expandable support frame and medical device |
US9744037B2 (en) | 2013-03-15 | 2017-08-29 | California Institute Of Technology | Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves |
US11234821B2 (en) | 2013-05-20 | 2022-02-01 | Twelve, Inc. | Implantable heart valve devices, mitral valve repair devices and associated systems and methods |
US10111747B2 (en) | 2013-05-20 | 2018-10-30 | Twelve, Inc. | Implantable heart valve devices, mitral valve repair devices and associated systems and methods |
US9615926B2 (en) | 2014-07-17 | 2017-04-11 | Millipede, Inc. | Adjustable endolumenal implant for reshaping the mitral valve annulus |
US10695160B2 (en) | 2014-07-17 | 2020-06-30 | Boston Scientific Scimed, Inc. | Adjustable endolumenal implant for reshaping the mitral valve annulus |
US10136985B2 (en) | 2014-07-17 | 2018-11-27 | Millipede, Inc. | Method of reconfiguring a mitral valve annulus |
US9180005B1 (en) | 2014-07-17 | 2015-11-10 | Millipede, Inc. | Adjustable endolumenal mitral valve ring |
US9622862B2 (en) | 2014-07-17 | 2017-04-18 | Millipede, Inc. | Prosthetic mitral valve with adjustable support |
US9913706B2 (en) | 2014-07-17 | 2018-03-13 | Millipede, Inc. | Adjustable endolumenal implant for reshaping the mitral valve annulus |
US9848983B2 (en) | 2015-02-13 | 2017-12-26 | Millipede, Inc. | Valve replacement using rotational anchors |
US11918462B2 (en) | 2015-02-13 | 2024-03-05 | Boston Scientific Scimed, Inc. | Valve replacement using moveable restraints and angled struts |
US10258466B2 (en) | 2015-02-13 | 2019-04-16 | Millipede, Inc. | Valve replacement using moveable restrains and angled struts |
US11166817B2 (en) | 2015-06-01 | 2021-11-09 | Edwards Lifesciences Corporation | Cardiac valve repair devices configured for percutaneous delivery |
US10278819B2 (en) | 2015-06-01 | 2019-05-07 | Edwards Lifesciences Corporation | Cardiac valve repair devices configured for percutaneous delivery |
US11576782B2 (en) | 2015-08-21 | 2023-02-14 | Twelve, Inc. | Implantable heart valve devices, mitral valve repair devices and associated systems and methods |
US10238490B2 (en) | 2015-08-21 | 2019-03-26 | Twelve, Inc. | Implant heart valve devices, mitral valve repair devices and associated systems and methods |
US10820996B2 (en) | 2015-08-21 | 2020-11-03 | Twelve, Inc. | Implantable heart valve devices, mitral valve repair devices and associated systems and methods |
US10335275B2 (en) | 2015-09-29 | 2019-07-02 | Millipede, Inc. | Methods for delivery of heart valve devices using intravascular ultrasound imaging |
US10555813B2 (en) | 2015-11-17 | 2020-02-11 | Boston Scientific Scimed, Inc. | Implantable device and delivery system for reshaping a heart valve annulus |
US11033390B2 (en) | 2016-04-29 | 2021-06-15 | Medtronic Vascular, Inc. | Prosthetic heart valve devices with tethered anchors and associated systems and methods |
US10265172B2 (en) | 2016-04-29 | 2019-04-23 | Medtronic Vascular, Inc. | Prosthetic heart valve devices with tethered anchors and associated systems and methods |
US11191656B2 (en) | 2016-05-16 | 2021-12-07 | Elixir Medical Corporation | Methods and devices for heart valve repair |
US10973662B2 (en) | 2016-05-16 | 2021-04-13 | Elixir Medical Corporation | Methods and devices for heart valve repair |
US20200146854A1 (en) * | 2016-05-16 | 2020-05-14 | Elixir Medical Corporation | Methods and devices for heart valve repair |
US11033391B2 (en) | 2016-12-22 | 2021-06-15 | Heart Repair Technologies, Inc. | Percutaneous delivery systems for anchoring an implant in a cardiac valve annulus |
US11986391B2 (en) | 2016-12-22 | 2024-05-21 | Heart Repair Technologies, Inc. | Percutaneous delivery systems for anchoring an implant in a cardiac valve annulus |
US10548731B2 (en) | 2017-02-10 | 2020-02-04 | Boston Scientific Scimed, Inc. | Implantable device and delivery system for reshaping a heart valve annulus |
US11737873B2 (en) | 2017-04-18 | 2023-08-29 | Twelve, Inc. | Hydraulic systems for delivering prosthetic heart valve devices and associated methods |
US11654021B2 (en) | 2017-04-18 | 2023-05-23 | Twelve, Inc. | Prosthetic heart valve device and associated systems and methods |
US10433961B2 (en) | 2017-04-18 | 2019-10-08 | Twelve, Inc. | Delivery systems with tethers for prosthetic heart valve devices and associated methods |
US10575950B2 (en) | 2017-04-18 | 2020-03-03 | Twelve, Inc. | Hydraulic systems for delivering prosthetic heart valve devices and associated methods |
US11389295B2 (en) | 2017-04-18 | 2022-07-19 | Twelve, Inc. | Delivery systems with tethers for prosthetic heart valve devices and associated methods |
US10702378B2 (en) | 2017-04-18 | 2020-07-07 | Twelve, Inc. | Prosthetic heart valve device and associated systems and methods |
US11786370B2 (en) | 2017-05-11 | 2023-10-17 | Twelve, Inc. | Delivery systems for delivering prosthetic heart valve devices and associated methods |
US10792151B2 (en) | 2017-05-11 | 2020-10-06 | Twelve, Inc. | Delivery systems for delivering prosthetic heart valve devices and associated methods |
US10646338B2 (en) | 2017-06-02 | 2020-05-12 | Twelve, Inc. | Delivery systems with telescoping capsules for deploying prosthetic heart valve devices and associated methods |
US11559398B2 (en) | 2017-06-02 | 2023-01-24 | Twelve, Inc. | Delivery systems with telescoping capsules for deploying prosthetic heart valve devices and associated methods |
US10709591B2 (en) | 2017-06-06 | 2020-07-14 | Twelve, Inc. | Crimping device and method for loading stents and prosthetic heart valves |
US11464659B2 (en) | 2017-06-06 | 2022-10-11 | Twelve, Inc. | Crimping device for loading stents and prosthetic heart valves |
US10729541B2 (en) | 2017-07-06 | 2020-08-04 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
US10786352B2 (en) | 2017-07-06 | 2020-09-29 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
US11877926B2 (en) | 2017-07-06 | 2024-01-23 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
Also Published As
Publication number | Publication date |
---|---|
WO2004030569A2 (en) | 2004-04-15 |
CN100553590C (en) | 2009-10-28 |
US20090306622A1 (en) | 2009-12-10 |
AU2009208049A1 (en) | 2009-08-27 |
EP1562522A2 (en) | 2005-08-17 |
JP2006501033A (en) | 2006-01-12 |
US20040127982A1 (en) | 2004-07-01 |
US9861475B2 (en) | 2018-01-09 |
EP1562522B1 (en) | 2008-12-31 |
ATE418938T1 (en) | 2009-01-15 |
CN1703176A (en) | 2005-11-30 |
DE60325634D1 (en) | 2009-02-12 |
CA2498030A1 (en) | 2004-04-15 |
AU2003277116A1 (en) | 2004-04-23 |
WO2004030569A3 (en) | 2004-12-29 |
HK1082175A1 (en) | 2006-06-02 |
EP1562522A4 (en) | 2007-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9861475B2 (en) | Devices, systems, and methods for reshaping a heart valve annulus | |
JP7469395B2 (en) | IMPLANTABLE HEART VALVE DEVICES, MITRAL VALVE REPAIR DEVICES, AND RELATED SYSTEMS AND METHODS | |
US20200352707A1 (en) | Implantable heart valve devices, mitral valve repair devices and associated systems and methods | |
EP1748745B1 (en) | Devices, systems, and methods for reshaping a heart valve annulus | |
US9504570B2 (en) | Device and method for reshaping tricuspid valve annulus | |
US7527646B2 (en) | Devices, systems, and methods for retaining a native heart valve leaflet | |
CA2910751C (en) | Heart valve assistive prosthesis | |
US7381220B2 (en) | Devices, systems, and methods for supplementing, repairing, or replacing a native heart valve leaflet | |
AU2018449153A1 (en) | Leaflet extension for cardiac valve leaflet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: AMPLE MEDICAL, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:RAHDERT, DAVID A.;MACOVIAK, JOHN A.;MACHOLD, TIMOTHY R.;AND OTHERS;REEL/FRAME:014759/0215 Effective date: 20031106 |
|
AS | Assignment |
Owner name: VENTURE LENDING & LEASING IV, INC., CALIFORNIA Free format text: SECURITY INTEREST;ASSIGNOR:AMPLE MEDICAL, INC.;REEL/FRAME:016127/0400 Effective date: 20041217 |
|
AS | Assignment |
Owner name: VENTURE LENDING & LEASING IV, INC. AND VENTURE LEN Free format text: SECURITY INTEREST;ASSIGNOR:AMPLE MEDICAL, INC.;REEL/FRAME:020814/0208 Effective date: 20080328 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: VENTURE LENDING & LEASING V, INC.,CALIFORNIA Free format text: PATENT TRANSFER STATEMENT (UNDER UNIFORM COMMERCIAL CODE SECTION 9-619);ASSIGNOR:AMPLE MEDICAL, INC.;REEL/FRAME:023699/0672 Effective date: 20091130 Owner name: VENTURE LENDING & LEASING IV, INC.,CALIFORNIA Free format text: PATENT TRANSFER STATEMENT (UNDER UNIFORM COMMERCIAL CODE SECTION 9-619);ASSIGNOR:AMPLE MEDICAL, INC.;REEL/FRAME:023699/0672 Effective date: 20091130 Owner name: VENTURE LENDING & LEASING V, INC., CALIFORNIA Free format text: PATENT TRANSFER STATEMENT (UNDER UNIFORM COMMERCIAL CODE SECTION 9-619);ASSIGNOR:AMPLE MEDICAL, INC.;REEL/FRAME:023699/0672 Effective date: 20091130 Owner name: VENTURE LENDING & LEASING IV, INC., CALIFORNIA Free format text: PATENT TRANSFER STATEMENT (UNDER UNIFORM COMMERCIAL CODE SECTION 9-619);ASSIGNOR:AMPLE MEDICAL, INC.;REEL/FRAME:023699/0672 Effective date: 20091130 |
|
AS | Assignment |
Owner name: MVRX, INC., CALIFORNIA Free format text: BILL OF SALE;ASSIGNORS:VENTURE LENDING & LEASING IV, INC.;VENTURE LENDING & LEASING V, INC.;REEL/FRAME:023882/0030 Effective date: 20091130 Owner name: MVRX, INC.,CALIFORNIA Free format text: BILL OF SALE;ASSIGNORS:VENTURE LENDING & LEASING IV, INC.;VENTURE LENDING & LEASING V, INC.;REEL/FRAME:023882/0030 Effective date: 20091130 |
|
AS | Assignment |
Owner name: VENTURE LENDING & LEASING IV, INC., CALIFORNIA Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE SIGNATURES ON THE ORIGINALLY DOCUMENT PREVIOUSLY RECORDED AT REEL: 020814 FRAME: 0208. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT/SECURITY AGREEMENT;ASSIGNOR:AMPLE MEDICAL, INC.;REEL/FRAME:037974/0732 Effective date: 20080328 Owner name: VENTURE LENDING & LEASING IV, INC., CALIFORNIA Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE OMISSION OF PAGE 3 IN THE ORIGINAL FILED DOCUMENT PREVIOUSLY RECORDED AT REEL: 016127 FRAME: 0400. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT;ASSIGNOR:AMPLE MEDICAL, INC.;REEL/FRAME:037974/0803 Effective date: 20041217 Owner name: VENTURE LENDING & LEASING V, INC., CALIFORNIA Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE SIGNATURES ON THE ORIGINALLY DOCUMENT PREVIOUSLY RECORDED AT REEL: 020814 FRAME: 0208. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT/SECURITY AGREEMENT;ASSIGNOR:AMPLE MEDICAL, INC.;REEL/FRAME:037974/0732 Effective date: 20080328 |